cx	cy	x	y	score	nptumor	nphit	tumor	name	status
240.35207910080698	9.62956855427723	195.20864185639448	-7.1142725304619	0.0004	153	25	BLCA	LY2183240	Experimental
756.3527808927612	-78.0579763649379	747.1953854196257	-12.4945598436007	0.592	264	112	SKCM	GSK2636771	Clinical trials in cancer
239.87140598005644	15.8869200498997	207.2769533761723	-26.1433325367684	0.0006	512	77	UCEC	PURVALANOL A	Experimental
215.5015377914662	-32.6714409496238	210.527671723408	-6.27632937655858	0.0006	502	53	KIRC	FENOXAPROP-ETHYL	Experimental
259.04782654609926	24.0861754611095	224.6532262403772	14.4893972003705	0.0006	512	77	UCEC	CHEMBL1221699	Experimental
201.3148125513821	-63.8511714794108	209.3681069209098	19.0302122769554	0.0008	423	88	COAD	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
171.62538101180053	14.2029024296853	214.1917301556881	4.51697154163503	0.0006	502	53	KIRC	CHEMBL232827	Experimental
257.78936914790114	80.7194338867193	225.63592485835647	9.11797014015991	0.0006	57	24	PAAD	DB07788	Experimental
770.037379797034	-37.3419810243956	726.7938990985768	-26.8737900034007	0.594	264	48	SKCM	ENMD-2076	Clinical trials in cancer
704.3125970302875	57.3598716514314	744.6573842867522	14.1051779123077	0.596	169	44	READ	BINIMETINIB	Clinical trials in cancer
840.0739963677353	3.02105784496234	839.9999776918339	0.00029048172768853	0.711	502	53	KIRC	DEXAMETHASONE	Approved in other pathologies and in clinical trials in cancer
190.02613031469767	63.1742042500346	219.53090099311387	7.21236200789201	0.0004	169	46	READ	LY2183240	Experimental
713.9752214066764	-13.825029424677	722.5830265943538	0.347038067584265	0.591	512	55	UCEC	TAK-593	Clinical trials in cancer
476.2076583939799	6.45190887473018	481.55333478203727	-2.11456039164455	0.311	202	29	LAML	PEGADEMASE BOVINE	Approved in other pathologies
566.4011883369745	-11.2716002142204	564.8924036294466	0.568821411135104	0.412	934	214	BRCA	ZSTK474	Clinical trials in cancer
361.51968757869946	-0.399317798508378	357.4147720971334	8.23337041358991	0.181	264	33	SKCM	ELLAGIC ACID	Clinical trials
649.8597088277587	10.6704129846726	686.0915990023844	-5.97213026107625	0.523	202	53	LAML	COPANLISIB	Clinical trials in cancer
721.2803969091476	-13.5947243641576	713.3570394904608	15.1246493926137	0.583	423	70	COAD	NAVITOCLAX	Clinical trials in cancer
603.9638844027521	-28.8994111895888	667.0675201349969	-6.73053393360169	0.521	599	107	OV	S-8184	Clinical trials in cancer
184.68313565186813	76.6715441772346	170.06294331630156	15.4763544613122	0.0006	435	211	THCA	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
749.464604616015	-49.2955932407098	724.18061805339	7.17009042291215	0.585	543	74	LUAD	XL147	Clinical trials in cancer
686.7618808163855	36.9298715596517	678.5129747802548	-18.7076635424037	0.522	202	53	LAML	XL147	Clinical trials in cancer
548.3134908825846	5.24486675584569	547.1027834238205	-0.0039110287711992	0.384	292	39	STAD	IBUPROFEN	Approved in other pathologies
190.38604286929285	-29.3147450969482	212.19579301324427	-10.2977254073223	0.0006	502	56	KIRC	130974-86-6	Experimental
196.1309682509022	39.7725385107205	212.76707139232087	-28.4133016703694	0.0006	512	75	UCEC	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
184.0447713436674	9.95323236250545	198.15535377182778	11.9836010481583	0.0006	202	30	LAML	GUANOSINE TRIPHOSPHATE	Experimental
235.1492157004428	-60.1716406335883	194.1638126368611	7.52913952910217	0.0004	343	44	HNSC	WORTMANNIN	Experimental
653.7920756795812	-93.4289224119672	689.7980077945846	-13.4300988317657	0.512	435	211	THCA	BI847325	Clinical trials in cancer
230.7961043039184	-0.345239632891719	194.14310819094973	0.709644351207317	0.0008	292	43	STAD	PI-103	Experimental
215.88716839972128	22.9912004864599	212.6043760174534	0.720149425080763	0.0008	543	74	LUAD	PI-103	Experimental
762.6134241715632	-13.6291528042717	717.5970085529176	-3.94139010404422	0.573	599	70	GBM	GDC-0980	Clinical trials in cancer
168.9549223498071	-55.4654132873489	206.7523525033739	4.82998815863857	0.0008	423	88	COAD	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
761.24630375436	-28.4553441675586	731.8195808985798	-4.84211606152371	0.592	343	62	HNSC	GSK2636771	Clinical trials in cancer
301.6966350609693	68.9341724164784	206.3539752465842	-31.7120639166901	0.0004	264	104	SKCM	UNC0638	Experimental
173.50353680936257	86.7749831138314	194.13130782519673	1.07850368232107	0.0006	169	43	READ	DB07788	Experimental
207.12146223062325	26.9956405149501	195.62767960759322	-9.02914120698756	0.0006	202	29	LAML	CHEMBL291678	Experimental
159.43319740756118	34.3771309571746	187.57644624229928	-4.29486883084473	0.0004	543	65	LUAD	NUTLIN-3A	Experimental
704.2985877998682	-17.9257377733346	722.9126542008001	11.0930056343886	0.584	264	28	SKCM	SARACATINIB	Clinical trials in cancer
208.74970204205073	16.3659674278729	189.617971106913	-14.8475136057875	0.0006	502	56	KIRC	5-NITROINDAZOLE	Experimental
198.16725663479005	-47.753061372091	177.17523993510358	-8.2225191178668	0.0004	264	49	SKCM	PIPERLONGUMINE	Experimental
747.2654768682171	-17.2719621630075	732.993980340681	14.3083582859201	0.592	343	63	HNSC	NVP-BGJ398	Clinical trials in cancer
703.103853667932	-22.6608494043324	732.3667151629916	29.4605646636674	0.585	264	35	SKCM	MOTESANIB	Clinical trials in cancer
133.46146852591943	25.7750641972437	161.28664355489727	35.3542803342166	0.0006	264	114	SKCM	PI-103	Experimental
356.1427512681888	-19.7420338420529	367.0185082370994	6.55951448267609	0.182	512	77	UCEC	JSM 6427	Clinical trials
622.1824166198287	-44.6495732618634	638.9822131629298	0.733723983768698	0.491	512	74	UCEC	INDISULAM	Clinical trials in cancer
714.6846373324207	-40.5989437764922	701.1832343589024	-2.52898230543326	0.562	599	68	GBM	GSK2636771	Clinical trials in cancer
220.92414454013283	9.70486849952863	203.8017657416475	3.20410908771214	0.0006	202	30	LAML	N,N&#39;-DIMETHYL-N-(ACETYL)-N&#39;-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE	Experimental
1015.6407697963332	-15.3553948266213	1027.818645326397	4.89365037545076	0.92	934	223	BRCA	TEMSIROLIMUS	Approved in cancer
1108.833164749789	48.0785038528131	1099.369029954427	-44.3918531082459	1	264	198	SKCM	SORAFENIB	Approved in cancer
1087.0988795248732	-18.5381525318911	1095.9275756049215	12.7350224651832	0.998	264	30	SKCM	IMATINIB	Approved in cancer
171.65661428177907	-22.4046570204537	197.79844605856607	2.48307252446602	0.0006	264	41	SKCM	1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA	Experimental
367.3981575934537	-5.47575864845302	368.8643347957812	-2.45359205822979	0.182	264	35	SKCM	KC706	Clinical trials
683.4161579848253	8.54312598519289	668.6653867428014	-8.3631562672449	0.521	502	58	KIRC	TAK-593	Clinical trials in cancer
340.40749450495525	35.4398994735825	291.48553045498875	1.83389097647068	0.111	57	24	PAAD	LAX-101	Clinical trials
686.7747276177764	-24.1874403038846	673.1248203339223	6.27010221267437	0.533	934	105	BRCA	OBLIMERSEN	Clinical trials in cancer
1024.7279322624754	8.31494269513564	1035.3133260010623	-3.86031473270759	0.928	202	32	LAML	TRAMETINIB	Approved in cancer
777.3429060646773	0.901059740850627	728.3773759734897	-8.83907404219644	0.594	292	43	STAD	XL147	Clinical trials in cancer
696.0184433327643	-15.4124512045992	733.667518116999	12.5758900199849	0.581	423	65	COAD	S-8184	Clinical trials in cancer
677.4213154911764	47.1623197313558	727.5244310551213	-4.59610284404687	0.592	389	42	LUSC	GSK2636771	Clinical trials in cancer
573.7094143486297	8.36028851317593	573.9781370019446	-0.647651385740119	0.412	934	214	BRCA	1312445-63-8	Clinical trials in cancer
844.8092116922102	3.72352947788909	849.9807947669756	2.45034678881416	0.722	502	57	KIRC	ZIV-AFLIBERCEPT	Approved in other pathologies and in clinical trials in cancer
745.5292706954103	-37.7376065538467	719.9928229097532	18.6472299752304	0.596	423	89	COAD	REFAMETINIB	Clinical trials in cancer
190.37584551432624	-39.0500369002483	201.36726965881073	25.4913057318367	0.0006	264	35	SKCM	2-FLUORO-4-[4-(4-FLUOROPHENYL)-1H-PYRAZOL-3-YL]PYRIDINE	Experimental
830.6217492950756	23.7756679833568	738.9438592169513	22.8281617901754	0.596	169	44	READ	REFAMETINIB	Clinical trials in cancer
271.4879940184198	39.1405875402804	166.1706885822405	-0.3424016941388	0.0006	512	77	UCEC	CHEMBL25826	Experimental
923.111101263879	-7.02537499882598	939.999962550114	3.99895279770135e-05	0.822	264	106	SKCM	DABRAFENIB MESYLATE	Approved in same tumor type
193.95659540457487	35.5706724947693	189.713054074074	8.98609556444308	0.0004	512	58	UCEC	ZEBULARINE	Experimental
212.3009991858567	0.655611139113745	207.9381993817871	-9.64154169343237	0.0006	502	53	KIRC	ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	Experimental
247.41797973356853	93.8124830194681	229.51319193465446	-24.2990090288858	0.0006	57	24	PAAD	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	Experimental
172.6784231776453	-38.0329219222153	204.47537539439483	-16.80999153414	0.0006	423	63	COAD	DB07268	Experimental
182.94340067182608	20.1771739818259	204.01687942833354	10.0175648119771	0.0006	502	53	KIRC	SODIUM	Experimental
180.64713677373362	35.19090253526	172.3780281006089	-2.2675694260617	0.0006	512	70	UCEC	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
243.72874512668244	52.2212780706459	169.60875085531487	-14.1256669787868	0.0006	57	24	PAAD	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
1084.2740116347247	-9.19233617921034	1091.00035294969	-1.76729005284869	0.99	153	18	BLCA	SORAFENIB	Approved in cancer
518.8290721577981	2.60258088884785	518.7008129049965	4.08484184714166	0.351	343	84	HNSC	IBUPROFEN	Approved in other pathologies
159.83162752967777	12.5080046353697	178.91584533208788	1.94044362280124	0.0006	502	53	KIRC	CHEMBL293212	Experimental
196.0260874902077	49.991249136343	189.34148248122386	-6.09030391585964	0.0006	512	77	UCEC	RU78300	Experimental
173.0665294516296	-32.3566734505308	193.0153209311208	22.4956403663991	0.0006	264	35	SKCM	CHEMBL29641	Experimental
236.37729392771405	98.4134637254447	235.23226461263368	14.3284889027533	0.021	512	91	UCEC	TRIPTOLIDE	Clinical trials
233.07551037379616	-55.8147598812314	209.6983897495472	-14.0605487483901	0.0008	502	58	KIRC	CEP-7055	Experimental
474.12806473163107	-6.78736671992124	474.9134364623326	-3.24991145032845	0.311	502	56	KIRC	SAPROPTERIN	Approved in other pathologies
1079.1157643787408	-6.29361917218731	1093.4766247615921	7.04232130016948	0.997	512	91	UCEC	REGORAFENIB	Approved in cancer
280.03655912601243	-19.0897895499757	299.5663120862923	0.486848108350841	0.111	502	53	KIRC	TBC 3711	Clinical trials
1089.0455789780872	3.68826668387618	1085.87512455017	-2.65120739237204	0.983	153	21	BLCA	REGORAFENIB	Approved in cancer
180.0697192940205	29.4198284956373	187.42926789706354	-4.94033634570906	0.0006	202	32	LAML	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
1041.0477198525662	-2.67490783370434	1034.3641159024187	-2.48517533442191	0.93	343	47	HNSC	TEMSIROLIMUS	Approved in cancer
185.30511482094636	-40.324672539949	197.7972390713861	-7.48153854730617	0.0004	423	58	COAD	NUTLIN-3A	Experimental
176.85496153937535	66.745904272528	169.40397440211459	-11.9358713005568	0.0006	512	78	UCEC	CHEMBL205098	Experimental
781.422360599697	-32.405365014762	733.0531449410881	-0.885546930652708	0.592	153	26	BLCA	GDC-0980	Clinical trials in cancer
675.0467685255985	6.86658677089179	668.4789606139294	2.26650285538062	0.523	343	52	HNSC	RIGOSERTIB	Clinical trials in cancer
1094.108044189192	-27.8174866139406	1081.9000956270584	-6.76155960781261	0.982	423	79	COAD	DOCETAXEL	Approved in cancer
550.9967059925764	10.5945110952441	541.9505989516881	-3.03922039596478	0.381	169	28	READ	RASAGILINE	Approved in other pathologies
1016.3600335731775	3.99518076133023	1019.5273518854913	0.0595952165878089	0.911	57	7	PAAD	ERIBULIN	Approved in cancer
1041.8800563042014	-7.64046814730813	1050.321803087484	-0.108197732634835	0.944	934	108	BRCA	PACLITAXEL	Approved in cancer
664.28483395111	33.5122877156855	684.6327809798328	7.27112809694086	0.524	202	23	LAML	AMUVATINIB	Clinical trials in cancer
691.2344596299979	-40.1510779143231	685.7619160814319	7.61470173457792	0.522	934	215	BRCA	SAR260301	Clinical trials in cancer
192.30257028133104	-88.7394205286515	203.4480370862769	36.5343621891379	0.0004	222	127	LGG	GSK429286A	Experimental
215.76388164476205	-9.36909277358444	211.67492498134598	10.8540239210349	0.0006	202	38	LAML	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
762.7061907485353	-20.2248962616355	739.6257984134602	-3.30236543579974	0.587	543	74	LUAD	SONOLISIB	Clinical trials in cancer
224.18549702789602	-44.0129511386228	202.57464485059967	-21.9064672866621	0.0006	264	35	SKCM	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE	Experimental
707.0961901085604	-9.44604012002858	720.9902605538988	4.77455551403	0.575	599	70	GBM	SONOLISIB	Clinical trials in cancer
644.2408593556513	-25.8734096985826	710.2405446720735	-0.00845668360170748	0.594	423	80	COAD	PF-04691502	Clinical trials in cancer
493.27948868721444	1.085230601587	493.84524873477034	2.73164892200748	0.323	502	57	KIRC	PEGAPTANIB	Approved in other pathologies
727.4382770279224	-39.4252759417422	697.9999845350386	-1.93209673398087e-05	0.553	153	24	BLCA	GOSSYPOL	Clinical trials in cancer
199.25507446161123	-9.43807961213162	193.11739189774784	-11.520512677776	0.0004	343	50	HNSC	FQI-1	Experimental
372.68481457171146	4.86603265742258	358.37298250811006	3.45810281189699	0.182	512	54	UCEC	MBX-8025	Clinical trials
1093.4235255120004	1.20957947333378	1088.0807160594375	3.79406896162641	0.988	292	35	STAD	BOSUTINIB	Approved in cancer
284.3591673672416	-29.4796834441493	303.4447907394215	2.4278550144636	0.113	502	56	KIRC	TETRAHYDROBIOPTERIN	Clinical trials
669.8330763449577	60.3510777133127	700.0145650382384	7.12863821923315	0.551	343	84	HNSC	S-8184	Clinical trials in cancer
682.5969924237386	13.1579809260638	686.8027770098868	3.15459351540881	0.533	202	24	LAML	XL999	Clinical trials in cancer
1107.1495894844816	14.6750293818687	1087.8228233425064	-6.43163562183872	0.997	264	37	SKCM	PAZOPANIB	Approved in cancer
363.56257657851387	10.1865166581662	362.2834811168144	-2.56642965822857	0.182	264	52	SKCM	ICO-007	Clinical trials
639.1639683259347	33.6972741630455	735.052638527032	-43.8449310008523	0.571	264	114	SKCM	AVI4126	Clinical trials in cancer
584.3865499905163	0.0865180438844675	581.6530872578197	-2.45789256881153	0.423	343	44	HNSC	CH5132799	Clinical trials in cancer
716.4286990973371	-46.9837117698837	748.0313124940056	-13.6582624487742	0.582	423	89	COAD	GDC-0623	Clinical trials in cancer
137.1783191660083	-13.7348517253021	210.2516096277137	-11.1169181833148	0.0004	512	54	UCEC	CHM-1	Experimental
281.8665793811654	33.8924623149352	174.78033388346032	7.75372450278775	0.0006	512	77	UCEC	RU83876	Experimental
239.4168897361347	-11.7092633678273	190.75955207485583	4.74997778861569	0.0006	512	54	UCEC	CHEMBL282146	Experimental
225.47950395120736	-37.3517399067356	206.7566060985445	-6.86523803470806	0.0006	512	77	UCEC	PAS219	Experimental
112.8346935844462	-16.2445994915514	198.59433547306188	-10.8717753532262	0.0004	57	24	PAAD	N-ISOPROPYLPHTHALIMIDE	Experimental
74.43766707275464	-10.3754318027748	237.02824981941356	43.5771159177889	0.0008	264	180	SKCM	PHOSPHONOTHREONINE	Experimental
337.15031772491415	51.9168261515574	309.7335665622799	-9.04287153131585	0.121	57	24	PAAD	ANTIBIOTIC K 252A	Clinical trials
771.7945554037392	40.0300750891162	732.8583555263959	23.4461914319918	0.593	512	142	UCEC	GDC-0980	Clinical trials in cancer
684.9714205008761	-28.9297423072173	651.5788020021116	-5.08374991774303	0.513	202	30	LAML	ISIS 2503	Clinical trials in cancer
205.43201337426845	2.76790386155199	180.36954752002117	-2.1612605127284	0.0006	502	56	KIRC	ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	Experimental
243.54595588867755	-14.9004359730866	189.12243094827386	1.15438260858195	0.0006	202	32	LAML	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
220.01888873258903	-26.1017548871393	185.3250682130397	-14.1821769874873	0.0006	502	53	KIRC	THIOCOUMARIN	Experimental
746.3693577108361	46.1741993642657	757.8591965059185	-13.1531721122507	0.592	169	46	READ	GDC-0980	Clinical trials in cancer
206.9598953110304	11.9486910572589	227.6612798591432	-14.9587233493587	0.0006	512	77	UCEC	GVD	Experimental
785.5526757154789	1.90271914860676	741.1644155673774	4.15354222860913	0.594	169	45	READ	ENCORAFENIB	Clinical trials in cancer
657.915521430275	-13.3678833596328	674.1949366873885	2.60379698655652	0.534	502	58	KIRC	MGCD-265	Clinical trials in cancer
538.6470230959426	4.7390150734908	539.8436192783128	2.0631020830433	0.381	423	65	COAD	IBUPROFEN	Approved in other pathologies
544.5543010832658	15.7754273336432	539.5025518060723	-0.156186222732231	0.381	222	55	LGG	RASAGILINE	Approved in other pathologies
774.3910881053157	-58.8095729129177	723.7482169953078	11.8408831584181	0.592	169	46	READ	GSK2636771	Clinical trials in cancer
746.3804460069333	-24.8364595806722	725.6922436931584	-4.659259109098	0.583	222	55	LGG	OBATOCLAX	Clinical trials in cancer
973.3205267123626	0.817074623386588	978.9998896018916	-9.51173259409188e-05	0.865	169	45	READ	CETUXIMAB	Approved in same tumor type
367.119616045855	-34.7636298657692	369.238539058282	-19.115717052498	0.181	264	185	SKCM	ANTIBIOTIC K 252A	Clinical trials
261.21365276787037	9.22481214942388	205.36297481235172	6.60931327946224	0.0004	512	84	UCEC	TELOMERASE INHIBITOR IX	Experimental
193.1954250096481	44.782756124804	182.3027505720087	21.8220837374747	0.0006	512	77	UCEC	RU78783	Experimental
849.3404122679797	3.47681735543125	848.3382536559673	-1.78407202547146	0.721	502	57	KIRC	DALTEPARIN	Approved in other pathologies and in clinical trials in cancer
954.8995262240537	-3.7187847069462	944.2139964705457	-1.65152982803556	0.831	934	214	BRCA	PEMETREXED	Approved in cancer
387.7111991539662	-0.682496447114403	373.00009557757977	-0.000123394665479282	0.192	343	62	HNSC	QUERCETIN	Clinical trials
559.4781778861392	-9.01260000950089	570.999773387425	0.000313689900849567	0.412	423	57	COAD	GI-4000	Clinical trials in cancer
678.0121388964944	54.3331517496109	725.0349770691903	-9.63512550202449	0.582	169	44	READ	RO4987655	Clinical trials in cancer
774.467977900108	53.3912851587268	707.6628524483809	21.1356810894139	0.552	57	24	PAAD	GDC-0980	Clinical trials in cancer
580.5642677834653	-25.224800876125	586.6620693596501	0.652992490317956	0.421	934	217	BRCA	ABT-751	Clinical trials in cancer
255.66740725023914	63.9261665526705	206.8265469491712	34.6073422784636	0.0006	435	185	THCA	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
173.16132641891065	21.6448103272942	189.3621918252914	-7.5329182445189	0.0004	343	44	HNSC	NAKITERPIOSIN	Experimental
687.481087185038	-0.790617600968204	705.6555933208225	-1.75639995194842	0.563	599	68	GBM	COPANLISIB	Clinical trials in cancer
478.36583380984814	-16.5533961724574	492.8465124745054	-0.095589650495441	0.321	57	24	PAAD	ISOPRENALINE	Approved in other pathologies
76.88846315099643	74.0298454417871	250.13919385652522	19.9836996493646	0.0008	264	177	SKCM	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
639.0672695551649	10.3351923461869	662.7237855909939	-2.84573662218531	0.513	502	57	KIRC	OBLIMERSEN	Clinical trials in cancer
793.0675675585129	-85.1777680345861	698.3981621838847	34.1796189915062	0.593	264	190	SKCM	BMS-908662	Clinical trials in cancer
721.7751600823515	-2.53459293398609	732.2823128981677	6.96013903677294	0.594	389	46	LUSC	PF-04691502	Clinical trials in cancer
166.98884438940982	-15.0739475398647	189.52041889164306	16.1871728595393	0.0006	502	56	KIRC	ARGIMESNA	Experimental
488.8125678858595	-5.45261643599335	490.9250280255409	-0.534672403610784	0.321	502	53	KIRC	DROTRECOGIN ALFA	Approved in other pathologies
1143.315600469902	-13.3588181805507	1110.866199950786	19.8010048639812	0.991	264	188	SKCM	ARSENIC TRIOXIDE	Approved in cancer
730.7675703449435	-2.41023801011801	748.9267719553825	3.70196527881808	0.594	343	62	HNSC	PF-04691502	Clinical trials in cancer
366.34316002508376	18.9063366715623	366.4293738858761	0.300324051424127	0.181	169	44	READ	ADENOSINE TRIPHOSPHATE	Clinical trials
665.8367564697613	-29.6959338828914	706.252675929794	-5.37195601953863	0.544	934	224	BRCA	SF1126	Clinical trials in cancer
203.53078001878438	-28.6284333388245	182.48958211429144	-5.93055992820746	0.0006	502	53	KIRC	2-PHENYLHEME	Experimental
879.999988492814	-8.52856715027883e-07	880.0000049677494	0.000310194228291039	0.755	512	120	UCEC	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
296.1784578150773	-0.355582732986306	296.29219665682393	3.14645033234592	0.112	502	53	KIRC	KD7040	Clinical trials
716.6887481454116	51.6703722215042	674.8344961361814	13.7805392224623	0.534	57	24	PAAD	AZD8330	Clinical trials in cancer
554.7411380763491	-7.3241749367526	558.7138160834169	-0.233239534175482	0.395	512	60	UCEC	IRBESARTAN	Approved in other pathologies
1050.0412922254568	-32.9624569627511	1043.8363076576823	-0.493583637958409	0.932	343	119	HNSC	DOCETAXEL	Approved in cancer
229.02508681775743	18.8080918363402	200.41053140926476	-7.33981567914623	0.0006	543	71	LUAD	PHOSPHONOTHREONINE	Experimental
215.57581462830655	57.1440124533019	199.44629893862344	8.2752906892988	0.0006	512	74	UCEC	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
586.1014948608519	32.3675922365166	659.6430086199024	-3.62840582048807	0.522	202	53	LAML	PWT33597	Clinical trials in cancer
734.8460250084581	22.0969959990952	730.4328345431843	-1.12870732434055	0.593	389	46	LUSC	PWT33597	Clinical trials in cancer
188.5862222552909	-15.1597428954106	185.8127751588556	4.98545679126119	0.0006	502	56	KIRC	N-OMEGA-HYDROXY-L-ARGININE	Experimental
767.8926875906823	-43.9917414374538	743.915218360914	-5.44051813158489	0.595	153	26	BLCA	SONOLISIB	Clinical trials in cancer
366.2938856379088	-16.1729623444255	359.17288485884905	4.07352977934897	0.181	423	65	COAD	EDARAVONE	Clinical trials
731.6974051640652	47.3592068071185	730.7124941661823	-0.546117158057086	0.584	543	72	LUAD	391210-10-9	Clinical trials in cancer
723.899062020718	12.2829672236415	727.1022794327298	2.8857273621436	0.581	543	63	LUAD	CC-401	Clinical trials in cancer
846.8423780891964	-0.784989558244888	844.0000132933118	0.000290683345383513	0.715	292	39	STAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
817.5976005382176	2.47732377844599	786.0000956883619	0.000529193627301083	0.651	543	67	LUAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
141.05464721542978	-58.4833185226081	248.63549179066385	-16.3287966942132	0.0006	435	211	THCA	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
247.0367962799525	41.4752311455868	194.91368270404905	1.73251718626261	0.0008	512	77	UCEC	NVP-BGT226	Experimental
1056.6999649136724	-9.92455585674594	1044.6615760045556	4.98751443574974	0.937	502	64	KIRC	REGORAFENIB	Approved in cancer
208.51561395647278	31.9397488454206	196.90357909398182	28.4518578295685	0.0008	512	58	UCEC	SCHEMBL2065429	Experimental
729.3672905920092	4.35789321086551	722.8650529774861	3.91292303038745	0.595	343	62	HNSC	BYL-719	Clinical trials in cancer
484.7264516309292	1.1175155488904	486.54156145403135	0.0231220870066409	0.321	502	58	KIRC	MINOCYCLINE	Approved in other pathologies
164.55032725963696	-74.014167514273	154.3844312574057	24.5855809390125	0.0004	435	183	THCA	NVP-BHG712	Experimental
173.90559120018227	-27.5479739908126	202.1537620656915	17.8098609243143	0.0006	264	35	SKCM	1-(2,6-DICHLOROPHENYL)-5-(2,4-DIFLUOROPHENYL)-7-PIPERIDIN-4-YL-3,4-DIHYDROQUINOLIN-2(1H)-ONE	Experimental
251.4501804130108	30.5530018174707	185.35041870894415	6.21049984007277	0.0006	169	43	READ	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
485.0296205712257	-8.01329628911765	478.50841609384634	3.60623649137779	0.311	502	57	KIRC	RASAGILINE	Approved in other pathologies
106.43047021823848	63.4860194679405	194.7841271783123	22.5595338201192	0.0006	57	24	PAAD	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
564.635197919632	2.07337251863589	571.0003358801339	0.000795670198101561	0.412	543	60	LUAD	GI-4000	Clinical trials in cancer
670.0644769615308	-60.4156048542651	713.4938716452265	15.5616021207454	0.523	435	183	THCA	GOSSYPOL	Clinical trials in cancer
552.8754499279112	-17.9295822255475	568.0264594438297	-8.14935265350414	0.412	435	183	THCA	MLN 2480	Clinical trials in cancer
1077.6625352303583	-31.3465761197671	1089.8152011332181	1.87396539968017	0.984	222	55	LGG	PACLITAXEL	Approved in cancer
369.5570819277682	11.7890663940556	356.5286286291021	-0.509135997273461	0.181	512	58	UCEC	ELAFIBRANOR	Clinical trials
210.07065348250737	-50.7501264685411	204.01717455024053	12.6724798345904	0.0008	423	88	COAD	DB07788	Experimental
372.73192717173856	-18.0376465501439	365.73377974344083	2.64834602600104	0.181	423	77	COAD	ADENOSINE TRIPHOSPHATE	Clinical trials
956.1632562555272	5.38017190795668	952.7858979283612	1.65157938448465	0.832	934	215	BRCA	CETUXIMAB	Approved in cancer
265.82937498012365	-52.5662651423755	221.56914859090693	-4.83057431265695	0.0006	512	85	UCEC	1-[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL-5-YL]-3-NAPHTHALEN-1-YLUREA	Experimental
593.486587986886	19.4197341156189	702.9530371521352	0.817276892762493	0.525	435	211	THCA	PIMASERTIB	Clinical trials in cancer
772.5494633454983	20.4552537054724	729.7781913790423	-6.46635072975255	0.592	512	77	UCEC	AFURESERTIB HYDROCHLORIDE	Clinical trials in cancer
700.6032751558148	-27.3898699771683	711.9764451137917	-20.1022186940281	0.582	264	35	SKCM	LY2228820	Clinical trials in cancer
198.33122770212685	57.5846642362453	237.21182117329866	6.01004388579901	0.0004	512	128	UCEC	KINETIN RIBOSIDE	Experimental
726.5409685917338	35.5036807106816	733.1994738557992	-16.4436112878547	0.594	169	46	READ	PKI-587	Clinical trials in cancer
660.8354867039518	29.2105923802098	670.9998898072503	0.000455973838711543	0.523	169	29	READ	NAVITOCLAX	Clinical trials in cancer
1081.6443587494975	-18.9144268488837	1082.5194603952787	3.74132768294061	0.984	512	74	UCEC	THALIDOMIDE	Approved in cancer
204.49382069161732	16.975298962768	208.903008589928	-2.37823917132391	0.0006	502	53	KIRC	DB07318	Experimental
590.1345249939594	-7.95349463213742	680.1069210067844	10.4577004656751	0.525	202	33	LAML	REFAMETINIB	Clinical trials in cancer
96.41523538833856	-12.3170730297572	171.4667051785255	-30.8491480944277	0.0006	57	24	PAAD	OLOMOUCINE	Experimental
735.1082841444709	-19.3589266284232	704.9135515829622	-1.35428271016031	0.553	343	84	HNSC	OBLIMERSEN	Clinical trials in cancer
162.83545104727094	-33.6748567787437	194.80473743272384	11.5741673816865	0.0006	264	35	SKCM	CHEMBL94417	Experimental
185.2021745686653	0.505376104818424	183.24908446468584	1.28539937374285	0.0006	502	57	KIRC	PIDOLIC ACID	Experimental
382.07741916639463	-21.1764618970082	352.7355304676402	0.881743520772034	0.191	264	82	SKCM	ADENOSINE TRIPHOSPHATE	Clinical trials
596.8684671969843	1.60086969990115	642.1534149634019	14.3519003709123	0.522	57	24	PAAD	GDC-0623	Clinical trials in cancer
249.16306562611325	2.69475353512237	203.76844655540256	21.548410912721	0.0006	502	56	KIRC	S-ETHYL-N-PHENYL-ISOTHIOUREA	Experimental
209.75070303104408	-65.6207889411232	203.8873352083598	-19.2800701356673	0.0004	934	215	BRCA	ML214	Experimental
648.2274822429086	-18.5395398868241	661.0836829093176	1.38393367752292	0.511	502	57	KIRC	DHA-PACLITAXEL	Clinical trials in cancer
632.1901996069099	-26.6517141733323	658.8027169936123	24.8290312923864	0.511	435	183	THCA	DHA-PACLITAXEL	Clinical trials in cancer
132.15190548499402	113.448296569364	220.92094416129473	80.2760240913321	0.0008	264	177	SKCM	FR 180204	Experimental
212.39515581748958	-36.3049748715517	201.80357176045885	-5.17134472111047	0.0006	502	56	KIRC	7-NITROINDAZOLE-2-CARBOXAMIDINE	Experimental
1023.6582807412751	-2.28444099504495	1038.159741881425	-1.96099408664594	0.93	543	73	LUAD	CETUXIMAB	Approved in cancer
696.8781122607528	-36.8470657253336	732.5284111626324	9.33678089035158	0.581	512	53	UCEC	BEVACIZUMAB + ERLOTINIB	Clinical trials in cancer
1094.894059739885	-3.50248295850128	1088.895619677119	1.86128282188895	0.986	543	72	LUAD	COBIMETINIB	Approved in cancer
687.4191873196187	4.6458862101737	732.8396747602067	-16.4527466471879	0.593	512	85	UCEC	XL-228	Clinical trials in cancer
684.424042311392	46.6759497146951	732.0660837859117	2.92811979016142	0.583	222	55	LGG	OBLIMERSEN	Clinical trials in cancer
727.3107374926005	9.90527977621446	710.1281667785406	-0.976214222270301	0.562	599	68	GBM	XL147	Clinical trials in cancer
229.15430201421705	24.5082933297417	230.03262562348613	21.4825980894715	0.0006	512	76	UCEC	10,11-DIMETHOXY-4-METHYLDIBENZO[C,F]-2,7-NAPHTHYRIDINE-3,6-DIAMINE	Experimental
741.7519212155926	32.3206962079792	716.797671681258	-13.0183929002469	0.583	543	74	LUAD	GSK2636771	Clinical trials in cancer
744.9663681274582	-31.5595962748882	752.1817896074705	11.9354626737804	0.582	264	28	SKCM	NEOVASTAT	Clinical trials in cancer
201.720283004462	13.3724246865993	211.9109822099861	26.0793970722204	0.0004	512	66	UCEC	AS-605240	Experimental
207.53948006971822	-36.9431734221009	215.8193289487028	-3.61969450784181	0.0006	264	35	SKCM	CHEMBL273158	Experimental
225.21851324247734	42.811038084108	199.50492109083154	2.14670341421441	0.0006	543	69	LUAD	DB07788	Experimental
659.7384121443755	-75.108084927001	620.8290185135972	-8.89887351987954	0.512	435	211	THCA	RO4987655	Clinical trials in cancer
550.8010290327343	-3.67157397658698	551.6171239116036	4.85062632033356	0.391	512	78	UCEC	CAFFEINE	Approved in other pathologies
940.1149266686891	16.1304269159396	928.0399224663903	-7.16267308899978	0.812	435	183	THCA	DABRAFENIB MESYLATE	Approved in cancer
143.61741751697738	-22.136723283899	177.11623098684254	6.02002481901081	0.0004	934	217	BRCA	ELCPK	Experimental
714.0579594534	41.3600705801636	716.3701595685313	4.06774426319407	0.573	599	70	GBM	PF-04691502	Clinical trials in cancer
187.57866519028957	-10.9373988270135	199.6278113317476	-20.0449418643529	0.0006	502	53	KIRC	PIMAGEDINE	Experimental
679.9948060758219	-4.21343705550368	691.1697485457096	-2.33341607957675	0.543	389	45	LUSC	OBLIMERSEN	Clinical trials in cancer
155.30263803430935	-57.4408943060553	210.63680393669478	7.95767833368291	0.0004	934	218	BRCA	CHEMBL254381	Experimental
190.9644994562249	-34.0587265340801	207.17590389159355	-14.6508745720334	0.0006	264	35	SKCM	CHEMBL197277	Experimental
1008.3396389879529	12.9388851528667	1046.8079208967276	2.17373310816879	0.93	435	211	THCA	TRAMETINIB	Approved in cancer
98.33079738247277	78.1263646608202	227.5936443056831	-7.60410014184839	0.0006	57	24	PAAD	SB220025	Experimental
633.0717430909458	-14.0922489865352	623.9998065918045	0.000341130598769723	0.471	512	75	UCEC	ABT-751	Clinical trials in cancer
175.21282558571858	44.4319991376272	177.9766068897227	-16.454853990122	0.0006	512	77	UCEC	RU84687	Experimental
766.6960204646932	-7.07955076366832	751.7011520330461	6.20865386593255	0.595	169	46	READ	SONOLISIB	Clinical trials in cancer
176.9852732801749	3.93617872412577	185.11332519909124	-2.65747116671469	0.0006	502	53	KIRC	CHEMBL390674	Experimental
1093.439243223271	16.8986227942541	1094.4860755934694	0.534984281314905	0.994	543	84	LUAD	REGORAFENIB	Approved in cancer
690.0628392681472	-19.3772591441612	725.196273121305	-0.381220439087429	0.596	423	80	COAD	XL765	Clinical trials in cancer
621.2090975622697	24.8439840202656	704.0025430430692	-39.4512571162191	0.532	57	24	PAAD	212631-79-3	Clinical trials in cancer
641.8096504033244	22.1807540367431	667.4522531635193	-6.73462499918196	0.513	202	32	LAML	TAK-733	Clinical trials in cancer
357.41652711445613	-3.62226479804735	357.2080370761451	-6.7782413169316	0.181	264	35	SKCM	DORAMAPIMOD	Clinical trials
203.40020296234522	30.366058542262	206.04353340251006	8.03764985083438	0.0006	543	69	LUAD	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
265.644675660301	-29.3663708455043	300.02799215526846	5.11000712090549	0.112	502	53	KIRC	STANNSOPORFIN	Clinical trials
859.9398810536862	2.64193267035949	857.7481804572308	0.101243564778315	0.731	502	59	KIRC	AFLIBERCEPT	Approved in other pathologies and in clinical trials in cancer
907.5389275435754	1.28627293075942	904.2127768613979	-2.35937636314418	0.783	512	57	UCEC	SULINDAC	Approved in other pathologies and in clinical trials in cancer
722.0820093618238	16.3629258249961	727.3721470564711	-11.0560227955957	0.583	543	74	LUAD	NVP-BGJ398	Clinical trials in cancer
221.38298662002575	19.041840149594	201.58785433523516	-15.6605108330007	0.0004	512	52	UCEC	CERULENIN	Experimental
196.46761472253274	28.9189165331708	202.4088336963993	-3.98221081534336	0.0006	169	39	READ	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	Experimental
911.4087308055546	-7.86132128940292	918.3113712736405	0.418490490482782	0.796	264	49	SKCM	NINTEDANIB	Approved in other pathologies and in clinical trials in cancer
632.3182402308274	-97.1415127795158	691.3656353695017	-3.21717232652873	0.54	222	134	LGG	SELUMETINIB	Clinical trials in cancer
657.8450443478002	-42.3124597218968	665.1826886512142	-0.636554514424006	0.523	934	215	BRCA	RIGOSERTIB	Clinical trials in cancer
116.16985215397015	78.5194423785931	221.70453832556032	24.0945599232355	0.0006	435	211	THCA	OLOMOUCINE	Experimental
607.8986594595514	34.7889153545717	692.6265214001605	-27.0318110224771	0.553	57	24	PAAD	BYL-719	Clinical trials in cancer
703.5740727777808	-56.3457888922319	744.3198270036486	7.75551407282774	0.594	423	80	COAD	XL147	Clinical trials in cancer
940.8122135723191	-6.02659479276139	932.4574923133844	10.4088204850577	0.815	435	211	THCA	CETUXIMAB	Approved in cancer
1137.1257358249486	37.8764640708494	1054.2510342276785	-20.3545224053719	0.997	264	199	SKCM	REGORAFENIB	Approved in cancer
210.5626905197721	-17.3775815644388	197.7289788234001	3.85432647288258	0.0004	343	44	HNSC	AS-605240	Experimental
146.1921840887878	-2.24967541277269	215.01710805991124	-7.56783651553405	0.0004	934	214	BRCA	154447-36-6	Experimental
784.0992642353192	-26.6821487573789	727.6603346087123	-14.9638889680408	0.581	512	53	UCEC	BEVACIZUMAB + TRASTUZUMAB	Clinical trials in cancer
621.4008309246714	38.3287049139494	667.9364870210514	-20.8653455404412	0.523	202	53	LAML	SONOLISIB	Clinical trials in cancer
1046.094407132924	-4.85233990888409	1034.799510774157	2.97999463768178	0.93	343	47	HNSC	EVEROLIMUS	Approved in cancer
172.15765064907995	-43.209233494081	172.04670439487137	-11.7361965556606	0.0006	264	33	SKCM	TETRADECANOIC ACID	Experimental
721.9907602152558	-18.9626402847533	674.1236961365477	3.81571793592889	0.531	153	22	BLCA	DHA-PACLITAXEL	Clinical trials in cancer
628.6069673881852	9.57354557574752	696.1332012148392	-30.4022181596199	0.523	435	183	THCA	ISIS 2503	Clinical trials in cancer
1045.5156663626099	28.4193401203448	1063.668695597427	7.15615287195254	0.953	57	25	PAAD	REGORAFENIB	Approved in cancer
175.394816306835	34.086886099354	198.01906521451855	33.6852032329002	0.0008	512	79	UCEC	O-PHOSPHO-L-TYROSINE	Experimental
194.2555187319399	1.84371180177831	218.2650975434515	-14.8480595007106	0.0006	502	53	KIRC	DL-2-AMINOBUTYRIC ACID	Experimental
1090.53218434986	-5.95073354259654	1088.0994449139466	1.93810923938827	0.984	153	18	BLCA	ARSENIC TRIOXIDE	Approved in cancer
149.23493148889	-28.8735598762483	217.00978392907658	-13.556042702533	0.0008	423	88	COAD	CHEBI:83275	Experimental
720.082939854645	-59.6944474757879	711.2326139587238	7.91041130418489	0.584	423	89	COAD	AZD8330	Clinical trials in cancer
772.5451335213643	-72.6642471390523	738.7647553734548	-27.2023957696929	0.595	264	113	SKCM	SONOLISIB	Clinical trials in cancer
109.67082881329719	45.6558684992774	151.53827687020487	-10.6627358618834	0.0006	435	211	THCA	PHOSPHONOTHREONINE	Experimental
103.13984216384979	17.4871030043864	203.77050051945773	16.7193027197313	0.0006	435	211	THCA	PURVALANOL B	Experimental
230.8623411880572	-37.9257814971851	206.06320258209774	-2.11038630427379	0.0004	343	44	HNSC	AS 604850	Experimental
225.33727171660738	16.9321335285884	204.27713555276156	2.99176796316374	0.0006	543	63	LUAD	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	Experimental
1027.8618881956952	2.24532799056774	1040.3707480778407	-0.255545195300328	0.932	599	108	OV	DOCETAXEL	Approved in cancer
746.2120440034156	-67.0142248963618	700.7697738941068	-13.2415293190129	0.543	934	224	BRCA	NVP-BGJ398	Clinical trials in cancer
137.44097556968143	-113.667965995134	133.03728315777815	7.70396887396601	0.0008	264	185	SKCM	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
728.8928151902176	-34.8207138717672	683.3996041614255	-0.0231319597153288	0.535	502	59	KIRC	VATALANIB	Clinical trials in cancer
191.0214052425614	55.4494318636752	170.7216255389206	18.7705490781818	0.0006	512	74	UCEC	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
1117.1747234566471	26.7815957796956	1110.6018839523372	-25.2218571057842	0.996	264	81	SKCM	CABOZANTINIB	Approved in cancer
718.8763870368864	40.2046909904928	719.5013917829585	11.572152560737	0.583	543	72	LUAD	TAK-733	Clinical trials in cancer
734.3010106056636	-9.76703367647602	715.9345656548192	-2.92893147461882	0.581	222	55	LGG	DHA-PACLITAXEL	Clinical trials in cancer
652.8076012941718	0.935755623410671	700.0183476546789	-9.83984560991985	0.553	343	84	HNSC	GOSSYPOL	Clinical trials in cancer
353.0574676837581	-6.66204406336519	371.6145232710577	2.08203878480299	0.183	264	35	SKCM	586379-66-0	Clinical trials
1031.238942980304	63.9677006994961	1035.0162355625955	-0.284784883264365	0.941	264	168	SKCM	CETUXIMAB	Approved in cancer
1086.11838414664	-5.10034533230333	1091.724806985223	1.00645840802008	0.99	292	32	STAD	CETUXIMAB	Approved in cancer
683.6712372036644	-56.9236789728681	664.9814653468626	-9.83998081250184	0.522	934	215	BRCA	MLN1117	Clinical trials in cancer
1083.6890947783302	12.3560146525104	1084.5819034339286	-2.44254255736752	0.983	543	82	LUAD	ARSENIC TRIOXIDE	Approved in cancer
202.55696953133844	-70.0008135298078	200.2205844031991	7.07068373982293	0.0004	292	35	STAD	PARBENDAZOLE	Experimental
205.81833433716642	-87.9883838581413	195.88018674361203	-6.66565419014501	0.0004	343	46	HNSC	LEXIBULIN	Experimental
220.11628354398024	-13.5722502319907	213.2753220850066	5.94306471318021	0.0008	543	69	LUAD	FR 180204	Experimental
1019.540551682098	-40.1401888894038	1031.9753622370652	-10.3292524284177	0.934	435	211	THCA	REGORAFENIB	Approved in cancer
693.2399225914722	5.46758723350337	725.5799554451933	-1.86296470096073	0.585	543	72	LUAD	REFAMETINIB	Clinical trials in cancer
224.36521383794187	-16.8399006927246	198.77317594195742	8.13363134473457	0.0006	264	35	SKCM	PYRIDINYLIMIDAZOLE	Experimental
182.0465956251446	64.8818975744613	203.081174070052	12.239812055873	0.0006	543	71	LUAD	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
696.147448271128	-52.4718482827169	666.6307691734311	8.45657276766178	0.523	934	215	BRCA	TASELISIB	Clinical trials in cancer
678.3192621616203	-20.3778524436975	673.7310606883359	8.33349944330962	0.512	202	32	LAML	GDC-0623	Clinical trials in cancer
225.82137976642204	-7.69043342210128	209.9334374173906	5.13860645920113	0.0006	502	55	KIRC	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
711.8215893320721	-0.56912875057256	730.3735246188301	-11.5560559146282	0.581	512	55	UCEC	MARIMASTAT	Clinical trials in cancer
718.323200775689	34.6819593694925	713.225478757525	0.26592861009658	0.584	512	77	UCEC	MK-2206	Clinical trials in cancer
708.3579758150358	20.4622003439445	690.5305897342377	0.223644557869193	0.535	202	24	LAML	DOVITINIB	Clinical trials in cancer
730.1289383799119	-48.4342640888237	715.9289492104868	-23.3592828476903	0.592	264	35	SKCM	AFURESERTIB HYDROCHLORIDE	Clinical trials in cancer
566.083744835243	13.4440343528075	570.4884828791376	7.82684891629151	0.412	934	214	BRCA	DS-7423	Clinical trials in cancer
159.88780891451157	-21.6366193928774	194.4727999887534	3.49492912177266	0.0006	502	53	KIRC	4R-FLUORO-N6-ETHANIMIDOYL-L-LYSINE	Experimental
1117.8975749302815	-24.5751489134595	1079.8741532309925	1.26487924987896	0.996	423	96	COAD	REGORAFENIB	Approved in same tumor type
656.588231075302	13.6282014985989	675.4318190696164	9.67815308635704	0.533	502	57	KIRC	GOSSYPOL	Clinical trials in cancer
671.2847793006215	20.0131537804276	677.3780830047143	-2.47574083124687	0.532	512	74	UCEC	212631-79-3	Clinical trials in cancer
274.07395159652856	-35.6695632358862	165.1080431445933	-35.8822358893965	0.0006	435	183	THCA	1,6-HEXANEDIOL	Experimental
702.8086938635464	33.2178647303202	739.6988233852645	-3.00487046490002	0.595	389	46	LUSC	BYL-719	Clinical trials in cancer
253.78155652294117	112.628738689542	244.47827576640898	-20.279303320021	0.0004	222	127	LGG	NPC-26	Experimental
851.7629371856692	-0.366111071959295	853.2056945364781	-0.748506461188754	0.725	502	57	KIRC	RANIBIZUMAB	Approved in other pathologies and in clinical trials in cancer
244.37240862973835	80.063657434532	210.04634333846306	11.8013078336106	0.0006	169	43	READ	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
206.69395779470798	-8.66156795515994	187.59356794920285	0.765784409006073	0.0006	502	53	KIRC	1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE	Experimental
780.4743441368743	-45.3278912778239	743.1547045067755	4.7915517076417	0.564	264	124	SKCM	RAF265	Clinical trials in cancer
687.444527544681	-48.7068434913471	678.1388317310737	-7.8184662191602	0.543	934	222	BRCA	GDC-0941	Clinical trials in cancer
700.1899484692436	-39.5963116374928	672.1601240721411	-14.5556492889673	0.533	202	24	LAML	CEDIRANIB	Clinical trials in cancer
721.0616733304948	29.2360134031833	719.6489507531602	19.0682518871176	0.594	512	77	UCEC	IPATASERTIB	Clinical trials in cancer
204.87352055149736	55.34649482359	202.09508399861684	17.4526574915886	0.0004	512	57	UCEC	MERCK60	Experimental
682.0509636828073	-8.40389412899506	684.5991478786281	2.10399631389362	0.541	389	45	LUSC	S-8184	Clinical trials in cancer
731.5166746239445	18.7276646146141	731.934948943734	-5.61417957333697	0.596	389	46	LUSC	DACTOLISIB	Clinical trials in cancer
750.9539332710256	5.57473414648399	732.5194617507537	4.30719949335059	0.583	169	28	READ	GOSSYPOL	Clinical trials in cancer
743.2017159599956	12.7963854695028	723.0384776787614	6.64983214326315	0.596	512	74	UCEC	391210-10-9	Clinical trials in cancer
362.27237057998383	-5.33593967400319	366.4713461329553	2.31515529564012	0.182	264	33	SKCM	AM-111	Clinical trials
282.5898292638226	-8.87882785566899	198.67643721238056	-37.0895925262566	0.0008	435	183	THCA	CHEMBL526479	Experimental
1067.344471345703	-5.30937257340474	1080.7382598725937	-3.16621485207725	0.982	292	55	STAD	DOCETAXEL	Approved in cancer
1053.2791485404225	-47.8808173302719	1029.5368734832127	7.623671131234	0.929	435	183	THCA	DASATINIB	Approved in cancer
911.7895981797759	1.11585156998683	912.6268876432214	1.48479544034024	0.792	512	52	UCEC	DALTEPARIN	Approved in other pathologies and in clinical trials in cancer
274.15399846855144	50.2964590365237	231.824124292727	7.80176852590921	0.0004	264	114	SKCM	AM580	Experimental
506.6802961964085	0.979724227155742	506.9999600892314	-3.00528348589069e-05	0.341	389	45	LUSC	RASAGILINE	Approved in other pathologies
212.7148809566304	-24.2343660789346	212.32648404467133	-15.704187619081	0.0006	264	35	SKCM	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	Experimental
91.41374284192062	3.69660656164876	209.89658036163848	-49.6227289096039	0.0004	435	183	THCA	UNC0638	Experimental
684.6214682744783	-4.58998648706785	683.8098912719358	-4.69893174554841	0.535	502	59	KIRC	CEDIRANIB	Clinical trials in cancer
181.35916304421556	-2.39207185107975	193.7192248278256	6.51015260871827	0.0006	264	35	SKCM	CHEMBL492265	Experimental
193.81478048674583	18.8981235903828	191.44708728528465	1.23754986995618	0.0004	153	18	BLCA	CHEMBL254381	Experimental
1006.8106774223968	-4.64200383696092	1033.2930256785678	0.940263560938547	0.924	599	107	OV	PACLITAXEL	Approved in cancer
168.38736335169733	6.63641286795178	197.3082153455011	-1.43735623525436	0.0004	343	47	HNSC	GW843682X	Experimental
337.1247373382872	-4.9459454128444	310.00015457457204	-0.000264697356215038	0.122	202	54	LAML	QUERCETIN	Clinical trials
175.17829601234516	16.6247921903196	212.49239517145233	-10.4725568522472	0.0006	264	35	SKCM	CHEMBL305178	Experimental
1076.3520969114772	-18.3642060304743	1086.0652658329525	15.2287323908063	0.981	264	32	SKCM	TAMOXIFEN	Approved in cancer
179.84915680530295	54.1140537945444	176.74616559820348	62.0671215346092	0.0008	264	108	SKCM	TAMATINIB	Experimental
786.2264500347675	-35.0772276718768	711.7524244088132	3.35467046362703	0.578	599	70	GBM	DACTOLISIB	Clinical trials in cancer
1045.5856944098177	5.46556295542703	1026.6965077468792	3.88586691544606	0.917	202	32	LAML	COBIMETINIB	Approved in cancer
1073.2916311019192	-6.85781426168865	1050.8392917489132	-5.30949249650803e-05	0.944	389	46	LUSC	PACLITAXEL	Approved in same tumor type
1028.4920303684444	-22.3203261021463	1042.787428028917	5.34043591254249	0.934	202	40	LAML	REGORAFENIB	Approved in cancer
768.454947077472	-16.7735712443686	756.1553946856214	-0.0313190262422722	0.6	423	91	COAD	SELUMETINIB	Clinical trials in cancer
1071.510314578499	-23.8066610712456	1055.999616460637	0.00023960307271409	0.951	343	84	HNSC	ERIBULIN	Approved in cancer
248.788394029599	-36.4383732305567	184.40163892839095	9.07852775633637	0.0006	502	53	KIRC	ALPHA-D-GLUCOSE-6-PHOSPHATE	Experimental
147.1065045723208	9.15941255777568	190.7585497791529	6.18277116957552	0.0008	423	89	COAD	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
700.330909885174	64.4390638045142	732.8053575349802	-9.87576678574158	0.585	543	77	LUAD	BMS-908662	Clinical trials in cancer
200.42620391670337	44.9659350966706	195.76710504713577	5.60838241173496	0.0008	153	29	BLCA	PI-103	Experimental
759.5678937077125	12.307879304255	715.452672606093	14.5159489244812	0.581	169	28	READ	DHA-PACLITAXEL	Clinical trials in cancer
237.55880491704244	-122.854290429845	157.31546006221782	-5.12201204704934	0.0008	264	177	SKCM	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
292.8423182032645	-4.14144455243999	204.11014057137405	33.5046760615162	0.0006	512	77	UCEC	DB08192	Experimental
658.9418546117321	20.8439579930575	679.2626057903078	2.02664433651785	0.522	202	53	LAML	PF-04691502	Clinical trials in cancer
160.68806620153774	41.4861767720888	197.26713986776204	-16.9776884661378	0.0006	202	53	LAML	PI-103	Experimental
742.1223538748249	-19.366180786848	726.0231244200404	-0.116359859997829	0.593	389	42	LUSC	GDC-0941	Clinical trials in cancer
178.32069849902274	-9.82201961813317	210.792876413886	-18.3198958156797	0.0006	502	53	KIRC	N-OMEGA-PROPYL-L-ARGININE	Experimental
980.7175916516513	-13.3658983154416	991.0733942696663	1.13077154635107	0.881	169	39	READ	ETOPOSIDE	Approved in cancer
700.4558387970291	-17.87745981642	748.5347716444982	-22.9421853010977	0.572	264	27	SKCM	X-82	Clinical trials in cancer
727.4277644692954	-94.9325441101901	713.8869894540157	16.938696917357	0.595	264	113	SKCM	PKI-587	Clinical trials in cancer
763.0611736170464	-35.4680448146076	729.872775775922	2.11862210092613	0.595	343	62	HNSC	COPANLISIB	Clinical trials in cancer
306.6055487487702	-7.27484674395865	303.9221235231322	6.7460093530799	0.111	502	53	KIRC	NADH	Clinical trials
158.83397345055698	50.894744397607	219.8669992897524	-29.3144985147183	0.0004	512	109	UCEC	CHEMBL254381	Experimental
644.9197179804521	3.32319797914678	671.8459970217734	-1.37466816139977	0.523	599	108	OV	GOSSYPOL	Clinical trials in cancer
163.1810502569398	-61.4579069005055	183.87425165824757	-13.0166354138833	0.0008	423	88	COAD	OLOMOUCINE	Experimental
242.715532012616	-44.6686114231446	199.12721620978246	-20.2705091519249	0.0004	435	183	THCA	878739-06-1	Experimental
719.8310654935534	1.40218329672945	728.9281128071389	3.35639188962034	0.593	389	46	LUSC	SF1126	Clinical trials in cancer
669.7443105412576	5.73100075612649	738.4563911734317	-2.75499600118383	0.594	292	43	STAD	PF-04691502	Clinical trials in cancer
766.3215322798093	-24.3288739307871	713.8138287744966	-6.54131821864843	0.582	512	77	UCEC	PF-04605412	Clinical trials in cancer
235.9640023634569	-35.7805408678582	214.33899517573252	8.6969233276144	0.0006	512	76	UCEC	BISINDOLYLMALEIMIDE III	Experimental
1093.4434009191973	-19.9020796718323	1109.1675578154338	4.29106546754701	1	423	89	COAD	TRAMETINIB	Approved in cancer
176.48374305883362	8.08538980374544	174.5077377456269	-12.7656644547746	0.0006	512	54	UCEC	KD3010	Experimental
229.88458851625282	-26.0267980107938	195.6763098213887	13.0060836207781	0.0008	423	89	COAD	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
649.1572358708032	110.410062952976	684.0139014312906	5.02313923780025	0.524	435	211	THCA	AZD8330	Clinical trials in cancer
1044.1879168306732	-40.9306449518715	1049.9997516702251	8.26880209388037e-05	0.944	153	23	BLCA	PACLITAXEL	Approved in cancer
854.6864005899623	4.16986896329399	852.999925620868	-0.000146378333738539	0.726	423	66	COAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
758.4804081500506	23.9473262820253	708.7262708163034	-3.54834626765603	0.583	512	74	UCEC	TAK-733	Clinical trials in cancer
350.8878208860091	-13.8673528989346	336.0001593952803	0.000214342934214073	0.151	343	84	HNSC	EDARAVONE	Clinical trials
264.22923643488934	95.845119659594	223.74301875555437	25.8463982302972	0.0006	57	24	PAAD	6-CHLORO-9-HYDROXY-1,3-DIMETHYLPYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
167.9751033922742	-40.4933758102768	200.93259777418285	12.7787701561529	0.0006	264	33	SKCM	6-CHLORO-9-HYDROXY-1,3-DIMETHYLPYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
191.6347503956408	-11.3174462749066	179.28015989647497	-2.24497306470948	0.0006	264	35	SKCM	CHEMBL494072	Experimental
686.5686428121661	29.5787485904915	668.2695993886929	22.4167652783942	0.523	57	7	PAAD	GOSSYPOL	Clinical trials in cancer
222.18917640429459	5.03782094708299	203.18047156154628	-0.687090318647961	0.0008	292	30	STAD	PURVALANOL B	Experimental
309.16027395942564	86.7545359194964	175.89433509470194	-29.1308305553421	0.0008	222	127	LGG	ISOCITRIC ACID	Experimental
140.15556417483242	85.159654932123	211.3344969225991	21.7520750184704	0.0006	264	50	SKCM	CHEMBL291678	Experimental
167.33477999648028	-29.3456072113129	197.72082107386257	-14.5162726021422	0.0008	423	88	COAD	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
244.56750290373537	-88.5346823712431	236.31483472584657	-26.7427007756169	0.0004	264	104	SKCM	5Z-7-OXOZEAENOL	Experimental
1130.0852770074805	14.8601342040125	1096.5604139898248	1.46032745215825	0.99	264	119	SKCM	TEMSIROLIMUS	Approved in cancer
747.1730073252018	14.0588955915727	721.1423303805002	-13.4816039929408	0.581	512	55	UCEC	PRINOMASTAT	Clinical trials in cancer
672.3228413659918	-26.4527238755165	703.3086992347291	18.3384036852772	0.552	264	30	SKCM	XL820	Clinical trials in cancer
668.4964623927738	73.8951793811506	697.649132075056	-11.0098206261389	0.552	57	24	PAAD	XL765	Clinical trials in cancer
294.45045813783884	3.99227188409139	300.2531767388993	2.86033217274553	0.111	202	26	LAML	ADENOSINE TRIPHOSPHATE	Clinical trials
728.5240464466166	63.219045117577	642.4167325131795	28.5792297994128	0.521	435	183	THCA	AVI4126	Clinical trials in cancer
217.51951523658133	-3.52357570544973	198.9195303037734	-4.94254910330301	0.0008	202	24	LAML	OLOMOUCINE	Experimental
774.0863393258039	-3.6811704953551	713.5506196703817	5.59926710133243	0.586	543	74	LUAD	PKI-587	Clinical trials in cancer
591.9274414093697	-33.4569491942231	643.5094798385044	5.59516993933175	0.491	264	124	SKCM	INDISULAM	Clinical trials in cancer
164.61732812021936	33.982472012531	202.6189669876991	6.57194039285764	0.0004	343	52	HNSC	LY2183240	Experimental
669.9855067741161	14.8499012243891	693.7221776538767	0.840838040262895	0.552	512	68	UCEC	SAR260301	Clinical trials in cancer
285.0971892508022	9.57763344455884	179.3448886670711	29.3039299588057	0.0006	57	24	PAAD	PI-103	Experimental
206.45525911099634	7.08298929398239	198.89009660206293	-0.838514706992214	0.0006	599	66	GBM	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
773.1438123284978	79.7493877957868	709.0910147290004	-23.3815317572336	0.552	57	24	PAAD	PF-04691502	Clinical trials in cancer
932.6975961334771	-25.7225222649344	948.0005744942534	-0.000350849275719156	0.831	222	129	LGG	PEMETREXED	Approved in cancer
303.16768484174304	-4.60927098008111	295.5159803312653	-1.16701702291061	0.111	502	57	KIRC	EDARAVONE	Clinical trials
110.87291236520299	99.5729568477801	137.82182106669705	-46.0619510394117	0.0008	264	158	SKCM	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
287.13429310063776	-22.1300846439322	190.07841293508736	18.0468199736001	0.0004	512	144	UCEC	LY2183240	Experimental
217.15122308246245	-23.3013125201625	201.63810345189685	8.05562019097647	0.0008	202	23	LAML	UNII-5277GPA358	Experimental
642.3410690035371	-79.4403278581816	679.4336402689981	-28.2764915023379	0.513	435	183	THCA	OBLIMERSEN	Clinical trials in cancer
169.02221207410827	56.183999629548	198.56678792500222	-2.96725745220107	0.0006	512	77	UCEC	RU82197	Experimental
673.4674018026914	-16.7303230134102	658.7851025123426	-12.8712737675319	0.512	202	32	LAML	RO4987655	Clinical trials in cancer
190.5405520699722	21.87299905703	213.93376538815042	15.9863595558197	0.0006	502	56	KIRC	SE-ETHYL-ISOSELENOUREA	Experimental
145.38952795730086	96.1817427591824	153.90797640649382	7.28073447485554	0.0004	435	183	THCA	KU 0060648	Experimental
546.9708391307181	-8.25418771647881	544.161754242783	-0.237660047377233	0.381	512	75	UCEC	ISOPRENALINE	Approved in other pathologies
262.3035034003828	-11.1236936327457	197.12297764385195	-26.8972515435109	0.0006	512	80	UCEC	CHEMBL291678	Experimental
943.966046321453	5.83732794192679	948.999906274211	-3.23666097301611e-05	0.832	543	70	LUAD	TEMSIROLIMUS	Approved in cancer
161.34576045953938	-5.71876457637114	190.3439619657366	-9.76593121014366	0.0008	202	25	LAML	PHOSPHONOTHREONINE	Experimental
357.1706437105862	1.13325462520052	365.3226092221857	-0.169613797526381	0.181	292	31	STAD	ADENOSINE TRIPHOSPHATE	Clinical trials
743.7571099109526	-52.8764159202838	714.0868081037464	-10.9898769327287	0.595	423	80	COAD	COPANLISIB	Clinical trials in cancer
781.6036415564694	68.3845592647783	715.992690793566	11.3247075431017	0.595	512	142	UCEC	SONOLISIB	Clinical trials in cancer
729.0918490234953	-77.1749597168397	680.0135639230248	19.1835401714334	0.583	264	123	SKCM	OBLIMERSEN	Clinical trials in cancer
151.00200421378855	-51.9591839032929	197.6193451259005	-4.32673287085595	0.0006	502	53	KIRC	VERDOHEME	Experimental
703.4508389089955	-43.0616199234951	686.570691332063	3.39728870414478	0.532	502	58	KIRC	OSI-930	Clinical trials in cancer
516.7175519806551	-15.8579520619826	535.5606605488784	-12.3307440646913	0.381	264	177	SKCM	ISOPRENALINE	Approved in other pathologies
1020.3000835820661	18.8952886895372	1028.5847571145716	-2.68048246880585	0.922	202	37	LAML	CABOZANTINIB	Approved in cancer
1082.1382698393684	21.5405820179171	1083.2980941329533	2.59145210112752	0.981	292	37	STAD	ERIBULIN	Approved in cancer
642.9701224218248	8.80750196036081	681.8773278365799	-12.0882340874225	0.523	202	22	LAML	PEXIDARTINIB	Clinical trials in cancer
1089.9647173774424	11.5068130245565	1080.1118965780693	-3.76927238564826	0.981	169	28	READ	ERIBULIN	Approved in cancer
154.34580628342397	-40.9389787034202	190.62874876290164	-15.3090280932197	0.0006	423	63	COAD	1,9-PYRAZOLOANTHRONE	Experimental
1119.806739867544	6.243762685185	1100.4414188519122	-6.45908613428219	1	423	93	COAD	SORAFENIB	Approved in cancer
232.53360007217856	-41.9361945148888	202.91499402750256	2.36035897996726	0.0006	502	56	KIRC	CHEMBL44833	Experimental
181.04576559983957	2.42795182429151	196.4847535046851	25.984698001635	0.0004	264	30	SKCM	32703-82-5	Experimental
909.7137570979895	-2.37475959816035	909.5253316546919	-1.14159770380223	0.791	512	52	UCEC	AFLIBERCEPT	Approved in other pathologies and in clinical trials in cancer
1099.817172945409	-17.2073874668174	1086.94732628455	-1.21662321429721	0.984	292	40	STAD	PACLITAXEL	Approved in cancer
804.4891792614416	-12.3680933420469	764.1201880778628	-10.8919945887524	0.594	264	113	SKCM	PF-04691502	Clinical trials in cancer
744.0641635107862	0.410430417155936	688.6841201645062	-16.1203091918649	0.522	202	53	LAML	GSK2636771	Clinical trials in cancer
828.3751040752738	2.06757269404622	777.0003277626605	0.00036214132219925	0.641	57	24	PAAD	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
639.0795432462061	-7.73990524250334	684.8702271553401	-0.281677927495821	0.532	153	16	BLCA	MLN1117	Clinical trials in cancer
202.01488139278104	20.2200232698623	188.56016002651066	8.31157135586227	0.0006	502	53	KIRC	BILIVERDIN	Experimental
642.6997815193263	12.671333481358	653.7794795456686	-1.87708064510684	0.511	502	55	KIRC	N-(4-CHLOROPHENYL)-2-[(PYRIDIN-4-YLMETHYL)AMINO]BENZAMIDE	Clinical trials in cancer
693.7738141888209	-46.1381287133802	664.1654620360638	4.55219555604049	0.521	502	54	KIRC	2-METHOXYESTRADIOL	Clinical trials in cancer
739.4794931895251	98.7601584860069	714.0830505821128	-7.29382293234988	0.536	57	24	PAAD	BINIMETINIB	Clinical trials in cancer
701.3162544356392	80.5666550142233	759.0362573419311	-49.8480484665183	0.594	264	113	SKCM	SF1126	Clinical trials in cancer
195.9297842808556	-20.040701429533	191.91885413628216	1.76505623947014	0.0006	264	35	SKCM	CHEMBL522579	Experimental
707.1295864120973	14.6671141901392	652.252417470484	1.68695624028123	0.522	202	39	LAML	ENCORAFENIB	Clinical trials in cancer
535.2111538120566	12.1304153195888	547.1507775688546	3.92414205452383	0.381	169	43	READ	ISOPRENALINE	Approved in other pathologies
139.78147977846294	37.1084154503165	202.12942513298603	-23.8529521283469	0.0004	512	70	UCEC	P-0850	Experimental
191.30403975599185	-72.9883172125178	197.20950857197357	-12.8759293944681	0.012	934	214	BRCA	TG100-115	Clinical trials
236.56287989543765	-52.8703845769541	192.82508778784347	11.6775430077762	0.0008	202	24	LAML	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
623.0133598162784	-36.6555535708755	668.7962023540944	1.57371250233632	0.522	202	53	LAML	SF1126	Clinical trials in cancer
216.13245849806762	34.8568712245165	215.3399333864988	-1.37237704690165	0.0004	202	45	LAML	LY2183240	Experimental
149.6486671077254	-39.623399756345	189.1251000341553	5.50526476572122	0.0004	264	27	SKCM	GW843682X	Experimental
728.7176899298286	51.9494441354003	725.342302049665	-10.4993299798434	0.582	512	77	UCEC	VITAXIN	Clinical trials in cancer
192.9250461980722	-64.5161149998559	214.9760087686795	3.15789871033394	0.0008	423	90	COAD	SB220025	Experimental
207.61567392949271	-4.66230464725362	203.8751203373909	-2.24957261315666	0.0006	512	63	UCEC	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
179.7781885778548	-60.6799947856198	201.51130278125012	-5.45136850851554	0.0004	343	53	HNSC	PARBENDAZOLE	Experimental
777.7237889535535	9.48733704143723	747.0903909320921	-14.7906053121593	0.595	169	46	READ	BUPARLISIB	Clinical trials in cancer
270.0712243237003	-46.4193102528047	180.63263012510802	6.61167642087668	0.0006	512	75	UCEC	OLOMOUCINE	Experimental
233.83122615449267	119.557782669355	230.5741203791551	-23.3728231376504	0.0006	435	211	THCA	DB06892	Experimental
732.0579863139706	-43.0345566719087	715.5611320842653	-4.29448656105569	0.581	423	65	COAD	DHA-PACLITAXEL	Clinical trials in cancer
160.88699743512245	19.6874907102936	210.92193674790286	-8.87825139788492	0.0006	169	44	READ	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
744.3792892078893	69.0875919828969	761.0165190807592	5.91985385283942	0.596	264	113	SKCM	XL765	Clinical trials in cancer
1030.3098931942277	7.76149294108302	1039.6996068338335	5.74808130010388	0.935	502	62	KIRC	LENVATINIB	Approved in cancer
235.14298330269716	-3.56047256770182	207.277253535431	17.090587706643	0.0006	512	77	UCEC	RU78299	Experimental
177.4300238677293	-35.0126773829639	207.24302741950785	16.7600532462075	0.0006	264	35	SKCM	CHEMBL559401	Experimental
676.5825327366709	-25.3502405190506	677.6444044820093	5.66432387447389	0.535	502	58	KIRC	LINIFANIB	Clinical trials in cancer
271.5754591370029	26.5473395327624	201.2746324484272	-2.42616030372369	0.0008	435	209	THCA	PLX-4720	Experimental
707.8396503402802	93.117571220356	754.1239698159986	18.9151903235963	0.594	169	46	READ	XL147	Clinical trials in cancer
629.9078712170008	-1.7540163388361	665.8259780489592	0.456943374164894	0.521	502	57	KIRC	BEVACIZUMAB + ERLOTINIB	Clinical trials in cancer
1033.911894779499	4.09754538202688	1041.4107810672833	0.901801238910139	0.933	502	67	KIRC	PONATINIB	Approved in cancer
1038.5223206636613	44.0837399408862	1030.0719772090804	9.3429047221305	0.936	57	24	PAAD	SORAFENIB	Approved in cancer
667.0911687529365	-37.8208302793396	759.380889686093	-22.1016789856758	0.595	264	48	SKCM	DOVITINIB	Clinical trials in cancer
244.3632339298812	-30.2275284678522	183.20984552530766	-9.88101434621922	0.0006	264	35	SKCM	3-(4-FLUOROPHENYL)-1-HYDROXY-2-(PYRIDIN-4-YL)-1H-PYRROLO[3,2-B]PYRIDINE	Experimental
279.36314781208864	-25.7042843454432	192.89429867503188	-17.6804607632928	0.0006	512	77	UCEC	PHENOL, 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]-	Experimental
229.46095790950514	-15.9061613731651	219.68644234245625	-0.165843930189112	0.0006	264	35	SKCM	1-(5-TERT-BUTYL-2-METHYL-2H-PYRAZOL-3-YL)-3-(4-CHLORO-PHENYL)-UREA	Experimental
553.2849075569793	5.47306987493587	554.0778603432236	0.0966919366146044	0.391	512	59	UCEC	ICOSAPENT	Approved in other pathologies
153.16836763325333	7.66161570088485	201.9330783794439	-2.06039339794518	0.0008	389	42	LUSC	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
1042.6772373408953	15.9585898424642	1046.5431378170329	-0.000612168527652557	0.94	512	105	UCEC	CETUXIMAB	Approved in cancer
554.6767591500922	-37.9534299553072	587.9997055763127	-0.000561662266136409	0.431	222	128	LGG	INDISULAM	Clinical trials in cancer
192.04503191036065	11.4013020867345	198.03635285371274	14.7483708003633	0.0006	502	56	KIRC	S-ISOPROPYL-ISOTHIOUREA	Experimental
681.5033575215524	22.9129049347774	724.7189086331631	12.5253195711699	0.582	543	72	LUAD	GDC-0623	Clinical trials in cancer
310.40062295546073	-63.4852118639106	216.1251519701137	-58.2542160867231	0.0008	264	112	SKCM	CHEMBL526479	Experimental
818.9051184888848	39.0975081905554	802.973253466451	-18.7075425997468	0.596	264	186	SKCM	391210-10-9	Clinical trials in cancer
230.43825082117507	-6.3076193443994	202.4935046821016	-29.4180662760151	0.0004	512	72	UCEC	SB 225002	Experimental
178.63974684060588	99.1570263105015	241.1024213103137	2.40292466539353	0.0006	57	24	PAAD	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
551.3481359585932	1.46408263129561	539.0877748366537	-0.331360798890216	0.381	512	55	UCEC	MINOCYCLINE	Approved in other pathologies
1096.6081522110694	11.8434803123727	1095.2010857491396	-8.97316790901385	0.997	512	74	UCEC	COBIMETINIB	Approved in cancer
180.82318618633428	43.4494869631283	188.35127588740764	-29.5845042748975	0.0004	512	73	UCEC	NAKITERPIOSIN	Experimental
153.96049590980846	-66.547383994707	213.0216643083458	-16.5192893156886	0.0004	934	215	BRCA	OLIGOMYCIN A	Experimental
142.43465587674666	-29.4415678331393	211.55943709026212	-8.92774830233111	0.0004	423	58	COAD	N-ISOPROPYLPHTHALIMIDE	Experimental
230.88522622514492	-19.7051315630164	209.66494121848788	16.7835866420776	0.0006	502	53	KIRC	DB06879	Experimental
195.2395455524487	-31.2055142793306	173.31921512390502	-3.23006394437016	0.0006	264	35	SKCM	SD-06	Experimental
226.7502165694931	-20.2364361872814	237.6622885641817	-2.1566787269615	0.021	512	54	UCEC	7-ETHYL-10-HYDROXYCAMPTOTHECIN	Clinical trials
718.8126591960735	11.5048699800006	724.0307768802506	-4.66474472182762	0.581	512	77	UCEC	ANTI-THYMOCYTE GLOBULIN (RABBIT)	Clinical trials in cancer
238.12508292423203	-15.8839960752473	203.10985147834432	0.838821049361854	0.0008	599	70	GBM	PI-103	Experimental
226.1480109626421	2.54592932467554	195.85716901839137	23.8434231944216	0.0004	512	66	UCEC	WORTMANNIN	Experimental
511.8339020825988	5.01071310764129	516.000000776685	0.000507215389802695	0.351	389	49	LUSC	IBUPROFEN	Approved in other pathologies
530.1837563781131	-5.03633100300655	548.6349985416235	3.96554653149906	0.381	264	50	SKCM	PEGADEMASE BOVINE	Approved in other pathologies
710.6069588847181	-35.5034354662902	752.3507209794184	7.63333911352811	0.594	423	90	COAD	ENCORAFENIB	Clinical trials in cancer
178.9327414980102	115.751392832372	208.31155636494748	32.5569620574014	0.0006	57	24	PAAD	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
707.1477432971001	-27.8360312413609	721.6195665985043	-8.32500563013537	0.582	423	89	COAD	BI847325	Clinical trials in cancer
647.9689078813258	-68.3186850263063	708.0711383994026	5.99642132322651	0.581	264	52	SKCM	LERAFAON	Clinical trials in cancer
199.0327019371706	-4.58979395070565	203.08264827495606	-41.4991654831701	0.0004	264	33	SKCM	KINETIN RIBOSIDE	Experimental
494.9913055234758	-13.9674882976923	489.44417662083794	3.20368785675169	0.311	435	183	THCA	IBUPROFEN	Approved in other pathologies
312.0394657174404	-26.1200112938012	226.47837684243052	-42.3292271245225	0.0006	435	211	THCA	SB220025	Experimental
688.9210980819851	22.8336937928341	728.6659989262323	21.3126807634619	0.582	169	44	READ	BI847325	Clinical trials in cancer
270.24970065305996	2.36194369135163	215.98088678404991	-34.3256349322598	0.0006	57	24	PAAD	CHEBI:83275	Experimental
702.5137488481233	-4.15468639264699	722.306382730127	4.66108411572964	0.581	222	55	LGG	S-8184	Clinical trials in cancer
184.640638069575	-13.4066948927253	205.25646027670683	-13.3275176140464	0.0006	502	56	KIRC	2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE	Experimental
181.14657105496238	-21.0808989652845	207.37154581498697	-9.36887044016385	0.0006	264	35	SKCM	3-[2-(PYRIDIN-4-YL)ETHYL]-1H-INDOLE	Experimental
693.9238910036341	-65.4998241890804	695.730966174062	10.3857401128407	0.595	264	115	SKCM	BYL-719	Clinical trials in cancer
1003.1479627766529	49.8226880619041	1015.8421661057522	-2.13530218900996	0.914	435	183	THCA	PACLITAXEL	Approved in cancer
1084.643510230997	-14.2169596440109	1083.002399858982	2.02968027294901	0.986	153	21	BLCA	BOSUTINIB	Approved in cancer
107.79430257632922	-0.216633261700849	243.49495412395817	-36.0694052824072	0.0004	435	183	THCA	VX-11E	Experimental
1094.0606371856015	6.62486761489612	1083.4355255111186	3.5271480266743	0.986	543	83	LUAD	BOSUTINIB	Approved in cancer
728.4513147049656	14.741114799807	735.0849913002611	13.5803670007165	0.582	512	74	UCEC	GDC-0623	Clinical trials in cancer
480.81977937177686	-6.03894871224824	478.4464443297287	2.11435764317184	0.311	202	24	LAML	ISOPRENALINE	Approved in other pathologies
140.0356023636195	4.65848766625768	185.3540333751844	-13.6433378777779	0.0006	169	39	READ	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
752.7420414198925	95.6697483000197	708.211438110288	19.0131624852688	0.584	169	44	READ	AZD8330	Clinical trials in cancer
1057.218580021907	23.2768159128106	1038.4572004303066	0.000741288309711763	0.932	512	102	UCEC	DOCETAXEL	Approved in cancer
218.17676437979566	4.61348842432321	191.8558615861387	-25.9816770936976	0.0004	512	57	UCEC	CHAETOCIN	Experimental
223.9714894909992	-28.2725644867867	210.23388166006015	-5.91111373007629	0.0008	202	24	LAML	CHEBI:83275	Experimental
230.79940365513997	43.436743473397	193.40001122676153	11.154945240262	0.0006	512	54	UCEC	DB08170	Experimental
1105.936003449138	29.4476234343434	1101.5636623401826	1.69453806709225	1	423	81	COAD	TEMSIROLIMUS	Approved in cancer
148.5733531482655	27.7505013115007	205.69140544761783	5.68245116385947	0.0006	502	53	KIRC	AZD7545	Experimental
298.4277913628093	-14.1422949224103	167.494302865241	-19.2257573545587	0.0004	435	183	THCA	5Z-7-OXOZEAENOL	Experimental
1035.2762957766256	12.0309447238893	1029.0000513883929	0.000146532991948334	0.921	423	90	COAD	CETUXIMAB	Approved in same tumor type
205.05164015059142	-43.7714144535397	217.36048417352652	1.34122439440625	0.0004	934	216	BRCA	GW843682X	Experimental
477.05733761838303	-3.58146728707897	479.7305305940188	-5.2911917443796	0.311	502	53	KIRC	AMPICILLIN	Approved in other pathologies
754.8155123440114	-5.82814452558512	743.6220258410694	-5.59123574206433	0.595	292	43	STAD	BYL-719	Clinical trials in cancer
1035.964444661659	20.0190540385952	1033.548487515947	2.84429134678817	0.923	202	38	LAML	PONATINIB	Approved in same tumor type
611.738043361628	-12.8339795066873	605.9997370103289	0.000180614723831241	0.451	343	46	HNSC	141400-58-0	Clinical trials in cancer
309.4881117850433	-10.3696569725938	307.0245643005635	-0.0237505952693482	0.111	502	53	KIRC	FORMIC ACID	Clinical trials
189.91261511357504	-25.0890643842149	210.98776196683318	12.6404368580311	0.0006	502	56	KIRC	N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE	Experimental
156.0352484056453	-33.9049786339683	193.3323166620392	21.1237814657816	0.0008	423	90	COAD	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
652.0273114658135	-19.5000933063645	679.9999981342032	-0.000153058945215889	0.533	599	60	GBM	NAVITOCLAX	Clinical trials in cancer
840.1187272422904	-3.80916452603978	843.999947606312	-6.66500222905597e-05	0.716	934	220	BRCA	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
628.1907710473	33.0650338771057	667.2048493127269	-3.93696050949779	0.521	502	59	KIRC	SKF-86002	Clinical trials in cancer
746.3692302190752	-11.1067310877443	736.571593998068	-6.55207852869739	0.594	389	46	LUSC	PKI-587	Clinical trials in cancer
746.5646337603455	22.8410877759711	734.3207906112171	-4.53349968051174	0.587	543	74	LUAD	COPANLISIB	Clinical trials in cancer
646.0080190336018	25.3914804904933	663.3180056348455	-10.0696856984414	0.522	202	22	LAML	PLX108-01	Clinical trials in cancer
246.63575959863465	24.7864522724823	181.40876250486133	27.3325939143385	0.0004	512	66	UCEC	937174-76-0	Experimental
266.7258808104991	-7.86290558319817	309.0002085294909	-3.10872311501953e-05	0.121	543	62	LUAD	LAX-101	Clinical trials
710.089811460635	-50.1773796382298	735.9898513256126	-4.99646693472596	0.583	423	65	COAD	GOSSYPOL	Clinical trials in cancer
679.8672549747076	-28.5548493385245	668.046472967271	-12.2140291051967	0.526	202	24	LAML	MIDOSTAURIN	Clinical trials in cancer
965.6000830511636	0.144478127188165	966.0000031497582	-0.000329571304973797	0.851	264	32	SKCM	IDARUBICIN	Approved in cancer
155.32731039578562	62.9811581921855	244.14754699615176	-41.3129194641483	0.0004	264	104	SKCM	VX-11E	Experimental
197.61250378554877	-69.4181384644354	192.60073774077705	-10.791632670423	0.0006	264	35	SKCM	N-(3-CYANOPHENYL)-2&#39;-METHYL-5&#39;-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-4-BIPHENYLCARBOXAMIDE	Experimental
228.11265293954065	-10.9169714010636	205.45174050165275	2.42494401635986	0.0004	153	18	BLCA	GW843682X	Experimental
183.96196705539617	-66.7672836837862	193.59017578303704	-19.4763288848393	0.0006	169	43	READ	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
709.4904465622462	9.49092308611341	736.6398526753218	5.72632395529581	0.594	389	42	LUSC	XL147	Clinical trials in cancer
795.7662149189581	37.8235310221253	702.6318784035033	-5.18656446804289	0.595	264	112	SKCM	COPANLISIB	Clinical trials in cancer
277.3083387512251	37.6989168098294	191.1794969963778	-12.0904447274502	0.0006	512	75	UCEC	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
216.57052383959638	-49.0694067319425	201.47543573628326	-6.99872818408085	0.0006	264	33	SKCM	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	Experimental
225.33703057197516	12.7364896403104	208.80104109175429	4.04078405945359	0.0006	543	63	LUAD	DB07268	Experimental
702.0837854771248	-12.6072174472461	726.7698470879724	-10.0084992328966	0.594	343	62	HNSC	XL147	Clinical trials in cancer
1089.5488235525836	-14.627973132714	1085.0769378731295	-2.08215557328867	0.977	264	31	SKCM	AXITINIB	Approved in cancer
542.3195555235274	-6.1479072465674	545.974488665199	4.54769279478018	0.381	512	56	UCEC	CHOLINE	Approved in other pathologies
185.1888364067694	-18.019512280616	205.44238880229858	-9.59830610755853	0.0004	343	45	HNSC	ML214	Experimental
776.427169484748	-11.5153812794076	647.8910978649766	-12.4313615480885	0.522	202	53	LAML	BUPARLISIB	Clinical trials in cancer
515.1100089164283	11.6650631793914	513.5252507842893	-4.23222783778829	0.351	343	84	HNSC	RASAGILINE	Approved in other pathologies
680.2156498108307	5.8142249496162	683.0753849652673	3.49669277857811	0.533	153	16	BLCA	RIGOSERTIB	Clinical trials in cancer
236.03897083779998	-26.91886631277	181.47222263633438	5.30764851372169	0.0006	502	53	KIRC	QUINONOID DIHYDROBIOPTERIN	Experimental
714.6305383781967	18.1386970992683	677.3810552206796	11.8684012788844	0.547	934	224	BRCA	SONOLISIB	Clinical trials in cancer
640.153673923114	62.9705374675203	636.957516406435	-0.714359645660352	0.511	435	183	THCA	S-8184	Clinical trials in cancer
705.4160302669962	7.55964456385607	737.1285306447894	5.85165589765865	0.583	543	74	LUAD	GDC-0980	Clinical trials in cancer
198.67006179463414	35.2753867065935	193.2805280674506	10.1812046993641	0.0006	543	63	LUAD	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
755.1286656013282	31.0516230404929	712.7166270235933	-20.6061489856586	0.583	169	44	READ	TAK-733	Clinical trials in cancer
643.8992147812771	-11.6829614909004	658.9166674478205	5.19466797407017	0.511	502	53	KIRC	NICOTINAMIDE	Clinical trials in cancer
1106.6290109472122	-57.7787285178242	1097.5482965096917	45.3983642775975	0.991	264	193	SKCM	BOSUTINIB	Approved in cancer
256.9140211737895	-12.6227224193061	186.1089096197912	5.65410404837564	0.0008	512	68	UCEC	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	Experimental
924.5692939813875	9.45179337739313	944.5019419826388	-3.24483522357878	0.822	435	185	THCA	TEMSIROLIMUS	Approved in cancer
1106.6863402851607	3.90768893052166	1096.0224113493807	0.451083768156423	0.994	153	24	BLCA	PONATINIB	Approved in cancer
709.3274900692263	-43.3696672707967	750.9635518226888	-6.21493577270394	0.594	423	80	COAD	PWT33597	Clinical trials in cancer
649.4108857566953	19.8902282492013	726.39316582651	13.1097195402785	0.593	423	90	COAD	BMS-908662	Clinical trials in cancer
791.4791552439124	-15.6101338128223	743.4471311177914	6.25087186439237	0.596	292	44	STAD	NVP-BGJ398	Clinical trials in cancer
198.18199343249807	5.54059350741119	217.7176260819966	-9.70334084858257	0.0006	512	75	UCEC	DB07788	Experimental
174.30442861701712	29.0990656551668	194.82422836120145	-4.45177443964826	0.0004	292	33	STAD	EVODIAMINE	Experimental
247.8662935072136	-11.5015456726617	202.71901030734995	-1.43821733186212	0.0004	543	62	LUAD	N-ISOPROPYLPHTHALIMIDE	Experimental
568.0563384960509	-23.8413805213618	574.4821785955822	3.09713944835767	0.422	264	105	SKCM	MLN 2480	Clinical trials in cancer
1020.9389420444135	-8.33052708408306	1029.9997861428567	0.000208936576655105	0.922	169	34	READ	DOCETAXEL	Approved in cancer
215.66972086994784	-107.685508179502	272.358987938314	5.01381359006655	0.0008	264	177	SKCM	OLOMOUCINE	Experimental
660.0119669397246	-17.4694714565711	668.6873460127249	3.9861122233674	0.521	502	57	KIRC	ABT-510	Clinical trials in cancer
675.6202091805668	-2.05101720130099	680.4732711614297	9.51845067067234	0.534	502	62	KIRC	LUCITANIB	Clinical trials in cancer
252.07858509304108	-72.5081424781763	295.2171751058808	-5.66168036232557	0.111	502	56	KIRC	L-CITRULLINE	Clinical trials
643.0238631982716	-15.8859130819622	658.2376235701428	-2.14520457519416	0.513	502	57	KIRC	OBATOCLAX	Clinical trials in cancer
783.9026360000971	-19.1143107578134	715.4278073975712	-5.0449968520827	0.595	169	46	READ	BYL-719	Clinical trials in cancer
1068.9140360726185	49.6039976131287	1078.2440865070228	4.91424169314257	0.986	169	47	READ	BOSUTINIB	Approved in cancer
676.5649421634569	40.1311812564193	747.6244142634922	19.2753630463636	0.595	512	141	UCEC	COPANLISIB	Clinical trials in cancer
210.82858730607953	-40.4528700524574	214.0687091287677	-14.3367428449053	0.0006	502	53	KIRC	3-PHOSPHOGLYCERATE	Experimental
229.09651896055783	38.6627580776096	205.4039747013776	-12.6735189855552	0.0008	512	76	UCEC	PHOSPHONOTHREONINE	Experimental
214.51325683559529	117.878309352471	253.72864908708746	2.38709858827428	0.0006	435	211	THCA	CHEBI:83275	Experimental
233.95450801829426	-17.2217349089676	199.36315130001884	-8.65952520349106	0.0006	502	53	KIRC	12-PHENYLHEME	Experimental
566.9960417472186	-2.02927072927201	570.8884072866549	-2.84384842053947	0.412	512	66	UCEC	DUVELISIB	Clinical trials in cancer
210.0545893330654	56.0312534559822	219.13382918621338	12.1819050048985	0.0006	512	77	UCEC	RU82129	Experimental
1051.0280775701613	-5.88758932142179	1046.160628576627	0.000737449759526498	0.941	389	45	LUSC	ERIBULIN	Approved in cancer
177.43714631054723	39.4157957381635	186.61453388668323	25.837088825473	0.0006	512	74	UCEC	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
359.69196452392123	5.02769174540731	360.6774728988576	0.169994499957511	0.181	292	37	STAD	EDARAVONE	Clinical trials
234.4166029701879	-30.7317106885869	182.13888942852572	16.2407885312966	0.0004	512	66	UCEC	AS 604850	Experimental
145.0518296380839	25.8478717300633	198.88478602569884	2.67915970208833	0.0004	292	32	STAD	NUTLIN-3	Experimental
1086.3220208696623	66.4743392080362	1136.005204027808	6.71513201736707	0.997	264	186	SKCM	COBIMETINIB	Approved in same tumor type
788.8502371456982	-61.8827842963499	728.5243581743972	64.7262035518152	0.581	264	123	SKCM	S-8184	Clinical trials in cancer
230.95421265065787	86.2135875493065	182.15964229780164	-29.8184972959348	0.0006	435	211	THCA	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
739.6626371977512	7.36882192095567	743.8660161501089	-1.46832721009628	0.593	343	62	HNSC	SF1126	Clinical trials in cancer
268.38106797732877	13.1800436994195	218.7780843007157	18.1577915656255	0.0006	512	77	UCEC	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
133.05971713464965	14.72353344111	220.35210346057798	0.0919027035790805	0.0008	502	58	KIRC	IMC-1C11	Experimental
724.1673062061254	-35.0402720775942	753.0953105616362	-21.9316356934005	0.595	264	35	SKCM	IPATASERTIB	Clinical trials in cancer
1023.2965695968842	-17.5491517717112	1017.308528506736	-0.870885785414202	0.911	202	32	LAML	DABRAFENIB	Approved in cancer
638.5384385707924	15.442986657051	672.5108957903984	-2.26872489746552	0.522	343	52	HNSC	SAR260301	Clinical trials in cancer
157.13384477653972	-11.433702255455	192.83295989741816	-2.23510039097482	0.0004	423	95	COAD	LY2183240	Experimental
555.830011784207	1.33794398239667	549.4333179635378	-0.0771747497298065	0.391	512	60	UCEC	UREA	Approved in other pathologies
240.9989913458326	-25.4732803678077	193.5592531064496	-3.3512859464754	0.0006	202	32	LAML	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
710.4394453937291	4.47657008909172	739.5249267619062	-10.3900084039143	0.583	169	28	READ	OBLIMERSEN	Clinical trials in cancer
643.5708762943932	17.1941669814529	646.9196865470059	5.08163575618346	0.504	202	25	LAML	MK-2206	Clinical trials in cancer
738.0265815456719	-3.34251095700367	715.9996569144031	-0.000169285261790719	0.573	153	19	BLCA	XL-228	Clinical trials in cancer
717.3576225023336	-21.5906855507349	725.3989134166752	7.20372230829389	0.581	264	33	SKCM	CC-401	Clinical trials in cancer
949.0732272797349	6.40576142043028	947.9997772450027	8.94130516826408e-05	0.831	343	44	HNSC	PEMETREXED	Approved in cancer
168.10859185133629	48.4616661625685	228.27244830905468	-8.63888013255962	0.0008	169	43	READ	FR 180204	Experimental
225.68770035246763	-2.64182253887492	176.77357980852028	2.21274557691106	0.0004	512	74	UCEC	BISTRAMIDE A	Experimental
524.6413968045625	-2.01068951959058	525.0000627523343	4.36173122011496e-05	0.361	543	69	LUAD	ISOPRENALINE	Approved in other pathologies
623.8034169608444	100.637250965398	742.5130545183396	-65.2257195475304	0.582	264	185	SKCM	RO4987655	Clinical trials in cancer
209.40427550454712	-30.4437044115472	201.45584763708422	-1.60121536721635	0.0008	423	89	COAD	DB06892	Experimental
186.1673383695081	24.3475801708893	204.19724229110176	13.0690333398593	0.0006	202	32	LAML	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
757.8364878870365	-46.3346700096417	743.0033372194162	-6.91047344557455	0.592	423	89	COAD	212631-79-3	Clinical trials in cancer
696.0527507095225	25.9160670351731	666.1497507631364	-12.5015207291358	0.533	57	7	PAAD	NAVITOCLAX	Clinical trials in cancer
856.7308612448834	-1.38573127276638	853.00007834738	0.000147084788068241	0.726	343	48	HNSC	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
199.70829787611783	-54.0721531397602	222.81957976867662	14.5928981964698	0.0006	264	35	SKCM	3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE	Experimental
244.39821200955103	1.50920439652009	207.514481433163	-0.639923260865942	0.0006	543	69	LUAD	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
116.42663216232285	-29.3329088890384	219.5988109756853	-3.32103243293568	0.0006	169	43	READ	SB220025	Experimental
793.8436032425617	-10.8099453676124	723.9134605963843	1.12615619871337	0.574	599	70	GBM	BYL-719	Clinical trials in cancer
693.1234763108262	46.0544625955463	694.78803432669	-4.05887773703262	0.539	202	37	LAML	SELUMETINIB	Clinical trials in cancer
762.0428505880541	65.8682284047208	666.6322295156722	6.1244521154149	0.583	264	124	SKCM	GOSSYPOL	Clinical trials in cancer
649.6469972451824	-22.9770961963756	679.2068792096137	-3.7741375317255	0.534	502	59	KIRC	ORANTINIB	Clinical trials in cancer
221.52938229184613	-4.75650399415511	216.14902873455785	4.02463847524928	0.0006	512	54	UCEC	CHEMBL281795	Experimental
644.8289988123	92.8072979437313	669.821624384048	-2.30283835075733	0.523	57	24	PAAD	TAK-733	Clinical trials in cancer
709.3118203414306	43.1725889005626	718.3688689271627	3.17552765104466	0.596	512	75	UCEC	REFAMETINIB	Clinical trials in cancer
755.5135025127216	82.5374790400643	686.2422458959879	1.38381513228049	0.552	57	24	PAAD	BUPARLISIB	Clinical trials in cancer
681.3618656319628	-14.7113293179689	681.220184344409	-1.42414795698642	0.533	599	109	OV	NAVITOCLAX	Clinical trials in cancer
726.2695438874406	19.8793497395204	739.2449159347225	17.7588285433705	0.593	512	77	UCEC	AZD5363	Clinical trials in cancer
704.5288185584778	23.2810229557994	727.5869760859413	2.48991821624236	0.581	292	37	STAD	S-8184	Clinical trials in cancer
250.14406275140482	37.6713616442312	214.01528585193796	-13.0941771021521	0.0006	512	55	UCEC	UNII-414MEG73VU	Experimental
1032.769379046086	-11.380780160751	1027.3132503632737	-0.59178801652547	0.921	512	59	UCEC	VINBLASTINE	Approved in cancer
356.7864902726604	15.7964906403745	362.9998792244546	-0.000291111393153187	0.181	222	55	LGG	EDARAVONE	Clinical trials
777.552510797296	17.7816888548111	742.8677306638939	6.43353582109415	0.596	512	74	UCEC	BINIMETINIB	Clinical trials in cancer
960.6984817791022	0.095639705805695	958.773306350036	-1.60791638760548	0.841	543	64	LUAD	PEMETREXED	Approved in cancer
1011.3619309595014	0.467211953294054	1021.3992004418144	-5.84293840299347	0.913	202	33	LAML	BOSUTINIB	Approved in same tumor type
576.6570956880037	-14.2380745963723	581.0023539491496	-7.11918597268277	0.423	934	232	BRCA	GSK2126458	Clinical trials in cancer
150.73591635115312	3.35717185116835	229.45576719103948	10.8250795590063	0.0006	512	77	UCEC	PHENYLMALONIC ACID	Experimental
721.9210255568119	100.710211815805	676.7386488382087	-27.9542053496443	0.583	264	123	SKCM	OBATOCLAX	Clinical trials in cancer
749.8707907015491	18.3177125007713	727.6311129326132	7.97402923312984	0.593	292	43	STAD	GDC-0941	Clinical trials in cancer
121.74907838705815	-4.07593448657931	210.87510999080328	-44.8733265191577	0.0004	264	79	SKCM	CYTOCHALASIN B	Experimental
684.9037928199081	77.2883218571235	647.3787447915438	12.4844014426908	0.523	435	183	THCA	ARQ736	Clinical trials in cancer
537.0891122878724	-26.4240713697426	557.6056856251147	-5.9005810358567	0.391	264	126	SKCM	IBUPROFEN	Approved in other pathologies
178.92102550863942	20.497748250199	210.0294851360821	-15.9307083196609	0.0006	512	70	UCEC	1,9-PYRAZOLOANTHRONE	Experimental
1030.5339197335356	16.8219832984661	1043.1429312121	-0.494448672437898	0.936	543	68	LUAD	VANDETANIB	Approved in cancer
186.79412618236472	-35.7948981883859	193.72013002278237	-19.5339676006192	0.0008	264	28	SKCM	ENMD-0276	Experimental
984.695155113763	10.4302289886686	1022.843649243385	24.3577341152697	0.93	435	209	THCA	VEMURAFENIB	Approved in cancer
686.3028327508538	-34.2887792716518	685.1575188039303	7.96353938554171	0.533	502	62	KIRC	ENMD-2076	Clinical trials in cancer
323.32339391153033	-5.58980942548939	215.89344908440177	-12.9315564274	0.0006	435	183	THCA	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
754.1465424609864	-27.6216756570385	731.5603721897592	10.7898090244098	0.594	153	26	BLCA	PF-04691502	Clinical trials in cancer
176.27781164733645	-5.1256510801405	180.7957132727932	16.4129926727405	0.0004	264	42	SKCM	EVODIAMINE	Experimental
1058.9615833883151	8.52904901539421	1088.719733712113	8.3020678033422	0.984	169	46	READ	ARSENIC TRIOXIDE	Approved in cancer
232.71808941050554	28.490400608253	185.1637941544765	10.9061200033717	0.0004	512	68	UCEC	LEXIBULIN	Experimental
1098.1200741201928	0.360492275627337	1096.0748045656228	2.67083405928952	0.994	292	36	STAD	ARSENIC TRIOXIDE	Approved in cancer
1127.3129480889238	0.0844438207119822	1099.4758707599674	8.82958821487489	1	169	45	READ	SORAFENIB	Approved in cancer
749.8320429747289	-32.0231476568153	743.4943786942496	0.297791976556482	0.593	292	43	STAD	GDC-0980	Clinical trials in cancer
695.0109258347368	69.6684795524529	667.9550164719604	0.665869335618709	0.523	153	31	BLCA	NAVITOCLAX	Clinical trials in cancer
740.5709741866838	22.9380832778358	739.1049241280954	1.39433011949217	0.594	512	87	UCEC	XL999	Clinical trials in cancer
187.61150315739133	32.1776266478586	176.49749388553096	1.19855825487082	0.0006	169	43	READ	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
164.85798996694047	3.40400163988667	196.33472218086828	18.8263317313867	0.0006	502	56	KIRC	CHEMBL444422	Experimental
166.0439800774459	-5.23255934645002	230.23213870390242	-18.184424204866	0.0006	264	35	SKCM	CHEMBL371491	Experimental
262.70698703228464	-5.36528180773684	196.45518308253293	6.35111010088269	0.0008	543	72	LUAD	DB06892	Experimental
820.5020174302738	-20.328091715353	690.5487989639397	-40.4954438984159	0.581	264	123	SKCM	DHA-PACLITAXEL	Clinical trials in cancer
232.48811681478142	12.1956369533166	184.14923570457137	-23.2777046613849	0.0006	169	43	READ	CHEBI:83275	Experimental
203.71473057256688	-1.76087941496831	207.91722971006882	-1.09170368165564	0.0006	202	30	LAML	2,2,2-TRIFLUOROETHANOL	Experimental
666.5062943631867	20.6115527049801	654.2636219235068	-0.117825539475206	0.513	57	7	PAAD	OBATOCLAX	Clinical trials in cancer
207.38089809035765	135.922107716902	239.70207577296074	31.4482590048331	0.0006	435	211	THCA	DB07788	Experimental
1038.4603206203622	5.86137783079445	1031.686854484877	0.59303836315803	0.922	512	57	UCEC	LENALIDOMIDE	Approved in cancer
716.094825786028	6.68805342010364	718.4812222800575	-7.83866193849934	0.583	543	74	LUAD	DACTOLISIB	Clinical trials in cancer
663.2616155485484	-13.1548850654049	655.1481376831525	13.8967578815759	0.514	202	32	LAML	AZD8330	Clinical trials in cancer
1069.339226678854	10.5912500016668	1101.307862818091	-9.44471252571816	1	169	44	READ	TRAMETINIB	Approved in cancer
904.324317131501	6.82519071678263	905.820359662336	3.84300375141441	0.784	512	107	UCEC	CELECOXIB	Approved in other pathologies and in clinical trials in cancer
154.15835977291277	13.9279067480131	227.0302631018132	-22.0214440475835	0.0004	512	104	UCEC	EVODIAMINE	Experimental
209.6920521810506	3.98475146095049	201.76174036047158	5.12119097335835	0.0008	153	17	BLCA	NVP-BGT226	Experimental
218.04842083780576	27.8840569205316	212.67480635787155	-6.78701004593182	0.0006	512	76	UCEC	1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA	Experimental
678.4862753794894	-103.859776630816	715.920849730973	-56.1131020892497	0.583	264	186	SKCM	TAK-733	Clinical trials in cancer
1032.7701762567806	-0.892063983937703	1046.4013710133902	0.407458528402231	0.937	502	59	KIRC	AXITINIB	Approved in same tumor type
384.679920934921	4.92815388816939	373.0000122576118	0.000493948795451615	0.192	543	75	LUAD	QUERCETIN	Clinical trials
223.49377772467494	26.5438088526181	189.8432283266519	7.24718961298049	0.0006	202	30	LAML	1,6-HEXANEDIOL	Experimental
1061.4297338172748	-8.79886489878285	1052.999693073038	0.000200503408450459	0.948	599	69	GBM	BOSUTINIB	Approved in cancer
270.3355679730991	80.0017079621962	177.19948218578313	-9.30678635042477	0.0004	169	39	READ	NSC632839	Experimental
1050.864127484857	8.24218960357649	1024.755579941779	-0.545766176611579	0.921	57	8	PAAD	DOCETAXEL	Approved in cancer
170.6017299770825	62.7780549841619	222.62250793923212	27.5894106048192	0.0008	512	115	UCEC	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
223.0163525400414	50.1925347269279	210.41735780873626	-21.3796050057635	0.0006	512	70	UCEC	DB07268	Experimental
704.9091913822745	28.8100133979599	740.7495538477873	11.9358925902831	0.6	512	77	UCEC	SELUMETINIB	Clinical trials in cancer
673.491790939487	-41.5929759883014	729.4005320121933	-6.62983823050126	0.593	423	80	COAD	GDC-0980	Clinical trials in cancer
462.28997439762253	-8.18084830453557	477.46342638237815	-10.3916014150125	0.311	435	211	THCA	ISOPRENALINE	Approved in other pathologies
650.1046991557071	-27.499560006858	661.9351649953843	8.37174364211228	0.511	502	57	KIRC	S-8184	Clinical trials in cancer
966.7855274636198	12.9154427263337	957.2722825227389	8.37709335516374	0.841	57	24	PAAD	ETOPOSIDE	Approved in cancer
683.393292246379	17.9628426447944	699.0369291347683	0.972313030182079	0.552	512	68	UCEC	MLN1117	Clinical trials in cancer
237.60452915970487	2.94229341869146	193.2338467730654	20.4315774856616	0.0006	169	39	READ	1,9-PYRAZOLOANTHRONE	Experimental
139.75367304725543	-8.15532981389822	187.30522406066856	13.8679331674266	0.0008	423	89	COAD	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
256.49025352193064	-105.199806914635	169.18468067632222	-60.6673376423755	0.0008	264	166	SKCM	PLX-4720	Experimental
325.6147471189725	44.074651739543	219.83388514229077	18.2071852547343	0.0008	169	47	READ	PI-103	Experimental
235.6848360397542	-21.7342900515966	168.8741400842892	8.92884030901376	0.0006	512	77	UCEC	CHEMBL56904	Experimental
712.7335547843672	68.0312501101418	735.5094122935973	12.4570222075893	0.553	57	24	PAAD	SONOLISIB	Clinical trials in cancer
1089.3526705569836	-1.37430473702122	1091.5114314886466	-3.57665129265047	0.99	292	35	STAD	EVEROLIMUS	Approved in cancer
309.53761531733034	6.10401472430794	301.8038057194075	-1.59473136290737	0.111	57	7	PAAD	EDARAVONE	Clinical trials
666.4194915197306	104.893838039055	655.3949204550684	-10.9424660624191	0.523	57	24	PAAD	BMS-908662	Clinical trials in cancer
835.170508742624	-38.7663908002542	774.6459570769672	44.0597070416266	0.6	264	188	SKCM	SELUMETINIB	Clinical trials in cancer
623.503875070962	64.2218292044958	658.0639103123015	26.8974255881404	0.522	57	24	PAAD	BI847325	Clinical trials in cancer
760.7153902187578	51.2775983035469	714.7124616102977	5.83114258278465	0.593	169	46	READ	PWT33597	Clinical trials in cancer
803.9585882434538	26.3393877422562	737.9257012340003	-9.18918354991757	0.594	512	142	UCEC	PF-04691502	Clinical trials in cancer
715.9830276669866	-3.81911447297941	707.1154605381233	-16.2342374493478	0.594	264	47	SKCM	XL999	Clinical trials in cancer
216.47336628085623	0.658000068913111	206.68856397144577	13.2530765686406	0.0006	502	53	KIRC	ALUMINUM	Experimental
1065.7886805265318	2.22988274732381	1056.9999167934177	-0.000214983061596286	0.952	153	30	BLCA	DOCETAXEL	Approved in cancer
230.7622697190425	-62.197252383947	195.58001175953737	5.85835353516381	0.0004	292	35	STAD	PIPERLONGUMINE	Experimental
795.5173350768316	82.2421574250458	776.9594582510034	-29.5471613440482	0.592	264	186	SKCM	212631-79-3	Clinical trials in cancer
771.6524931365502	14.9174405534778	716.8931715569674	1.3095275798587	0.587	543	74	LUAD	XL765	Clinical trials in cancer
1115.4741231783557	15.2179935640834	1094.6897364627011	-0.95267733633068	0.996	169	47	READ	REGORAFENIB	Approved in same tumor type
139.78480019683167	14.4648738099826	194.6963621510547	11.7538675481337	0.0008	934	220	BRCA	NVP-BGT226	Experimental
806.8308046124666	4.51818255658642	707.5244811017667	-35.211226091556	0.595	264	112	SKCM	BUPARLISIB	Clinical trials in cancer
350.5609920509072	0.15431554469518	357.85271437512205	-4.48688815768105	0.181	169	39	READ	LAX-101	Clinical trials
129.42243527713498	91.1054974270538	200.5248890841777	-27.6096722149125	0.0006	57	24	PAAD	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
167.37585960669358	16.3086875519102	197.80569555152047	-2.76161244468676	0.0008	543	72	LUAD	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
176.14071262007653	-18.8525187672134	234.65259826171777	-15.3053187253931	0.0006	264	35	SKCM	3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE	Experimental
193.53601767587207	-42.8259092705144	186.63821047530894	12.778551331513	0.0006	502	56	KIRC	L-NIO	Experimental
306.9613712413511	-2.08869588348483	318.00006646831747	-0.000196907313238626	0.131	502	58	KIRC	TG 100801	Clinical trials
225.4785803190748	103.475070131504	167.68875993479836	-2.40165631656691	0.0008	435	183	THCA	N-{2,4-DIFLUORO-3-[(5-PYRIDIN-3-YL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)CARBONYL]PHENYL}ETHANESULFONAMIDE	Experimental
284.5246985591195	-73.2239812162976	221.7113176584507	-22.5626241796936	0.0004	222	127	LGG	PIK-75	Experimental
201.42609897260752	3.15838803419052	203.17770939058008	3.56145163168617	0.0004	292	32	STAD	GW843682X	Experimental
492.614473784147	-3.36314289309399	489.41524390071885	3.54025063053859	0.321	502	56	KIRC	MICONAZOLE	Approved in other pathologies
210.5018358669753	-12.4276952934142	219.16517591154476	-7.32170619461522	0.0006	502	53	KIRC	L-THIOCITRULLINE	Experimental
779.4335635261795	-4.29510186080594	718.8792570782942	6.30562724322209	0.582	543	72	LUAD	BI847325	Clinical trials in cancer
198.61131185271887	17.0781719674894	172.11922001557068	-17.3035578309974	0.0006	512	76	UCEC	5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE	Experimental
165.33644634763579	27.259469882079	221.99320059234063	2.14762122853324	0.0004	512	94	UCEC	NSC632839	Experimental
736.9907284219696	-48.4192253364225	740.1332542188554	0.996843988744331	0.596	423	89	COAD	BINIMETINIB	Clinical trials in cancer
715.3191437801851	1.90005826344577	741.8329308051153	16.3330579796216	0.584	264	29	SKCM	BMS-690514	Clinical trials in cancer
643.0512675696324	-34.154182202688	687.57947328042	-1.57000553659236	0.548	934	224	BRCA	DACTOLISIB	Clinical trials in cancer
1019.016171290535	-24.9952386381486	1046.004872860222	-3.50276004300645	0.937	202	55	LAML	SORAFENIB	Approved in cancer
314.0604868254452	-13.3036230550615	299.7470073674198	-2.8598908709323	0.111	202	32	LAML	ANTIBIOTIC K 252A	Clinical trials
930.5343537274656	0.145152212047265	930.2226426758231	-9.02940448668232e-05	0.812	202	23	LAML	BORTEZOMIB	Approved in cancer
209.23371371565892	36.2963004099798	216.84642904414338	23.4407200120231	0.0006	512	67	UCEC	154447-36-6	Experimental
702.0889877474253	47.7334834523005	726.6953246107419	14.2329318713794	0.576	512	142	UCEC	DACTOLISIB	Clinical trials in cancer
609.9680327270878	-5.06091933013084	675.2414912537378	23.900622923439	0.522	202	53	LAML	GDC-0980	Clinical trials in cancer
157.56559735339968	8.31850192826175	188.13434241713435	24.470436282571	0.0006	264	35	SKCM	TRIAZOLOPYRIDINE	Experimental
329.8719655775497	-21.5792593733887	307.6066194600973	8.01830379064191	0.121	57	25	PAAD	ADENOSINE TRIPHOSPHATE	Clinical trials
582.0678288161998	11.3685831023847	585.000034828128	-3.22637428239341	0.422	264	57	SKCM	REOLYSIN	Clinical trials in cancer
198.09876743862696	-41.6905832188649	182.02459291532438	-5.85057967439252	0.0004	423	57	COAD	BRD63610	Experimental
704.7862107433878	2.80895577809102	686.5488124671399	-2.09245988237262	0.541	389	45	LUSC	DHA-PACLITAXEL	Clinical trials in cancer
769.4843985020271	-51.5129676986908	728.695476398621	-33.6741240144001	0.596	264	45	SKCM	MIDOSTAURIN	Clinical trials in cancer
691.5280117062819	1.08566290926129	699.5882117094454	-0.918634436220032	0.553	389	45	LUSC	GOSSYPOL	Clinical trials in cancer
736.9024452046496	38.6863066647672	724.4848517153305	0.997288730256173	0.593	169	46	READ	SF1126	Clinical trials in cancer
155.25808597079617	-2.44612343067081	201.6474875668853	5.39526735721756	0.0004	934	219	BRCA	PARBENDAZOLE	Experimental
769.9898986677046	10.5621824184356	749.9996484204786	-0.000185055132817524	0.611	543	61	LUAD	SIMVASTATIN	Approved in other pathologies and in clinical trials in cancer
752.5336436742629	-37.1651393397411	748.908811192228	15.6263946172462	0.598	264	37	SKCM	MK-2206	Clinical trials in cancer
384.94140264880974	12.8699208551368	363.5296809440242	10.2990889189887	0.181	169	44	READ	ANTIBIOTIC K 252A	Clinical trials
1059.3059546738154	38.9431539037665	1078.540922949182	-2.14196054545513	0.972	57	25	PAAD	ARSENIC TRIOXIDE	Approved in cancer
139.8508320821975	59.3986989816254	213.57606712066556	-29.5775985825721	0.0006	435	183	THCA	N,N&#39;-DIMETHYL-N-(ACETYL)-N&#39;-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE	Experimental
308.92727759090485	-14.5415068923993	292.28907890574635	1.80120469810549	0.112	502	53	KIRC	TREBANINIB	Clinical trials
1102.3399828907416	11.7163254366718	1100.4078343896472	-0.197191634839612	0.999	543	78	LUAD	SORAFENIB	Approved in cancer
134.1263060797855	8.96951335186486	215.83515650989457	-1.26530224513084	0.0004	512	88	UCEC	NUTLIN-3A	Experimental
222.79478644702158	70.2608130908023	237.25179499957085	35.8532883182552	0.0006	57	24	PAAD	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
664.5527588572398	-42.8966641994773	674.980773165845	-1.90945820322054	0.521	502	57	KIRC	BEVACIZUMAB + RITUXIMAB	Clinical trials in cancer
383.1574737745709	-4.4766014482089	373.00012729417733	-6.50020501780091e-05	0.192	389	45	LUSC	QUERCETIN	Clinical trials
743.2280329450371	-76.0239726209082	678.482778718061	1.71962561144437	0.543	934	224	BRCA	GDC-0980	Clinical trials in cancer
756.2978112949525	18.2067250236004	742.4246793888743	6.23850929402761	0.593	153	26	BLCA	GDC-0941	Clinical trials in cancer
176.32374047649685	-71.2692413906892	220.01898634261667	9.41689294818752	0.0008	423	80	COAD	PI-103	Experimental
1049.8670726983135	-1.1039455810166	1050.975754759208	-1.45851986287948	0.94	502	65	KIRC	SORAFENIB	Approved in same tumor type
385.80748608326326	27.3798191951333	369.22326262096703	13.8104452430439	0.181	264	123	SKCM	EDARAVONE	Clinical trials
174.2442818723395	-9.52170571861473	198.09138209949336	-16.1296613333486	0.0006	502	53	KIRC	CHEMBL493448	Experimental
125.95404987672441	33.0237889900422	216.71035543367222	7.8924871262866	0.0006	502	53	KIRC	1-[4-(AMINOMETHYL)BENZOYL]-5&#39;-FLUORO-1&#39;H-SPIRO[PIPERIDINE-4,2&#39;-QUINAZOLIN]-4&#39;-AMINE	Experimental
1103.6480536061724	-9.84614361510992	1090.2303508156454	11.7044715230559	0.995	264	40	SKCM	LENVATINIB	Approved in cancer
616.1739327362982	79.5115599530906	649.4752500879803	-32.5245632572191	0.513	435	185	THCA	NAVITOCLAX	Clinical trials in cancer
634.9393193228307	-9.25281103772497	654.7293181134992	-9.29119536674739	0.513	202	23	LAML	ENMD-2076	Clinical trials in cancer
211.83921128061678	63.3159480121324	201.6442592802128	16.6141652689527	0.0006	169	39	READ	6-CHLORO-9-HYDROXY-1,3-DIMETHYLPYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
807.8065362542258	15.6106600461133	720.3720774511319	-2.80782548491123	0.584	543	72	LUAD	PIMASERTIB	Clinical trials in cancer
775.187914231651	-20.1466319667514	739.7947843747493	-0.0295130012502796	0.595	153	26	BLCA	BUPARLISIB	Clinical trials in cancer
1073.9913413233514	-0.0160629415481139	1106.0521427540573	-2.36190259755767	0.992	512	119	UCEC	ARSENIC TRIOXIDE	Approved in cancer
378.342279128052	6.56231871778579	373.1419520128305	0.0974313928104493	0.192	423	80	COAD	QUERCETIN	Clinical trials
186.67721934970453	44.9454401559744	182.75813256241497	0.767194371157416	0.0008	512	85	UCEC	DEXFOSFOSERINE	Experimental
230.7482029058393	5.16851517796107	198.012295051386	11.2930559655626	0.0006	543	69	LUAD	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
997.4513718637788	-10.5906345890247	999.3487149994522	-1.40913383669113	0.891	423	59	COAD	ETOPOSIDE	Approved in cancer
913.941132922409	-2.52201631898697	912.4792188065641	-0.529851195243737	0.792	264	29	SKCM	SULFASALAZINE	Approved in other pathologies and in clinical trials in cancer
740.6091479287226	83.7703843425796	696.964533232238	6.51404096343845	0.524	202	67	LAML	DACTOLISIB	Clinical trials in cancer
248.8337232701004	-4.44721310473423	202.12314046862673	-25.0378243769237	0.0006	169	43	READ	PHOSPHONOTHREONINE	Experimental
1041.3328015303157	-19.2427029138059	1076.1154419171176	-9.57185444681545	0.981	264	123	SKCM	ERIBULIN	Approved in cancer
648.4862921267156	-41.7906033981834	679.7861663890566	-17.1842941835548	0.545	934	222	BRCA	BUPARLISIB	Clinical trials in cancer
1027.2574131687734	30.0360916710434	1061.584036755824	14.5982807168216	0.94	435	209	THCA	DABRAFENIB	Approved in cancer
1019.5810159500046	46.3321031961516	1008.7497823769367	13.1162658036842	0.912	435	183	THCA	DOCETAXEL	Approved in cancer
305.33491870718336	2.8362611370876	317.99995279972666	-6.25715504156688e-05	0.131	153	22	BLCA	EDARAVONE	Clinical trials
745.128619218666	37.9340573797482	746.1730933595522	-11.3003987625676	0.581	512	77	UCEC	7-HYDROXYSTAUROSPORINE	Clinical trials in cancer
579.6209991343895	-1.79594877353748	577.0438982897857	-0.202999527950851	0.421	343	44	HNSC	ABT-751	Clinical trials in cancer
649.7965515631664	-8.46392592886255	687.0706144145264	-11.0745256592245	0.544	934	222	BRCA	XL147	Clinical trials in cancer
488.5837964203013	-1.05197398944856	482.2770621751164	5.84305366375247	0.311	502	53	KIRC	RETEPLASE	Approved in other pathologies
212.1212657118552	-44.5430916148926	205.48412971797012	-5.82857968769395	0.0004	202	24	LAML	CYTOCHALASIN B	Experimental
752.5613992792919	12.2709553680593	741.92222238199	5.49467905812548	0.596	343	62	HNSC	DACTOLISIB	Clinical trials in cancer
633.0089967378777	78.1543741588945	696.2430816203866	33.5268094939798	0.553	57	24	PAAD	PKI-587	Clinical trials in cancer
757.9029884088596	-17.1119194068943	727.9178575975974	9.08327377658657	0.593	343	62	HNSC	PWT33597	Clinical trials in cancer
245.42220406745508	36.213809690742	227.1975556075957	-1.95549109678694	0.0006	512	77	UCEC	RU79256	Experimental
276.7025700798949	-55.5609258151569	227.86229939902583	23.9932636315516	0.0004	264	106	SKCM	P-0850	Experimental
496.7834458159331	-1.73737513354897	498.7161026645413	-3.37264055634387	0.331	934	105	BRCA	RASAGILINE	Approved in other pathologies
723.8968129292043	-28.7268893277312	738.8248816828855	-6.63517728670809	0.595	343	62	HNSC	SONOLISIB	Clinical trials in cancer
193.1016828060631	-53.2315514674611	209.4439879958137	-2.72404100170797	0.0006	423	81	COAD	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
1047.1764299864258	-9.42927451767571	1044.9999232119192	-0.000171578441040765	0.939	599	61	GBM	DASATINIB	Approved in cancer
696.813996637666	-22.3441740444417	719.682222129338	-16.0816974256213	0.592	423	80	COAD	GSK2636771	Clinical trials in cancer
1084.9736698062861	7.00168827970634	1072.9998337629706	5.98794558754889e-05	0.97	292	37	STAD	TEMSIROLIMUS	Approved in cancer
763.4767016930352	26.9090842519514	746.5668196412269	10.898152847214	0.594	512	75	UCEC	ENCORAFENIB	Clinical trials in cancer
149.42447289908344	-99.5205513408402	192.73674625754975	2.60375195486222	0.0004	934	217	BRCA	TIPIFARNIB-P2	Experimental
401.0266862749114	-5.50907313454232	382.62405536280875	-0.731708002557752	0.192	264	115	SKCM	QUERCETIN	Clinical trials
252.42718509557423	21.6362384639555	177.97048567364303	-29.3933478454088	0.0004	512	105	UCEC	GW843682X	Experimental
990.6932989560121	-9.07740070152519	1004.6071161403105	-4.84535519016322	0.891	512	106	UCEC	PEMETREXED	Approved in cancer
375.4468897627483	15.2513154302815	365.6156801873396	-9.48828755411978	0.182	169	39	READ	AM-111	Clinical trials
272.3103814569204	67.2387363452945	167.7108166983291	2.56897788693513	0.0006	57	24	PAAD	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
730.2656654864795	23.5162075358514	729.119520207501	9.43982423542963	0.585	543	74	LUAD	PF-04691502	Clinical trials in cancer
1036.1681555108353	-4.08661797358144	1032.069144687789	0.162233027672983	0.922	502	59	KIRC	THALIDOMIDE	Approved in cancer
786.4941682310697	-8.43688957820987	757.6091901949592	0.338205084402773	0.596	512	142	UCEC	XL765	Clinical trials in cancer
178.05363295287285	-30.0080554571462	189.80485506943177	10.1498637064756	0.0006	264	35	SKCM	2-CHLOROPHENOL	Experimental
533.8345737070317	26.453501945034	537.1872040510501	10.3461130922569	0.381	264	123	SKCM	RASAGILINE	Approved in other pathologies
697.2340833306323	37.8723029278281	690.9998403009758	0.000394624242289865	0.546	169	46	READ	DACTOLISIB	Clinical trials in cancer
1052.2119658653482	3.25543261425784	1039.1058231283905	0.183042041591079	0.936	202	24	LAML	SUNITINIB	Approved in cancer
190.02765106536194	-2.57009923026067	191.94869559629183	-2.84508007675367	0.0004	343	48	HNSC	TIPIFARNIB-P2	Experimental
330.0673936036236	-40.0431378260969	293.19454096022065	5.97678634803992	0.111	435	211	THCA	ANTIBIOTIC K 252A	Clinical trials
181.68711377263014	-26.2680428651514	216.7148359683717	-33.710402270839	0.0006	264	35	SKCM	D13	Experimental
639.5630463673838	5.98409492307573	659.9052696087377	-6.20088798063352	0.512	502	53	KIRC	ICRUCUMAB	Clinical trials in cancer
212.23247927394044	19.0847374284376	216.17380186513466	-2.88424444351745	0.011	343	45	HNSC	TRIPTOLIDE	Clinical trials
656.9847081219809	-24.6128723030074	684.745771834499	-1.70002058586033	0.543	343	94	HNSC	NAVITOCLAX	Clinical trials in cancer
633.8213409120949	21.4191878369898	700.2215239562531	12.6440551108963	0.542	934	222	BRCA	GSK2636771	Clinical trials in cancer
647.0257480844775	-14.4960016604124	655.7086901020725	-5.7243860266683	0.511	502	53	KIRC	DICHLOROACETIC ACID	Clinical trials in cancer
1001.5199782714484	-7.33396545282685	1002.7202309452524	1.44242723770611	0.892	512	62	UCEC	IDARUBICIN	Approved in cancer
728.3077244080639	28.2001843222141	722.2146850891339	-3.23207793943868	0.574	599	70	GBM	SF1126	Clinical trials in cancer
1107.1325377737764	9.44881695377961	1102.989592617899	-7.96109130177774	0.998	264	32	SKCM	VANDETANIB	Approved in cancer
137.80589060330874	-35.0037819204728	187.6086564464163	17.8284264109971	0.0004	934	216	BRCA	NAKITERPIOSIN	Experimental
485.8772184743642	8.67303208487505	498.0000835787828	0.000168895276601688	0.331	153	22	BLCA	RASAGILINE	Approved in other pathologies
238.2271866272468	-7.3430774181457	222.80336800805	-11.8357900493724	0.0004	512	71	UCEC	BIX-01294	Experimental
735.2240088755607	28.9100021015696	706.5088607613341	-0.414121744255908	0.581	169	39	READ	CC-401	Clinical trials in cancer
1041.5837576387682	9.40698512012375	1032.9811929670982	-2.35691436501537	0.929	543	68	LUAD	PANITUMUMAB	Approved in cancer
306.1808527799716	30.4780479493004	226.36593232267816	-41.5123590322837	0.0006	264	131	SKCM	2,2,2-TRIFLUOROETHANOL	Experimental
720.959628068215	-7.32762006572025	707.2417959413747	-22.2898727874845	0.587	264	33	SKCM	ENZASTAURIN	Clinical trials in cancer
1086.8488203593045	17.6846771671004	1091.5171239574777	-3.68668879774765	0.993	512	91	UCEC	PONATINIB	Approved in cancer
658.5864053292242	-6.62826046285139	694.7372526024521	4.82539776294425	0.547	934	224	BRCA	XL765	Clinical trials in cancer
716.3451497257469	-9.98580651062815	723.8236406572463	-6.92552224972741	0.584	543	74	LUAD	PWT33597	Clinical trials in cancer
370.1442391004585	-11.7902706651685	363.7188162409498	-3.05933977347183	0.181	543	75	LUAD	ADENOSINE TRIPHOSPHATE	Clinical trials
732.8483728788617	-59.9807801200549	721.2019606222117	32.289163173552	0.594	264	113	SKCM	DACTOLISIB	Clinical trials in cancer
1017.635823851791	-1.71942858672014	1016.140557276881	-5.9764518593297	0.902	264	45	SKCM	BORTEZOMIB	Approved in cancer
256.5466313966295	-61.4440311897368	185.02236681038707	-48.9931694303682	0.0006	435	211	THCA	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
1025.6956463684805	-12.5595147438635	1036.4479503433538	2.08130600228969	0.936	502	61	KIRC	PAZOPANIB	Approved in same tumor type
157.06470587524927	-48.4073469283522	196.5409910549547	21.5563740696657	0.0006	934	236	BRCA	NUTLIN-3	Experimental
759.144753788394	-60.1184713893908	694.8674762791392	-21.8212329416056	0.583	264	131	SKCM	ISIS 2503	Clinical trials in cancer
668.9528145086905	27.5591899810541	760.8048931922139	0.190199439093931	0.596	169	46	READ	NVP-BGJ398	Clinical trials in cancer
722.4885214280728	6.56869830158962	681.6229789542465	2.47765146030957	0.533	512	93	UCEC	NAVITOCLAX	Clinical trials in cancer
816.7358801720293	-5.41591431826583	748.2030116519904	-19.570543916472	0.595	512	141	UCEC	BUPARLISIB	Clinical trials in cancer
733.0497873580448	10.3597300748452	733.770361156732	-11.8031297842338	0.593	343	62	HNSC	GDC-0941	Clinical trials in cancer
207.33750246870702	51.3095488890067	222.54220779715203	-17.1270329519635	0.012	512	66	UCEC	TG100-115	Clinical trials
211.77910663472483	73.8983041667053	176.72984410299972	18.059589682055	0.0008	512	82	UCEC	STAUROSPORINE	Experimental
1092.3698839223155	29.6740630697419	1050.2264830157887	-16.9085894765658	0.926	435	211	THCA	BOSUTINIB	Approved in cancer
393.3701696361817	6.39754224382102	377.07481420909437	-0.040273127116734	0.192	169	46	READ	QUERCETIN	Clinical trials
717.5320650442015	-16.8696477081014	714.6741128007803	-0.289303087744429	0.574	599	70	GBM	PWT33597	Clinical trials in cancer
170.22176913750968	39.0101712101019	202.1251592025941	6.35997915217217	0.0004	169	38	READ	BRD63610	Experimental
194.5373211328821	23.4458449750052	210.51652986115369	9.94804973856515	0.0006	543	63	LUAD	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
129.50505650081098	-23.1658822873392	260.433750339203	40.8402296554841	0.0006	264	131	SKCM	N,N&#39;-DIMETHYL-N-(ACETYL)-N&#39;-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE	Experimental
255.12972568659643	10.1762035523945	209.67111394178613	31.2025893446431	0.0006	512	77	UCEC	RU85493	Experimental
614.680852831425	50.1634547768295	666.8284166433658	-23.2958082615298	0.535	57	24	PAAD	391210-10-9	Clinical trials in cancer
144.6760834114113	-38.9431640556475	204.00353545841043	12.7102789568569	0.0006	343	56	HNSC	NUTLIN-3	Experimental
205.5620087850097	-56.7995346935148	223.1816706115006	1.27134127987256	0.0008	423	88	COAD	FR 180204	Experimental
240.7304932891314	29.4553175000178	194.1192008394033	-9.21004807931638	0.0006	169	44	READ	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
212.9326428565379	-89.8227723883036	213.26583830628272	17.1595946509615	0.0004	934	223	BRCA	LY2183240	Experimental
181.06160731091367	-7.0508920951136	202.42406675002718	-4.72859710843568	0.0008	292	30	STAD	PHOSPHONOTHREONINE	Experimental
575.5352892967236	1.52165193337646	570.4420294064844	-2.50445767951737	0.412	343	44	HNSC	DS-7423	Clinical trials in cancer
912.9624690393821	6.49486696758237	918.1213134631644	1.09400256877348	0.796	512	89	UCEC	NINTEDANIB	Approved in other pathologies and in clinical trials in cancer
793.7107251773474	8.17803509761313	734.3501208293995	12.6165858561285	0.582	169	44	READ	GDC-0623	Clinical trials in cancer
1045.1958213860673	0.101266353532225	1033.528306985983	-4.22217921398055	0.928	502	57	KIRC	BEVACIZUMAB	Approved in same tumor type
600.1756229137259	-59.1539405511961	666.4657212623372	-40.9240384950378	0.526	435	211	THCA	BINIMETINIB	Clinical trials in cancer
657.8170554864953	8.34270238385966	645.0175826998288	-0.732584026840868	0.491	512	85	UCEC	141400-58-0	Clinical trials in cancer
851.0516050233102	-11.0514756478681	848.999843800942	7.21186086138914e-05	0.721	435	183	THCA	NADROPARIN	Approved in other pathologies and in clinical trials in cancer
537.0108175597959	-6.1922628464753	540.6619615779609	4.70474096195159	0.381	512	80	UCEC	PEGADEMASE BOVINE	Approved in other pathologies
311.40659198181277	-45.3409464533713	219.15689145926913	4.89315847953344	0.0006	435	211	THCA	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
723.2287171112994	-51.8875500119236	741.1796405938167	-18.5385470239025	0.595	423	89	COAD	PIMASERTIB	Clinical trials in cancer
360.30522924893893	-15.4661785126051	367.5568345911529	-3.715044056225	0.182	423	63	COAD	AM-111	Clinical trials
679.5840958590104	-79.1898627825881	683.5211190822765	-4.60051532984744	0.571	264	141	SKCM	NAVITOCLAX	Clinical trials in cancer
480.8392867947302	-1.36739457681588	478.8360861434171	-0.963313627816888	0.311	502	58	KIRC	IBUPROFEN	Approved in other pathologies
160.28311809919717	30.1287273393845	195.56455093087735	-7.24011425138934	0.0004	543	61	LUAD	BRD63610	Experimental
163.29147121150285	-19.5986663752741	206.88609399180774	2.95907472298222	0.0004	343	44	HNSC	154447-36-6	Experimental
122.52552781444291	-68.1656669411277	161.8717797532874	-10.9620468687681	0.0004	222	128	LGG	32703-82-5	Experimental
711.6490474040911	-10.1913353083878	689.2201941801131	1.86380041514724	0.543	389	45	LUSC	OBATOCLAX	Clinical trials in cancer
739.194477244167	-33.0432195293469	747.8900940174667	14.4250415892111	0.594	423	80	COAD	SF1126	Clinical trials in cancer
682.7955080725699	108.313532060066	658.4273539463479	10.0620094890287	0.535	57	24	PAAD	PIMASERTIB	Clinical trials in cancer
1013.3859549318994	-7.29140415445207	1026.334999180266	-0.68465227980505	0.921	599	107	OV	ERIBULIN	Approved in cancer
751.4597109397672	38.9438637642314	723.6907639938345	-8.01109436689148	0.593	153	26	BLCA	SF1126	Clinical trials in cancer
1077.220601186888	16.3561775325555	1087.9217669301026	5.58045415890729	0.983	423	97	COAD	ARSENIC TRIOXIDE	Approved in cancer
283.7932658089635	-44.5766495105996	202.62596511603235	-14.8727383107043	0.0006	169	43	READ	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
710.242554675977	34.8048305739107	658.6536992657082	21.5516691026298	0.522	202	53	LAML	XL765	Clinical trials in cancer
1110.32832477792	-19.5894249474946	1090.2312100587646	-8.7559428041136	0.986	423	96	COAD	BOSUTINIB	Approved in cancer
215.26639066008207	8.81980282834013	212.09107062370114	20.5840842146342	0.0006	512	76	UCEC	INOSITOL 1,3,4,5-TETRAKISPHOSPHATE	Experimental
205.5679616395368	-22.4910091653211	219.5907059722207	10.2709156897654	0.0004	934	214	BRCA	LEXIBULIN	Experimental
371.0078854617999	-2.13687680176741	376.6489629326864	1.50223002654889	0.191	512	58	UCEC	UNII-JMC809G4ZH	Clinical trials
1100.3924499814157	5.77719072560362	1085.743615052519	-0.0562742067331783	0.984	169	29	READ	PACLITAXEL	Approved in cancer
480.957840855191	7.91707198516917	474.9201702960955	1.09162516279571	0.311	502	53	KIRC	ALTEPLASE	Approved in other pathologies
588.27340204846	8.31077200223621	590.0000685102967	-3.50528235912861e-05	0.433	512	67	UCEC	GSK2126458	Clinical trials in cancer
585.7664025841148	-17.4722394901129	614.9986280721849	0.00138126082856616	0.461	934	219	BRCA	141400-58-0	Clinical trials in cancer
808.0542472646235	-23.7081856885407	742.315822728387	-4.40132195227943	0.581	169	28	READ	S-8184	Clinical trials in cancer
751.0071768606493	56.1243545539237	722.9602137844986	-20.9590478145292	0.595	512	142	UCEC	BYL-719	Clinical trials in cancer
180.86365815048498	15.4042864245414	203.3650738093692	12.4955436586433	0.0006	512	76	UCEC	3H9O	Experimental
180.49293335494545	6.69383577122557	215.85662044638383	0.542485400927035	0.0006	502	56	KIRC	3-BROMO-7-NITROINDAZOLE	Experimental
121.47389029908149	11.6996174441842	186.53936774432472	25.685708811028	0.0004	435	213	THCA	LY2183240	Experimental
356.0288797406437	29.1134924290718	340.0873273929285	-0.173451495298309	0.152	57	24	PAAD	QUERCETIN	Clinical trials
742.3499666257596	-7.54611181751034	726.31253786456	-1.74632360074679	0.595	153	26	BLCA	COPANLISIB	Clinical trials in cancer
1106.3667554648573	-3.62123785043596	1096.2965694270122	5.85795984207198	0.998	423	61	COAD	VANDETANIB	Approved in cancer
212.6934451169548	28.837254043587	232.91874236998063	-0.596363399939548	0.0006	512	74	UCEC	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
726.5845863799508	46.8853091168529	735.8611650252357	0.618693981580009	0.585	543	72	LUAD	BINIMETINIB	Clinical trials in cancer
738.8920158498954	-69.7404866023478	737.4722484533058	7.76511549917723	0.583	423	65	COAD	OBATOCLAX	Clinical trials in cancer
204.32418149800128	34.9103659589198	205.67953526596975	-5.71628262493385	0.0004	543	79	LUAD	LY2183240	Experimental
368.70918474222754	6.58678598900212	360.7038643980915	1.03503453006135	0.182	543	63	LUAD	AM-111	Clinical trials
231.84425706515955	33.5842044730334	172.8433714374277	13.3446198229005	0.0006	512	75	UCEC	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
300.58817637136605	13.0686109330724	165.79854250757447	19.2928712022437	0.0006	57	24	PAAD	PHOSPHONOTHREONINE	Experimental
175.8110596127389	12.1488063969173	194.4649926495121	6.98823655472887	0.0008	512	58	UCEC	NETOGLITAZONE	Experimental
227.87575898276972	30.1465987562373	191.2929946331803	5.69708471516873	0.0004	543	70	LUAD	KINETIN RIBOSIDE	Experimental
166.32828876335748	-22.9656434893803	183.4717935450329	-10.1997750956873	0.0006	502	57	KIRC	BROLUCIZUMAB	Experimental
634.6673864793382	-45.8138335619946	629.5694145834252	15.8082641025201	0.522	435	211	THCA	212631-79-3	Clinical trials in cancer
123.07055997380846	61.840341335242	183.15409616468548	-4.16776409780334	0.0004	57	24	PAAD	BRD63610	Experimental
217.0767010643148	-56.3930799058258	206.11345911017514	-10.2131639984132	0.0004	934	221	BRCA	PIPERLONGUMINE	Experimental
668.9293936457974	36.2925540938112	667.5929961572172	9.89154812827428	0.516	202	32	LAML	BINIMETINIB	Clinical trials in cancer
698.3085808977055	-82.7274544784954	668.0481854231165	38.894340617785	0.524	435	183	THCA	RAF265	Clinical trials in cancer
718.0611021204996	-33.2307043453856	740.3272492238677	14.1800617176218	0.595	423	80	COAD	SONOLISIB	Clinical trials in cancer
198.2256364425277	22.46303711055	215.8640894093613	-3.12538352617372	0.0006	543	63	LUAD	1,9-PYRAZOLOANTHRONE	Experimental
189.43458995279866	3.21209862106272	208.14061130511286	1.99682457518793	0.0004	292	44	STAD	LY2183240	Experimental
473.1283128683911	2.53644012240184	482.41931379633513	1.62393007338892	0.311	502	53	KIRC	TENECTEPLASE	Approved in other pathologies
215.05236983249023	-14.8967736684653	183.448089579421	-5.44460563485404	0.0006	512	75	UCEC	CHEBI:83275	Experimental
186.19168639823303	-27.8402195353329	196.66865436792943	-12.0651260464435	0.0006	502	56	KIRC	6S-5,6,7,8-TETRAHYDROBIOPTERIN	Experimental
196.58806732473448	80.6313144937517	188.9412402015444	0.787274706365167	0.0006	543	78	LUAD	PURVALANOL B	Experimental
1065.1112317387344	-35.9004220005673	999.0843688177655	-0.648387003286189	0.912	435	183	THCA	SORAFENIB TOSYLATE	Approved in cancer
194.46088687497993	-6.41428993767312	215.61396017540363	30.259664945165	0.0006	512	77	UCEC	RU85053	Experimental
600.0166201911478	-16.1201430261809	637.489121998364	-18.8241660957381	0.512	435	211	THCA	GDC-0623	Clinical trials in cancer
793.3275805370566	24.2788520290518	761.3676807844137	10.9420284690415	0.593	169	45	READ	BMS-908662	Clinical trials in cancer
722.6625849984106	73.189200055142	727.8231168336097	0.101545110166342	0.586	512	80	UCEC	SARACATINIB	Clinical trials in cancer
188.624999773606	8.26709260698237	191.87726498626304	0.123345390624991	0.0006	502	56	KIRC	5,6-CYCLIC-TETRAHYDROPTERIDINE	Experimental
651.3596839165903	-15.2893636743619	684.0242765547508	14.222880065759	0.531	934	105	BRCA	DHA-PACLITAXEL	Clinical trials in cancer
116.64426692170859	28.9772986450124	186.23304657945457	7.48138928545541	0.0006	435	183	THCA	2,2,2-TRIFLUOROETHANOL	Experimental
184.97155815766453	-59.6096834002411	205.78528246471345	-4.59883732543312	0.0006	264	33	SKCM	DB07268	Experimental
167.68797140362548	-35.5457793306036	210.86744009054917	-5.44132306563915	0.0006	264	35	SKCM	1BMK	Experimental
726.9425607167059	-22.0404420468754	734.9271609551	7.28378186917598	0.594	343	62	HNSC	PKI-587	Clinical trials in cancer
196.37982093490675	-12.234908341082	193.77799552030464	15.3319114552696	0.0006	502	53	KIRC	4-(IMIDAZOL-1-YL)PHENOL	Experimental
211.40936170216654	-59.1526004337394	206.3321109326461	-5.75110022254626	0.0006	502	53	KIRC	CHEMBL245549	Experimental
1098.2693602678391	-23.8252045635499	1093.690638119456	1.45962495043261	0.988	512	52	UCEC	BEVACIZUMAB	Approved in cancer
186.29982722000446	-54.5920666525116	187.38479635242916	-7.01541403547071	0.0004	423	59	COAD	NSC632839	Experimental
170.95658423458676	-6.63187521887755	213.25355208468056	16.0033209702665	0.0008	264	30	SKCM	NVP-BGT226	Experimental
1035.7564599434274	-34.8455456556755	1081.020425587487	6.77499138230087	0.993	264	98	SKCM	PONATINIB	Approved in cancer
354.40819337772	6.75730850923389	361.32318291925236	4.32075281759035	0.183	264	40	SKCM	VX-702	Clinical trials
593.7479476289282	43.6318976587197	640.8548470295322	-2.44530667050853	0.522	57	24	PAAD	ENCORAFENIB	Clinical trials in cancer
211.2333219288346	24.0854430151647	201.41773351471818	6.62383372604552	0.0006	543	63	LUAD	6-CHLORO-9-HYDROXY-1,3-DIMETHYLPYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
1026.6053006932705	-29.2719962663053	1020.327626020095	4.81456397217084	0.913	202	33	LAML	SORAFENIB TOSYLATE	Approved in cancer
201.32054225045817	70.6382059850091	214.02752466327152	-17.5877534719584	0.0006	57	24	PAAD	DB07268	Experimental
771.9200313430596	-25.6719558816864	738.5830598038659	-8.63855242245018	0.594	292	43	STAD	SF1126	Clinical trials in cancer
247.88676491436001	13.9003585309698	228.61154044788944	1.65645681098431	0.0006	169	44	READ	DB06892	Experimental
192.64584970377635	-46.9619944984801	207.3503146628205	1.68349713497696	0.0006	502	56	KIRC	CHEMBL228077	Experimental
294.8731496280174	-35.2042554938218	237.05653718041296	12.3113056225079	0.0008	435	211	THCA	FR 180204	Experimental
543.7941933990392	3.39178914254637	547.4648482462965	-4.24642460088114	0.383	512	58	UCEC	TREPROSTINIL	Approved in other pathologies
745.6970460395934	8.03234643811692	712.9721826129183	-4.63944766924533	0.575	599	70	GBM	PKI-587	Clinical trials in cancer
985.1353285111759	38.7548911496964	1048.4323643655416	21.3525117249706	0.96	264	168	SKCM	VEMURAFENIB	Approved in same tumor type
491.41536840392814	11.9582019153232	489.00010811732005	-0.00032892231047299	0.321	599	107	OV	RASAGILINE	Approved in other pathologies
220.87421795460017	-35.3038126743256	216.62508673374	-10.8262778672483	0.0006	502	56	KIRC	N,N-DIMETHYLARGININE	Experimental
752.5326123823901	-12.3232255045417	721.498353587275	-32.5347183555323	0.582	264	52	SKCM	ISIS 5132	Clinical trials in cancer
324.43071264203064	30.3230752936486	154.17456128792776	-7.41240846419223	0.0006	57	24	PAAD	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	Experimental
155.44055279898885	4.27631824879603	195.13062590837544	-7.85518630730371	0.0006	502	56	KIRC	6-NITROINDAZOLE	Experimental
1008.3955034283399	-10.2694400255092	1019.9999577762153	5.1094285936415e-05	0.911	502	57	KIRC	ERIBULIN	Approved in cancer
619.1098811025657	0.088358056104596	663.9888882521982	-14.4681593537689	0.523	202	23	LAML	TANDUTINIB	Clinical trials in cancer
159.0696849173155	111.145351838331	193.56098443822552	15.2623313200934	0.0008	222	133	LGG	NUTLIN-3	Experimental
744.0542172163052	-45.3172406285702	748.1074630840385	0.797196577686009	0.595	423	80	COAD	PKI-587	Clinical trials in cancer
677.9337626983098	-49.3791178933566	659.741031076201	6.83580159031203	0.523	202	53	LAML	BYL-719	Clinical trials in cancer
218.78099921571214	92.8414249208016	234.34980319371437	-7.64006087057868	0.0004	512	110	UCEC	NUTLIN-3	Experimental
227.7483779160971	47.3741158940387	170.95235504404036	3.30772295972218	0.0006	512	77	UCEC	RU82209	Experimental
207.19166320636413	45.7380795703291	173.79894709450488	-7.77544577004068	0.0006	512	77	UCEC	PHENYLPHOSPHORIC ACID	Experimental
258.4072316796666	-31.9748640949914	193.718445003348	-31.9268225880011	0.0006	512	77	UCEC	ISO24	Experimental
663.2934461953339	4.54579639138851	676.5361681977687	4.05994664712625	0.523	599	107	OV	OBLIMERSEN	Clinical trials in cancer
990.5952596066072	-1.38383554888631	997.3117909857897	4.07615488982043	0.891	512	92	UCEC	ETOPOSIDE	Approved in cancer
711.3471629754147	-70.3882306239883	664.8778408391291	7.77953660853609	0.524	435	211	THCA	ENCORAFENIB	Clinical trials in cancer
689.0674471762804	-10.5153453330096	676.5527010424881	5.53868037297184	0.533	222	57	LGG	GOSSYPOL	Clinical trials in cancer
629.0150114132023	37.9455811227212	659.0955356231722	-0.774400557516827	0.513	57	7	PAAD	OBLIMERSEN	Clinical trials in cancer
575.5845566481457	22.3117667978769	583.0416864730666	-0.552602373877335	0.421	435	183	THCA	ABT-751	Clinical trials in cancer
557.1746294662854	15.475001605912	568.3821647427301	-7.90549943398446	0.412	934	214	BRCA	DUVELISIB	Clinical trials in cancer
148.34051697483685	-17.2805541888003	211.5667368783875	1.15786221821986	0.0006	502	53	KIRC	(2S)-2-METHYL-2,3-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5-AMINE	Experimental
951.9971143673738	-20.2606312855989	942.6067051904522	0.087502773368044	0.825	57	24	PAAD	CETUXIMAB	Approved in cancer
584.8772234666183	4.90025300989106	582.0001013155555	0.000353271605035843	0.424	202	23	LAML	CRENOLANIB	Clinical trials in cancer
636.8056489335296	-17.359182066151	641.9998804754877	-0.000139740598342541	0.491	292	30	STAD	141400-58-0	Clinical trials in cancer
248.80472328037519	73.3369008868687	177.90586755393485	-3.45307431362448	0.0006	512	77	UCEC	CHEMBL87580	Experimental
256.8530975837573	2.05681047956676	209.80584550841195	22.0715611444949	0.0006	169	44	READ	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
129.1074334068765	44.3506802010007	197.95921511982317	-62.0614244719131	0.0006	264	133	SKCM	GUANOSINE TRIPHOSPHATE	Experimental
651.9868222484853	-33.6540320455603	717.7931841195823	2.63276252423657	0.582	423	89	COAD	RO4987655	Clinical trials in cancer
192.8213303135671	6.81696108316686	187.6804021433738	0.680076345078533	0.0004	343	47	HNSC	SB 225002	Experimental
794.8666047387603	-2.39828383907491	730.8217244488179	-27.201828996353	0.594	169	46	READ	PF-04691502	Clinical trials in cancer
265.39269852611824	58.6028470241911	204.98420037537946	-11.1229506103941	0.0006	543	69	LUAD	CHEBI:83275	Experimental
247.65183815806725	-53.9763725845868	221.38981655221605	7.10574027504936	0.0006	502	56	KIRC	CHEMBL107201	Experimental
226.8921698170211	34.3241082905886	219.0650224734148	7.10796173128244	0.0006	512	54	UCEC	KD-3020	Experimental
1118.6771014255066	-0.926047130808797	1105.4917428245503	5.15561634382476	1	512	74	UCEC	TRAMETINIB	Approved in cancer
696.4854611251363	0.963166792804486	733.6314525260445	-1.84418036883437	0.584	512	77	UCEC	KX2-391	Clinical trials in cancer
667.1273033343173	-7.96382110871798	664.8091244660515	0.0492241842375734	0.521	599	107	OV	DHA-PACLITAXEL	Clinical trials in cancer
679.1758970039938	64.9327571505744	739.0063897911397	-25.622705375736	0.592	512	141	UCEC	GSK2636771	Clinical trials in cancer
373.8308877112657	23.1043084938958	372.99998302596697	0.000204649119041278	0.192	153	26	BLCA	QUERCETIN	Clinical trials
1058.8572206468332	-20.5850847486209	1013.2499221093509	5.32643889654992	0.909	264	109	SKCM	PANITUMUMAB	Approved in cancer
769.3772022395468	2.9638648174132	741.1578579457046	-23.901831531571	0.593	169	46	READ	GDC-0941	Clinical trials in cancer
301.6755509541313	-0.557024496879308	299.0831834694933	-3.70477460770462	0.111	502	53	KIRC	PLASMIN	Clinical trials
1070.2469731038957	-13.7185886775524	1105.4077747005765	0.126312582755986	0.997	169	44	READ	COBIMETINIB	Approved in cancer
703.5792705736023	-48.9451008487805	736.8757482602522	0.328673730548644	0.592	343	62	HNSC	GDC-0980	Clinical trials in cancer
263.04823040940767	-81.5102614373971	217.30244187267948	17.7449484023468	0.0004	222	132	LGG	PARBENDAZOLE	Experimental
381.1500862534988	0.416806625344378	372.8021496685635	5.05326380345383	0.191	512	76	UCEC	ADENOSINE TRIPHOSPHATE	Clinical trials
762.414796683092	7.50067623874969	711.5109258927065	0.538713626805986	0.587	543	74	LUAD	BYL-719	Clinical trials in cancer
259.30526500678604	29.3931955716573	188.6211498167651	-21.8982785004175	0.0006	512	77	UCEC	MALONIC ACID	Experimental
1001.4370855841255	-39.4954734025779	1016.0423479257189	-18.9584400568961	0.911	435	183	THCA	ERIBULIN	Approved in cancer
194.8895409717762	-2.08171099079462	214.91884245985963	-23.6630306510448	0.0006	512	59	UCEC	LGD-1550	Experimental
727.9110153916772	-15.2336866791829	721.5709453617335	3.30866318614926	0.583	153	27	BLCA	DACTOLISIB	Clinical trials in cancer
194.476836498164	92.2742456728199	202.29952940951364	-44.690435827716	0.0006	57	25	PAAD	PURVALANOL B	Experimental
214.31347749760232	-19.9005687189608	212.54949498084827	8.57639840000115	0.0006	502	53	KIRC	CHEMBL243978	Experimental
737.5946186897249	47.3727401812678	728.9372671210778	4.52386360613946	0.594	153	26	BLCA	XL147	Clinical trials in cancer
190.2285484445061	49.6477029513922	219.9599687443103	-22.0628675904865	0.0006	512	77	UCEC	PP121	Experimental
236.09206986638867	-101.57729083285	171.64053994076397	22.6522135911309	0.0004	264	104	SKCM	878739-06-1	Experimental
233.646093055346	47.0950303086688	210.99025921416282	3.71469132197655	0.0006	512	78	UCEC	761437-28-9	Experimental
156.5720855970598	-26.0190243480767	190.7435354031698	16.5546130941329	0.0006	264	49	SKCM	NUTLIN-3	Experimental
678.7901954685123	14.5923849189555	702.7482457381071	1.7336749785743	0.562	599	68	GBM	BUPARLISIB	Clinical trials in cancer
787.9793312559381	51.5966212573214	713.6386747847217	-15.0234176146878	0.593	512	141	UCEC	GDC-0941	Clinical trials in cancer
622.6090818678434	-10.0112751919331	672.2992491721965	-8.73923503017818	0.513	435	183	THCA	OBATOCLAX	Clinical trials in cancer
225.9958019874343	-57.2189215739882	190.6991732120074	-6.41329389350449	0.0004	934	215	BRCA	P-0850	Experimental
364.54466368881015	-10.3414665104348	373.00005691011535	1.92499453532946e-05	0.192	292	44	STAD	QUERCETIN	Clinical trials
580.3265474043072	-7.11376916561414	581.3026256986874	2.66172697577576	0.422	343	44	HNSC	DUVELISIB	Clinical trials in cancer
155.0201668748997	36.607203323796	195.3271504758342	-19.4703528833966	0.0006	502	56	KIRC	2-AMINOTHIAZOLINE	Experimental
725.7560487477081	-5.24612770758688	722.8771769958477	4.86907823409479	0.583	292	40	STAD	GOSSYPOL	Clinical trials in cancer
704.1405668001166	116.370350851751	658.1834103871031	28.36359022857	0.594	264	190	SKCM	ENCORAFENIB	Clinical trials in cancer
218.96441247297187	-45.0705812176046	189.52406220228363	-17.5911827629793	0.0006	264	35	SKCM	N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-	Experimental
181.39666724900758	-11.0133609909196	202.3839694261348	-16.7000307011497	0.0006	502	56	KIRC	N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE	Experimental
479.80794040532436	18.3867198722292	471.6537722199585	0.102388459221146	0.311	57	24	PAAD	CHOLINE	Approved in other pathologies
465.39185922106117	9.66979890254629	473.0922022606893	7.18803289567086	0.311	435	183	THCA	RASAGILINE	Approved in other pathologies
767.4147144138403	-97.5470762987499	751.5504570999598	60.5210017288009	0.596	264	186	SKCM	BINIMETINIB	Clinical trials in cancer
768.0667143149564	-30.5342417627948	735.6733645893673	5.37693371817136	0.595	153	26	BLCA	BYL-719	Clinical trials in cancer
364.7010392402534	3.6530176357569	365.57734159164283	2.02605381850179	0.181	543	72	LUAD	ANTIBIOTIC K 252A	Clinical trials
183.25543365716604	89.2136866781916	233.3908768803517	-14.5945610259737	0.0006	512	70	UCEC	6-CHLORO-9-HYDROXY-1,3-DIMETHYLPYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
164.87882358921894	58.942360322186	186.1414275022998	5.47072726235604	0.0006	543	70	LUAD	OLOMOUCINE	Experimental
164.9640799995981	-10.4693904078959	184.48841471765084	1.90655721541498	0.0004	264	44	SKCM	FQI-1	Experimental
375.3077478709992	0.613264285116259	372.011072275676	-0.752374103999045	0.191	512	74	UCEC	ANTIBIOTIC K 252A	Clinical trials
937.7136971571597	5.63184912146414	939.9999975822054	0.000387377776860376	0.822	543	64	LUAD	EVEROLIMUS	Approved in same tumor type
254.84757385281657	50.5088048603415	168.05164737847934	-6.04523099827912	0.0006	512	77	UCEC	SB220025	Experimental
733.6436705781505	-36.1312265616358	729.1004255702351	-5.82997043274395	0.58	543	72	LUAD	SELUMETINIB	Clinical trials in cancer
118.15046131457672	-93.3970977856221	134.61463082112672	-20.304446161897	0.0008	264	185	SKCM	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
565.8743300021509	36.1037047826123	568.9312061825933	8.70229335460112	0.411	435	184	THCA	INDISULAM	Clinical trials in cancer
143.94406499214512	20.8567314834942	208.31159153064684	8.27313598590104	0.0004	343	50	HNSC	PIPERLONGUMINE	Experimental
679.3561806848703	10.1116743439862	656.1599956806966	1.84906444359717	0.511	502	56	KIRC	L-NNA	Clinical trials in cancer
691.2301953997329	58.1908904046457	678.2503943949807	-35.7005645275863	0.531	57	24	PAAD	CC-401	Clinical trials in cancer
70.06456902753698	39.8645165294946	184.59496984594395	-7.58654939787834	0.0004	222	127	LGG	MERCK60	Experimental
682.0185816968216	-24.6399009550828	678.7031438373665	1.01461908858823	0.533	502	62	KIRC	NAVITOCLAX	Clinical trials in cancer
608.2896263389138	21.2618580931884	675.7906385864917	-7.87379930876409	0.522	202	53	LAML	GDC-0941	Clinical trials in cancer
551.5485661913043	27.1930574328443	571.0002918208293	0.000104993730815295	0.412	57	24	PAAD	GI-4000	Clinical trials in cancer
700.4739299790001	5.00594469490238	728.7881393705475	6.0788331428663	0.584	512	75	UCEC	AZD8330	Clinical trials in cancer
562.7707746813822	-4.90978789364553	571.5586089472731	2.50377710909424	0.412	343	44	HNSC	ZSTK474	Clinical trials in cancer
203.55183480083156	-50.491732314114	198.1664062140517	21.387889146542	0.0006	264	35	SKCM	CHEMBL379760	Experimental
698.4592982110549	-44.6433340183321	723.9988676683901	6.27313467794056	0.581	423	63	COAD	CC-401	Clinical trials in cancer
155.37412729389789	31.6221227784315	192.72708056527426	2.52150465090767	0.0004	343	45	HNSC	937174-76-0	Experimental
259.12520810081173	-43.2672402853898	175.07688760043172	52.0159089914641	0.0006	435	183	THCA	GUANOSINE TRIPHOSPHATE	Experimental
156.9262859854494	26.3995566657591	200.60917385204422	-4.46222197495263	0.0004	153	21	BLCA	PIPERLONGUMINE	Experimental
162.82192111503124	-15.052871552899	222.05669126932253	-4.11792204317794	0.0006	502	56	KIRC	1,2,4-TRIAZOLE-CARBOXAMIDINE	Experimental
251.48423735032918	-50.7357462783645	191.0457995963483	11.9093595215322	0.0006	502	57	KIRC	TROMETAMOL	Experimental
138.05023758140467	-1.97655248743607	208.21655490192902	9.18729750105786	0.0006	502	56	KIRC	S-(DIMETHYLARSENIC)CYSTEINE	Experimental
713.4115407354727	-29.3503493315785	671.1906480709315	-6.88767752091735	0.533	934	106	BRCA	GOSSYPOL	Clinical trials in cancer
168.2831189827453	21.8676049122058	198.19596644166046	-0.160883521273263	0.0008	202	25	LAML	SB220025	Experimental
215.20463269628618	-41.063278131066	211.25467997589843	-0.352413955732345	0.0004	343	50	HNSC	KINETIN RIBOSIDE	Experimental
178.62461833135868	-41.8222082808416	184.6217676135495	0.494226628050455	0.0008	423	88	COAD	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
215.76462859138834	-27.8747794128097	183.93499393332553	-4.70917925383719	0.0006	264	35	SKCM	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE	Experimental
221.48153980454055	-9.02266686657703	198.32898149449542	-19.2684734783993	0.0004	264	31	SKCM	CHEMBL254381	Experimental
744.5329976665304	-59.4030350722225	666.5705506411623	-3.48942955625148	0.522	343	52	HNSC	MLN1117	Clinical trials in cancer
545.5959283916159	-3.48660169875851	546.5729136508452	-1.48762381151528	0.382	264	27	SKCM	CAFFEINE	Approved in other pathologies
668.8585135503465	-13.5374547536642	650.3421431591619	2.84535258936313	0.511	57	7	PAAD	DHA-PACLITAXEL	Clinical trials in cancer
289.1254241113077	25.2724255072787	252.0442620755549	-27.6841406334865	0.0004	264	104	SKCM	NVP-BHG712	Experimental
709.8436634117938	-5.35363464085842	733.5397077479196	-11.6887089033119	0.592	292	43	STAD	GSK2636771	Clinical trials in cancer
700.4656877691599	25.8495663248956	738.1915233018643	1.47403546553596	0.596	389	46	LUSC	XL765	Clinical trials in cancer
738.8826051006977	-25.8972034699969	720.6866490202574	-25.613381524674	0.594	264	35	SKCM	AZD5363	Clinical trials in cancer
208.88840141663115	-77.9709567714313	174.6535793504191	7.18538498046883	0.0004	264	104	SKCM	KU 0060648	Experimental
671.2910471084972	10.3017656328695	679.0321265448533	4.56587015002697	0.532	153	16	BLCA	SAR260301	Clinical trials in cancer
238.7635861339977	-30.6370648513169	219.57419778566205	11.2184254486103	0.0006	502	57	KIRC	CAND 5	Experimental
1028.6553959330345	12.3171852260824	1042.1715236491116	-4.0994307852875	0.936	502	60	KIRC	VANDETANIB	Approved in cancer
151.37954517119425	21.9042130236701	200.72885755281658	25.8090286941001	0.0006	169	39	READ	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
694.0988684243717	95.9047009382237	719.056347039196	8.75762667755248	0.554	57	24	PAAD	DACTOLISIB	Clinical trials in cancer
649.7319658855042	76.7951296103167	724.090794936626	24.8373165235725	0.552	57	24	PAAD	NVP-BGJ398	Clinical trials in cancer
184.61848187080054	5.10699346630639	204.58171674995324	-1.81588290491754	0.0006	502	56	KIRC	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	Experimental
145.09195898241086	-33.5483690550559	197.00979544210503	7.00685672790087	0.0006	502	56	KIRC	GAMMA-IMINO-ATP	Experimental
191.10271056764242	26.0793636527441	182.76034506380498	-14.6340504015815	0.0006	512	54	UCEC	2-({[3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YLSULFONYL)PHENYL]CARBONYL}AMINO)BENZOIC ACID	Experimental
1029.7812308778337	-15.6175340133446	1038.0000117171141	1.09738969058526e-05	0.931	153	22	BLCA	ERIBULIN	Approved in cancer
484.90279676370346	-3.45689756573648	488.9999434083996	0.00013238309929875	0.321	543	62	LUAD	CHOLINE	Approved in other pathologies
372.92796107840184	9.01789013351663	362.5351098365608	4.091245488688	0.181	512	54	UCEC	LAX-101	Clinical trials
201.29057674936675	-37.7497503089284	195.17849724562788	7.54302389042732	0.0008	202	24	LAML	DB07788	Experimental
526.0388914765821	13.3233574773311	543.1699125671448	-4.36356824182531	0.381	423	88	COAD	ISOPRENALINE	Approved in other pathologies
201.28078511715466	38.8257148631927	194.39866322884166	2.85540198162812	0.0008	202	24	LAML	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
200.18919190664826	-19.50523783763	220.85918985056836	9.95360596802175	0.0004	264	31	SKCM	NSC632839	Experimental
387.77607526736904	-10.8469311574472	378.5773368612488	-6.10826504342532	0.192	512	143	UCEC	QUERCETIN	Clinical trials
701.6853010887472	-33.6678846607245	730.753947597333	6.37643048965583	0.596	423	80	COAD	DACTOLISIB	Clinical trials in cancer
798.3246243206917	-46.337125330911	729.6907391479135	47.0226905123095	0.594	264	112	SKCM	XL147	Clinical trials in cancer
1019.3009487908209	7.69275834772327	1029.0276493851984	-3.37071289635469	0.922	502	58	KIRC	LENALIDOMIDE	Approved in cancer
1035.6191981223876	-51.8562681568413	1035.4020336220408	-29.4259734228713	0.939	435	211	THCA	SORAFENIB	Approved in cancer
698.4154238344644	30.1890910452939	696.4940461281974	-3.69206284070276	0.553	512	68	UCEC	RIGOSERTIB	Clinical trials in cancer
182.61408147847612	-35.4857257857512	188.4273287887921	-7.52744312078812	0.0006	264	35	SKCM	L09	Experimental
212.8823109025656	13.6987335563651	184.01960494814224	-25.6743891269597	0.0006	512	77	UCEC	N6-BENZYL ADENOSINE-5&#39;-DIPHOSPHATE	Experimental
752.8413444270775	-20.9772105580836	733.2920093103793	0.0700693083849728	0.594	292	43	STAD	PWT33597	Clinical trials in cancer
263.41987443699895	-33.2399768064586	201.11069578474834	0.597147326770937	0.0004	153	18	BLCA	NUTLIN-3	Experimental
274.54593525065553	14.0551504977997	179.55797025370703	-10.2615827906423	0.0006	512	84	UCEC	PURVALANOL B	Experimental
252.04922474196994	-11.2539480804357	194.9202929729359	-12.0782753413222	0.0008	543	72	LUAD	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
152.35410955181396	28.474515128556	192.75240213348314	7.82469977496612	0.0006	502	54	KIRC	BETA-D-GLUCOSE	Experimental
202.1201604395165	51.2004086685915	198.47977464123827	-19.5305855743949	0.0006	512	76	UCEC	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
1073.0679357034699	-53.853491507419	1094.5457232071624	-18.6273230240254	0.993	264	148	SKCM	SORAFENIB TOSYLATE	Approved in cancer
1021.5103829396633	3.09406220157376	1030.2072881276124	-1.88875581999051	0.921	57	8	PAAD	PACLITAXEL	Approved in cancer
677.4742132201036	2.17439583645913	672.598284647986	-2.41820100581435	0.523	934	113	BRCA	NAVITOCLAX	Clinical trials in cancer
748.4488207262739	-6.11384375842849	717.4379323717869	-13.5130695612064	0.583	169	28	READ	OBATOCLAX	Clinical trials in cancer
493.8553268403626	5.5950262009338	488.4414320402002	-4.14632944051391	0.321	502	57	KIRC	ALFUZOSIN	Approved in other pathologies
664.9325548333677	15.9214059740793	717.9649243377944	2.96375665698997	0.581	292	37	STAD	DHA-PACLITAXEL	Clinical trials in cancer
358.27538197029253	-9.51024256652695	358.4983612082047	3.4166927021007	0.181	169	28	READ	EDARAVONE	Clinical trials
1112.2153721464147	7.00959327656471	1088.5053025269985	2.40729540968505	0.998	512	83	UCEC	DASATINIB	Approved in cancer
280.5669995234165	100.747449551706	209.66701640074092	5.84530201675807	0.0006	264	114	SKCM	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	Experimental
668.821340009017	0.561138194500074	675.4261122472891	13.6125982605217	0.535	202	24	LAML	LINIFANIB	Clinical trials in cancer
171.69381386648075	-16.6220746960844	195.52976008480087	-15.1930784714787	0.0006	264	35	SKCM	N-ETHYL-4-{[5-(METHOXYCARBAMOYL)-2-METHYLPHENYL]AMINO}-5-METHYLPYRROLO[2,1-F][1,2,4]TRIAZINE-6-CARBOXAMIDE	Experimental
162.41968796368408	-25.0698533927128	214.8614015545571	-6.71927236568217	0.0006	502	56	KIRC	7-NITROINDAZOLE	Experimental
644.1039542546616	-19.9455776314024	672.2428533052517	6.61427812400302	0.522	502	54	KIRC	EZN-2968	Clinical trials in cancer
1108.1199495803203	21.6604770536608	1102.2080740526876	-10.3952089563787	1	512	109	UCEC	TEMSIROLIMUS	Approved in cancer
747.2858271778672	32.9255153573025	719.5010396961206	-8.59604432713536	0.593	512	77	UCEC	TRICIRIBINE	Clinical trials in cancer
740.2108188645888	55.7683897203407	751.0539250114998	-4.65010905044869	0.596	169	46	READ	XL765	Clinical trials in cancer
675.1737142273679	12.0157137865941	675.7557948128555	-6.83733975517544	0.521	502	57	KIRC	ROMIPLOSTIM	Clinical trials in cancer
286.54840097733484	81.3806382655165	198.79311383335508	-25.8552549554483	0.0004	222	130	LGG	EVODIAMINE	Experimental
752.6687133073077	23.4388185363277	731.257341518029	-22.4202481192573	0.595	512	74	UCEC	PIMASERTIB	Clinical trials in cancer
711.0791199412911	-56.9821111860771	733.2956551236683	-19.8724092008724	0.595	423	80	COAD	BUPARLISIB	Clinical trials in cancer
175.69168619661707	-56.7755244288018	166.25539978471375	13.5809597349812	0.0006	264	35	SKCM	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	Experimental
366.10998737313696	-0.884676641336483	363.44303870874325	-3.67154653215607	0.181	512	54	UCEC	CIS-VACCENIC ACID	Clinical trials
1153.3553346113827	13.3835661687536	1074.7478358337307	27.5937113674404	1	264	189	SKCM	DABRAFENIB	Approved in same tumor type
209.44414178048444	84.5379358415084	226.84565362929393	-8.10397281585483	0.0004	264	106	SKCM	SALERMIDE	Experimental
189.94254476827194	-58.3494126648003	197.0547497769763	16.2026841977704	0.0006	264	35	SKCM	CHEMBL85860	Experimental
742.9304243073238	-111.501803598593	783.1895856909251	1.28660328653905	0.582	264	186	SKCM	GDC-0623	Clinical trials in cancer
584.6994034969595	-10.2372318183445	591.5875270377102	-1.54097677703953	0.433	343	45	HNSC	GSK2126458	Clinical trials in cancer
638.8506746189347	-12.8583641790385	674.4185944975409	3.48901770644193	0.523	343	52	HNSC	TASELISIB	Clinical trials in cancer
260.204904501042	40.7405756195495	196.70011970671268	5.8403204289248	0.0006	57	24	PAAD	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
203.19500405196018	-33.3848858949769	177.71202015463257	-22.3913753312442	0.0006	512	75	UCEC	3-METHYL-1-PHENYL-3-PENTANOL	Experimental
171.01530119900264	26.0812735767568	207.7920999865242	-10.1020343191472	0.0008	202	25	LAML	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
1070.996983579067	40.7008721637598	1080.9708801938295	8.79825692036502	0.981	423	65	COAD	ERIBULIN	Approved in cancer
663.7871286591529	-51.9207736011437	671.4617205341186	2.10702267912257	0.531	934	105	BRCA	S-8184	Clinical trials in cancer
184.50553276471317	39.5149785104516	227.04999944007568	-7.97130895204344	0.0006	512	77	UCEC	CHEMBL94061	Experimental
160.1785107503868	3.53389421912016	185.52226630037535	13.05238686043	0.0006	264	35	SKCM	BMS-640994	Experimental
159.22538107875081	-17.6049561044201	200.98765856276876	-12.5854812801654	0.0006	502	53	KIRC	ETHENO-NAD	Experimental
898.0450220969249	-4.87415908177798	901.2095797974794	0.111587917032921	0.781	264	120	SKCM	NADROPARIN	Approved in other pathologies and in clinical trials in cancer
261.66526907373293	16.6280846597879	211.01189693747045	-20.0366686631912	0.0004	169	40	READ	KINETIN RIBOSIDE	Experimental
148.4773402670829	-10.8807569331077	194.95669703544584	-21.8870969368636	0.0004	934	220	BRCA	FQI-1	Experimental
1052.2020430455666	55.99383363845	1065.0525333484861	-4.39800704544859	0.927	435	211	THCA	COBIMETINIB	Approved in cancer
996.631058597634	10.4582580551879	999.0646950104592	-1.55583897938931	0.891	512	59	UCEC	ERLOTINIB	Approved in cancer
152.6408456549867	-16.5688925913349	188.54286526180937	-2.32454392610725	0.0006	264	35	SKCM	8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM	Experimental
369.3348967927112	2.06513649626496	361.0342243973097	-0.0206163430786432	0.184	512	58	UCEC	BEZAFIBRATE	Clinical trials
133.77769492823114	74.6840496667277	220.61819089274167	58.42331011852	0.0008	264	112	SKCM	N-{2,4-DIFLUORO-3-[(5-PYRIDIN-3-YL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)CARBONYL]PHENYL}ETHANESULFONAMIDE	Experimental
643.2325593563104	-7.49537576579081	671.6649049232219	-4.9546100964119	0.523	502	56	KIRC	219580-11-7	Clinical trials in cancer
585.0684328375653	-5.02301599788899	581.0002612585674	0.000655720325937637	0.423	512	67	UCEC	CH5132799	Clinical trials in cancer
198.48198430204616	0.441042887203793	198.8461271280333	-1.96990714484537	0.0008	292	36	STAD	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
221.82980786336384	45.6229877749213	206.39044904792112	1.53739841506786	0.0006	512	54	UCEC	79558-09-1	Experimental
214.88424462235324	48.8703213124505	219.75379182799975	-14.8250392555468	0.0006	169	46	READ	PURVALANOL B	Experimental
228.34383637231272	-41.7493742462101	192.33570303186585	-11.3316333786288	0.0006	502	56	KIRC	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N&#39;-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	Experimental
1020.737539910192	12.5063565869195	1027.9998712134077	-0.00025177258066833	0.92	343	47	HNSC	CETUXIMAB	Approved in cancer
1028.8216644732058	-3.46668623637544	1046.9096536459717	-4.26617873327359	0.936	502	59	KIRC	SUNITINIB	Approved in same tumor type
89.24245937340258	30.9395629568055	169.31810708000793	34.8380877851853	0.0006	435	211	THCA	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
271.4465935524901	-8.77168746393815	187.3823822761237	-16.1071677510134	0.0006	512	70	UCEC	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	Experimental
143.69057417966303	-81.9372235863835	198.84400177061133	64.0230275352401	0.0008	264	185	SKCM	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
598.3279207448193	65.6505091918783	748.8451829389744	32.4592974960292	0.595	264	186	SKCM	PIMASERTIB	Clinical trials in cancer
74.6373279646383	15.1605641778543	207.64718235437786	-3.97546328557792	0.0004	222	132	LGG	CHEMBL254381	Experimental
222.86712626080418	57.4311560088918	185.18618165105707	15.9102738378486	0.0006	169	39	READ	DB07268	Experimental
257.09725400252034	-6.68585874939777	228.841184266815	4.33750636748982	0.0004	512	90	UCEC	FQI-1	Experimental
269.862968522625	-65.8234966117444	204.54037483227492	-9.52895778364518	0.0008	423	91	COAD	PHOSPHONOTHREONINE	Experimental
674.530031614018	-33.1359582489761	704.2966418735314	4.00482456142709	0.544	934	224	BRCA	PWT33597	Clinical trials in cancer
181.38800817781123	23.9993513503578	205.06931312165545	-14.1054947494549	0.0008	202	24	LAML	PURVALANOL B	Experimental
260.29888616379543	-15.810847851694	191.60978777390855	25.6192847801473	0.0006	512	54	UCEC	CHEMBL202609	Experimental
704.7436917616016	40.1008513694223	723.4058743565826	-0.377074216836718	0.583	292	37	STAD	OBLIMERSEN	Clinical trials in cancer
574.7779675665306	-39.0128456411791	597.512739707371	0.128095055498306	0.441	264	114	SKCM	ABT-751	Clinical trials in cancer
245.23079576761768	6.19588997718012	195.05000601723944	-7.58422283249445	0.0006	512	77	UCEC	N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE	Experimental
708.3181549294818	-20.9994393021104	733.0006626328062	11.8409061938762	0.596	292	43	STAD	XL765	Clinical trials in cancer
341.22017265432424	-14.1926589231796	328.00005933773207	-0.000206660218736943	0.142	934	223	BRCA	QUERCETIN	Clinical trials
731.9519216827822	-28.6515343918653	690.217482071443	7.1227676709309	0.551	343	84	HNSC	DHA-PACLITAXEL	Clinical trials in cancer
217.1471327443015	17.6617089622427	200.09273171865803	-12.4890251848255	0.0006	543	69	LUAD	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
164.1612253090508	54.3678776823921	218.6633125098974	-14.5140484097762	0.0006	512	54	UCEC	78617-12-6	Experimental
220.22760345298244	22.8929396509366	206.26865732752356	7.94157801743245	0.0008	202	24	LAML	FR 180204	Experimental
1130.3993870293725	-38.5661860428901	1130.5504875989252	-21.8473768593494	1	264	186	SKCM	TRAMETINIB	Approved in same tumor type
233.913374439124	-11.6976966475404	199.63852362198358	-11.8881127189511	0.0008	343	62	HNSC	PI-103	Experimental
713.6869415884033	11.1171824591109	665.1330757565418	18.6353147482989	0.511	57	7	PAAD	S-8184	Clinical trials in cancer
762.9969618785067	32.3893752118257	722.1934704956556	2.19262574241168	0.584	543	72	LUAD	AZD8330	Clinical trials in cancer
306.64877803839835	-85.5165176522944	183.18186439707742	41.0229551655202	0.0008	264	183	SKCM	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	Experimental
179.45245071058122	10.6978422363072	198.66903395412794	-6.55743908500085	0.0008	292	31	STAD	DEXFOSFOSERINE	Experimental
208.825704327188	100.977663279337	210.22420447195233	15.8317818910979	0.0004	57	24	PAAD	NSC632839	Experimental
812.2119446741889	-64.091969602117	724.7725034677368	-9.54891391148067	0.596	264	186	SKCM	REFAMETINIB	Clinical trials in cancer
1095.8041218550657	-11.0288197564237	1067.9988020373714	-0.00106652628846859	0.964	343	84	HNSC	PACLITAXEL	Approved in cancer
167.94546703004409	-96.2167921709893	160.07636083019378	-32.4395577293171	0.0004	264	187	SKCM	LY2183240	Experimental
737.4733172756099	16.461751604286	734.6225834274935	-13.1508130129153	0.596	153	30	BLCA	NVP-BGJ398	Clinical trials in cancer
193.45606760569032	-16.1661743997055	217.23692593429436	24.317572116227	0.0006	264	35	SKCM	6((S)-3-BENZYLPIPERAZIN-1-YL)-3-(NAPHTHALEN-2-YL)-4-(PYRIDIN-4-YL)PYRAZINE	Experimental
175.77056719189375	-13.640725506648	220.2877539036855	0.279037754411775	0.022	343	44	HNSC	TG100-115	Clinical trials
989.0151837414136	-17.9109895948476	999.0191283366213	-4.01685179637218	0.891	169	41	READ	PEMETREXED	Approved in cancer
774.1570941589814	64.7089122811588	694.8739526276368	1.37866008498088	0.551	389	57	LUSC	NAVITOCLAX	Clinical trials in cancer
502.06837470359625	-4.25488312916687	498.0000041887338	-3.54186604454299e-05	0.331	599	108	OV	IBUPROFEN	Approved in other pathologies
1078.213941830555	7.61813150377134	1093.932159992304	-0.828714515397223	0.997	423	89	COAD	COBIMETINIB	Approved in cancer
916.3043893598814	1.53736080257374	913.6929781940478	-2.9196175005286	0.791	512	64	UCEC	NADROPARIN	Approved in other pathologies and in clinical trials in cancer
533.1601281491331	-11.4794910412972	548.4424478834286	-4.3783489399973	0.384	169	28	READ	IBUPROFEN	Approved in other pathologies
192.32331657979415	125.791021528693	192.8629007132908	39.294132149693	0.0006	57	24	PAAD	DB06892	Experimental
175.35398086943445	-49.646680216763	226.19861115848585	3.9175434074923	0.021	934	214	BRCA	TRIPTOLIDE	Clinical trials
636.5337772251321	-63.6377391015083	663.4669372710099	-23.0750552758523	0.523	435	183	THCA	RO5212054	Clinical trials in cancer
72.41347971189684	-61.2188964629918	272.83242008777006	-22.0773251226619	0.0008	264	181	SKCM	PURVALANOL B	Experimental
316.9483870627079	15.3169066691909	306.8057277980073	-5.9767376380596	0.111	435	183	THCA	EDARAVONE	Clinical trials
167.92466604929288	11.1446408552409	220.88531613215613	4.96405642443642	0.0006	264	35	SKCM	CHEMBL203567	Experimental
240.02642131318768	-71.5856220127523	224.33844537978126	43.317247932896	0.0006	435	211	THCA	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
696.4086881723679	-9.48428133593166	733.4205325289635	-5.80878910873412	0.595	292	43	STAD	COPANLISIB	Clinical trials in cancer
615.4573458255525	-25.2548377239986	665.4022334563098	-14.2270944278353	0.543	264	112	SKCM	ARQ736	Clinical trials in cancer
681.8034118199528	-32.897469246697	687.9870861521802	-1.0436630237657	0.532	502	59	KIRC	X-82	Clinical trials in cancer
167.70197737676693	-19.3674135752188	216.68923756340342	-8.24336034379894	0.0004	264	28	SKCM	BMS-536924	Experimental
1078.6647392692062	-13.1668576629574	1092.9276092473835	17.4708557997155	0.997	264	44	SKCM	SUNITINIB	Approved in cancer
706.6700180195465	-103.640776545321	705.29699433963	61.7883652185888	0.582	264	186	SKCM	BI847325	Clinical trials in cancer
142.00190706392766	-15.0279719470219	209.92487505283708	-14.4143769508291	0.0006	423	63	COAD	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
177.392528621649	0.27337874049735	215.23641466181672	11.8426705278744	0.0006	502	53	KIRC	OXAMIC ACID	Experimental
166.48818393752796	-47.306341753829	183.96054493191477	-0.168741962178956	0.0004	934	214	BRCA	AS 604850	Experimental
252.21837089057146	-22.7259369506722	220.36114646885667	-23.2522914971	0.021	264	112	SKCM	URSOLIC ACID	Clinical trials
497.5986366779127	2.82926789105846	495.26986679305617	-1.7083656830398	0.324	502	60	KIRC	CARVEDILOL	Approved in other pathologies
287.7216506599993	60.5503521369082	185.925572807296	-39.4861415868985	0.0004	57	24	PAAD	KINETIN RIBOSIDE	Experimental
261.410110693798	-27.768844316666	189.24802891388492	-3.32851490831581	0.0006	502	53	KIRC	CHEMBL376632	Experimental
695.0762533574292	-4.33040220212956	670.4797996278519	-0.405278731993803	0.534	502	62	KIRC	DOVITINIB	Clinical trials in cancer
319.749206587757	-16.1079488545292	327.00010288120353	-0.000320111771088705	0.141	423	57	COAD	LAX-101	Clinical trials
668.6478407157539	-47.9478902610933	727.4754800022826	-14.3871390559034	0.583	423	89	COAD	TAK-733	Clinical trials in cancer
162.9739621604204	-1.021536989412	211.06571867489941	-4.43409245917218	0.0008	543	72	LUAD	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
1004.1802036439157	1.01953415289151	1007.2956256444634	0.884213550012532	0.891	512	56	UCEC	GEFITINIB	Approved in cancer
692.3314079272009	30.4332078070452	737.171045617358	-6.29470443564242	0.594	153	26	BLCA	PKI-587	Clinical trials in cancer
241.13229401227193	-3.25970351968067	205.15566108240904	-19.0426305361162	0.0006	512	78	UCEC	PF-562271	Experimental
206.90954160553957	21.3523135873508	190.62998830078593	-8.58422501164432	0.0008	543	78	LUAD	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
721.1976257712084	21.4605792804717	728.283933079057	-0.619772050973893	0.586	599	71	GBM	NVP-BGJ398	Clinical trials in cancer
566.8867438732582	6.26544668475799	566.7039318176387	0.168907226650845	0.412	512	66	UCEC	DS-7423	Clinical trials in cancer
219.9188805892104	-31.0214913520338	189.5747871839198	-22.8380993039214	0.0006	264	35	SKCM	2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE	Experimental
677.6205576017211	92.3693465392593	661.8291806903738	-39.3853816309518	0.553	57	24	PAAD	COPANLISIB	Clinical trials in cancer
673.2533601928831	33.3284673632864	683.1439550184924	-4.09101705499165	0.533	153	16	BLCA	TASELISIB	Clinical trials in cancer
166.60123235400317	74.9792759735022	233.99913377817813	-5.59824852177894	0.0004	435	184	THCA	NEOPELTOLIDE	Experimental
759.917220338597	0.16415992772292	723.1103859251747	-19.8578746809196	0.592	169	44	READ	212631-79-3	Clinical trials in cancer
744.051697021643	17.7245043853504	718.4257432604597	-2.68290657437694	0.584	512	77	UCEC	VOLOCIXIMAB	Clinical trials in cancer
1051.6742470944891	16.1122030252258	1028.001483034352	-4.95481365818659	0.92	934	237	BRCA	EVEROLIMUS	Approved in same tumor type
194.3480410516492	109.097334350763	239.16149130446044	19.1203399666207	0.0006	57	24	PAAD	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
221.1644146339369	14.7452296880801	190.20543230701898	4.27941058530064	0.0006	502	57	KIRC	AT001/R84	Experimental
224.4374760888107	-12.1186260197456	193.2027136270828	-2.97077868015487	0.0004	512	53	UCEC	BRD63610	Experimental
244.9853438678112	-34.7788317711238	186.63828648591584	-6.59223820497141	0.0006	502	53	KIRC	ADENOSINE-5&#39;-[BETA, GAMMA-METHYLENE]TRIPHOSPHATE	Experimental
476.90181633494836	0.641094716459662	482.95638268236195	-2.56674772598103	0.311	502	53	KIRC	SUCRALFATE	Approved in other pathologies
751.6627427560705	-0.964188395374777	738.3306532114894	3.13365437617472	0.595	292	43	STAD	SONOLISIB	Clinical trials in cancer
768.7545244623018	31.5111278972072	702.5049555099605	-3.93706593102115	0.556	512	86	UCEC	MASITINIB	Clinical trials in cancer
741.2476724901826	-14.0943731518304	730.4273031879432	-7.15232104458187	0.593	153	26	BLCA	PWT33597	Clinical trials in cancer
172.532158455508	-63.7570053697596	224.1239074272613	-5.24916035580918	0.0008	934	225	BRCA	PI-103	Experimental
664.675068984994	-1.49331558786895	651.537181025524	8.68330698550653	0.512	202	32	LAML	BI847325	Clinical trials in cancer
182.51163671847684	-49.6540163279875	217.1907592565149	19.0255864118726	0.0006	264	35	SKCM	209410-46-8	Experimental
187.87572468687472	-49.0976673711047	200.12828328491292	18.6416392112505	0.0006	423	63	COAD	6-CHLORO-9-HYDROXY-1,3-DIMETHYLPYRAZOLO[3,4-B]QUINOLIN-4-ONE	Experimental
724.7685524703246	0.422616062347657	679.8985885750365	-0.327339377018006	0.533	153	22	BLCA	OBATOCLAX	Clinical trials in cancer
693.0000844994809	-30.5214147784108	715.1129035482702	44.8865097051794	0.565	264	72	SKCM	FORETINIB	Clinical trials in cancer
1025.023437546099	15.2398579212313	1039.6406501106526	2.8244512024516	0.93	543	63	LUAD	ERLOTINIB	Approved in same tumor type
720.5515010766225	-40.362168383199	726.1076635180202	-22.2208520112995	0.595	423	80	COAD	BYL-719	Clinical trials in cancer
673.2544835093606	-22.1368029240257	664.1259038475878	-7.37363837979206	0.521	502	57	KIRC	JUGLONE	Clinical trials in cancer
1027.4002195038042	-7.97629069221949	1022.9223317290819	-0.309974954604286	0.914	202	25	LAML	ARSENIC TRIOXIDE	Approved in same tumor type
631.9955682705663	-5.89074108270873	640.4899925761378	-5.59553469559251	0.491	264	29	SKCM	SERDEMETAN	Clinical trials in cancer
1102.8459553300386	0.151572402540921	1100.3432386188424	0.222142315519477	1	292	33	STAD	SORAFENIB	Approved in cancer
298.85898004044765	-3.6553965289159	311.2826028007267	0.10377743960089	0.121	502	54	KIRC	FG-2216	Clinical trials
711.0192895058714	26.0234504265812	669.9429253306469	16.5177344613478	0.523	202	39	LAML	BMS-908662	Clinical trials in cancer
715.7717953835328	29.9521777720826	719.2930240067888	0.417553363894626	0.576	599	70	GBM	XL765	Clinical trials in cancer
170.30382046715758	-11.6415111612533	212.94320605933018	5.03809365587699	0.0004	343	47	HNSC	CHEMBL254381	Experimental
801.7195537151688	53.6465285174154	691.2768820211058	17.4558078146752	0.552	57	24	PAAD	GSK2636771	Clinical trials in cancer
982.4290142887648	-3.94054977030078	1002.3272605766956	5.23226860501552	0.892	169	42	READ	TEMSIROLIMUS	Approved in cancer
188.97946221184978	-43.9698667196007	202.85068225832933	-11.8168714667963	0.0006	264	33	SKCM	1,9-PYRAZOLOANTHRONE	Experimental
151.1768375358448	-22.1998487682137	198.4768713059374	10.5084495809101	0.0004	343	46	HNSC	EVODIAMINE	Experimental
671.0660330748016	-3.46822859824363	670.612860580239	-4.82136825563157	0.544	264	30	SKCM	TELATINIB	Clinical trials in cancer
207.79362711296721	-133.745083731006	238.23486981875618	-62.356170174985	0.0008	264	185	SKCM	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
535.1371573361239	-0.30689326673459	545.9866666388905	2.29955926413504	0.381	423	65	COAD	RASAGILINE	Approved in other pathologies
372.5952540872754	-6.88614461633131	368.1452791986793	-4.83647834857061	0.182	512	70	UCEC	AM-111	Clinical trials
580.327677749403	3.28140833698356	587.4121664467881	1.54079537141774	0.432	343	44	HNSC	1312445-63-8	Clinical trials in cancer
182.92145496886815	-76.1234674813129	217.48009570423872	-5.05840943959674	0.0008	423	92	COAD	PURVALANOL B	Experimental
727.5313761450766	-9.68685705984478	742.707587774036	1.15850363499464	0.595	389	42	LUSC	COPANLISIB	Clinical trials in cancer
697.0317629021629	9.6882985668463	663.231443453466	14.4897538014457	0.515	202	32	LAML	PIMASERTIB	Clinical trials in cancer
489.0321849246545	3.91369349702339	489.00015495383974	0.000139557986585714	0.321	423	60	COAD	CHOLINE	Approved in other pathologies
172.5174863176417	9.48762686051714	203.67563567558636	-9.15477407445087	0.0006	502	56	KIRC	CHEMBL227937	Experimental
185.4414424847734	-23.1273537226949	201.48570780507166	-1.76849107028875	0.0006	264	35	SKCM	2-AMINO-3-(1-NAPHTHYLMETHYLOXY)PYRIDINE	Experimental
1001.5021612050309	-2.44786006709055	1001.9998872915372	-0.000106015010032934	0.891	292	32	STAD	PEMETREXED	Approved in cancer
764.6826448135954	18.7145899557485	707.2133054929842	-11.7613341635416	0.595	169	44	READ	PIMASERTIB	Clinical trials in cancer
724.6381843229984	-9.29165003859978	709.1063525519214	-8.57552002712788	0.581	512	55	UCEC	AC1L3WNB	Clinical trials in cancer
240.77418529518025	-34.445567755311	202.46077424398982	14.083409164959	0.0006	502	56	KIRC	L-CANAVANINE	Experimental
149.4355535898046	-35.3108736267519	217.04106355131523	-12.8300865909523	0.0008	264	33	SKCM	UNII-5277GPA358	Experimental
147.7923595466156	44.7283167789594	185.0343155093045	-20.8597797222503	0.0006	57	24	PAAD	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
1103.0795674558033	-22.0642175281363	1106.9495510104696	-2.69604379807788	1	423	66	COAD	EVEROLIMUS	Approved in cancer
184.87854432703185	-8.21091803574683	199.69639398941703	10.5334584912835	0.0006	502	57	KIRC	VEGF-AS	Experimental
738.2888809768723	-40.5867817473726	718.766481190328	10.5501136722683	0.596	423	80	COAD	NVP-BGJ398	Clinical trials in cancer
1112.1066065146058	-0.343012534385196	1099.325845988738	2.67596265331173	0.998	512	96	UCEC	VANDETANIB	Approved in cancer
1104.7048996455053	-15.2724335014112	1096.281524500745	-2.32538701846602	0.996	292	37	STAD	REGORAFENIB	Approved in cancer
147.9262646049015	-46.0235841832859	199.48196387520497	-3.70751059296117	0.0004	934	214	BRCA	WORTMANNIN	Experimental
241.05551236884094	-20.0065235779275	213.8902797246114	14.9710599071399	0.0006	512	77	UCEC	RU90395	Experimental
193.1247823499262	-23.3239817504411	201.4273683737715	6.5294987645741	0.0006	502	56	KIRC	S-ETHYLISOTHIOUREA	Experimental
212.5261349417654	-4.11047535671489	187.69509324230606	-12.7571362133413	0.0006	264	35	SKCM	CHEMBL478649	Experimental
243.2353011051787	20.5869893408606	209.0364750066001	11.4726397988193	0.0006	512	76	UCEC	3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	Experimental
652.6079694531367	-55.6403020486388	696.0064144933593	20.2727586214978	0.526	435	211	THCA	REFAMETINIB	Clinical trials in cancer
757.9593056937185	-23.0117630516953	728.2414445227618	-2.95177086377134	0.588	292	43	STAD	DACTOLISIB	Clinical trials in cancer
206.13550875405025	40.4225930049201	209.65122799872785	-1.90568819634689	0.0006	512	70	UCEC	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
778.3687823677377	-26.2865482567697	745.8315653149423	-8.42635522823866	0.595	343	62	HNSC	BUPARLISIB	Clinical trials in cancer
1037.1408590069655	0.402470868227255	1034.882068460731	-2.44760665041667	0.931	934	105	BRCA	ERIBULIN	Approved in same tumor type
219.2757859439618	-19.2283306971272	201.61856458857454	-9.78579961058222	0.0006	202	32	LAML	DB06892	Experimental
730.1215032698016	88.8578422851845	733.8360660834135	-4.0880619502542	0.596	169	44	READ	391210-10-9	Clinical trials in cancer
499.332056239318	9.8002326781554	497.28418651724706	3.37211108211613	0.331	934	217	BRCA	CAFFEINE	Approved in other pathologies
623.593698650385	0.222101255823645	692.4561040274831	0.281449616961936	0.544	502	58	KIRC	XL-647	Clinical trials in cancer
665.3981835108688	47.9724570705422	702.6739374569045	5.08085802501606	0.552	57	24	PAAD	XL147	Clinical trials in cancer
92.0927187494501	-83.4864537096783	186.63615390313262	-40.9983379863002	0.0008	264	183	SKCM	SB220025	Experimental
310.13511448150166	1.20567063293174	303.14242761742776	-2.05363522877701	0.121	502	57	KIRC	GLICLAZIDE	Clinical trials
662.1059057792473	-47.6030597902803	680.7034322326133	-8.22687909645333	0.535	502	59	KIRC	MOTESANIB	Clinical trials in cancer
743.546676675046	27.6584929339982	735.0621119024145	-2.06798826874694	0.592	389	46	LUSC	GDC-0980	Clinical trials in cancer
261.67582859946833	52.8855659007089	209.44763368633406	38.4878292520215	0.0004	512	110	UCEC	PARBENDAZOLE	Experimental
721.7219172431526	-23.6348149917067	740.9114505209005	5.08977687477523	0.595	389	42	LUSC	BUPARLISIB	Clinical trials in cancer
661.0784612204416	12.92356865694	683.4148616235026	-17.6391578494677	0.544	264	31	SKCM	AMUVATINIB	Clinical trials in cancer
289.0737972961	-0.285137810908537	200.06681042227635	2.06118817601021	0.0008	389	46	LUSC	PI-103	Experimental
238.81742473949618	67.834328191393	181.2337269140007	12.557375934331	0.0006	57	24	PAAD	1,9-PYRAZOLOANTHRONE	Experimental
608.9284620019065	-42.011843633349	653.5456476621476	-7.96945061244401	0.513	435	211	THCA	TAK-733	Clinical trials in cancer
759.0842287470583	-9.99299951561005	748.6799624570258	5.47772684470715	0.593	512	75	UCEC	BMS-908662	Clinical trials in cancer
1041.230734414148	2.32525143121637	1027.5148350274544	0.953767863089979	0.924	502	57	KIRC	PACLITAXEL	Approved in cancer
757.7380469273254	-39.2193700713821	738.1821111822206	9.02691792285691	0.595	292	43	STAD	PKI-587	Clinical trials in cancer
198.79971294589853	-34.2931266639474	193.9140768737562	-15.3664914321487	0.0006	502	53	KIRC	ADENOSINE-5-DIPHOSPHORIBOSE	Experimental
197.10211506184964	10.8606617087993	200.69263394294688	10.1058690284272	0.0004	153	22	BLCA	FQI-1	Experimental
217.4966042218655	13.3207505527643	190.3025872073883	-29.9552919015796	0.0006	57	6	PAAD	DEXFOSFOSERINE	Experimental
168.38440559946162	133.147742196661	157.37427734542237	30.3569307050823	0.0004	222	132	LGG	LEXIBULIN	Experimental
762.8547289140839	-41.4499483905835	714.8762330932808	-3.75480935095214	0.586	543	74	LUAD	BUPARLISIB	Clinical trials in cancer
774.6107343362715	-31.9962867319398	738.306978923571	11.6447386705231	0.596	153	26	BLCA	XL765	Clinical trials in cancer
196.8470941635802	-58.4718125975973	185.11951045232792	7.82836527998234	0.0006	264	35	SKCM	2-AMINO-3-BENZYLOXYPYRIDINE	Experimental
756.9136656987392	-33.4185108739815	730.9082330097477	6.54182834089943	0.594	264	40	SKCM	LUCITANIB	Clinical trials in cancer
189.05593016496044	-7.01795860688284	196.1603655341779	-0.371040678771578	0.0006	502	53	KIRC	THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE	Experimental
712.7013924981429	-18.647763854523	733.1557012247744	5.95253593549592	0.595	292	43	STAD	BUPARLISIB	Clinical trials in cancer
1002.8645337422937	-21.6559332619103	1061.3617120471924	3.21531465942007	0.942	264	126	SKCM	DOCETAXEL	Approved in cancer
698.4481148655135	18.2988137926856	718.127769267883	22.8577120838937	0.595	169	46	READ	COPANLISIB	Clinical trials in cancer
540.9635557247216	-12.7992714074831	537.4562046441569	3.49332414425612	0.381	169	39	READ	CHOLINE	Approved in other pathologies
155.9437800118581	-20.135859170386	200.35703028140324	-9.68489711509324	0.0004	153	19	BLCA	TIPIFARNIB-P2	Experimental
198.42186663145537	-25.3470827298826	208.6462443295985	-20.5507724073345	0.0004	264	47	SKCM	PARBENDAZOLE	Experimental
950.27241651733	1.55282871937274	955.2266129240843	1.6089074325011	0.841	543	66	LUAD	ETOPOSIDE	Approved in cancer
543.086997262956	8.15789866704716	541.8973095016249	0.00367653392891043	0.381	292	37	STAD	RASAGILINE	Approved in other pathologies
210.94005637083157	8.15077253369986	229.63423667028502	16.1868882403796	0.0004	512	60	UCEC	CYTOCHALASIN B	Experimental
150.31068213059987	78.4206908990043	212.11999785908762	-0.873846606540582	0.0006	57	24	PAAD	FR 180204	Experimental
507.67443140615404	-3.29492681623006	507.0000340100749	0.000127937488059615	0.341	153	16	BLCA	CAFFEINE	Approved in other pathologies
678.5651914654261	18.88425435773	733.5599165433214	2.41116321540949	0.595	389	46	LUSC	SONOLISIB	Clinical trials in cancer
689.558658699684	12.6013916757093	670.0841983624691	-2.32226266734233	0.524	222	56	LGG	NAVITOCLAX	Clinical trials in cancer
996.5549490139241	-4.64643869560965	1004.6511331128411	1.40886582524899	0.891	423	68	COAD	PEMETREXED	Approved in cancer
194.06359188404386	14.4382139919034	217.64604363860076	-3.40502274703658	0.0006	502	53	KIRC	(3R)-3-[(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YLOXY)METHYL]-2,3-DIHYDROTHIENO[2,3-F][1,4]OXAZEPIN-5-AMINE	Experimental
161.26551728952688	90.8405396460566	221.81208016459883	42.5817142493357	0.0006	57	24	PAAD	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
248.4074642138353	-32.2986073883912	195.36431651721426	11.1961417665634	0.0006	502	53	KIRC	AR-C102222	Experimental
122.54263250101482	-44.8567436037318	231.0771260058155	-1.39245743008951	0.0004	222	130	LGG	CYTOCHALASIN B	Experimental
170.73616789399807	18.2511661195224	206.67282323536364	-17.4003626133708	0.0006	502	53	KIRC	ANISTREPLASE	Experimental
170.92649613153912	-0.559960453169452	181.63683858415132	-9.03203442197264	0.0008	934	215	BRCA	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	Experimental
338.5776035960011	13.693294066441	139.2499716198314	35.6380830642302	0.0008	264	177	SKCM	DB07788	Experimental
612.1790522657027	8.1934385224738	712.663210661164	37.2160049946798	0.54	57	24	PAAD	SELUMETINIB	Clinical trials in cancer
162.1632062413397	-54.1842651432034	182.97075850271628	-19.782802793705	0.0006	512	77	UCEC	DPI59	Experimental
190.00844059233032	-19.8165502540641	205.1049909060712	21.951442832446	0.0006	264	33	SKCM	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	Experimental
733.9595868351162	51.4885603973168	724.171408321413	21.4626172421771	0.581	512	54	UCEC	SKF-86002	Clinical trials in cancer
170.09747864828233	31.4797586346667	178.59888354257964	12.1353835815959	0.0006	512	76	UCEC	BISINDOLYLMALEIMIDE VIII	Experimental
887.6876485786938	0.151445016248431	887.9999058109681	0.000107530902596409	0.764	512	62	UCEC	SIMVASTATIN	Approved in other pathologies and in clinical trials in cancer
1064.8297679349075	19.29279957319	1087.2982460447731	-7.94745518169316	0.984	169	39	READ	VANDETANIB	Approved in cancer
683.9321370136714	-20.0116243506596	696.2687835777098	5.50596660732072	0.553	512	68	UCEC	TASELISIB	Clinical trials in cancer
173.45787694119585	5.66007315990265	213.04694368468736	-2.78410544679173	0.0006	502	53	KIRC	CHEMBL258208	Experimental
863.0827767164676	-1.22112217238265	862.7268207236559	-0.0184841654188403	0.736	502	66	KIRC	NINTEDANIB	Approved in other pathologies and in clinical trials in cancer
103.817465211012	32.2329717877398	185.28540650520176	-3.94829438234751	0.0006	169	43	READ	OLOMOUCINE	Experimental
833.7024869801872	14.2187357665543	822.9998293363253	6.62678928620153e-05	0.692	169	41	READ	SIROLIMUS	Approved in other pathologies and in clinical trials in cancer
222.22279256973158	-50.0354645592332	198.2751150101656	5.26430005739667	0.0004	423	71	COAD	KINETIN RIBOSIDE	Experimental
1032.2141790454473	-6.71481209292688	1030.4218280028576	4.65042216546362	0.922	502	61	KIRC	DOCETAXEL	Approved in cancer
673.1773785712438	1.92809702288341	694.0596956048101	-11.078383074755	0.533	934	105	BRCA	OBATOCLAX	Clinical trials in cancer
1082.833706656309	0.482911444229444	1083.6346984774625	-3.3997937779896	0.988	512	111	UCEC	BOSUTINIB	Approved in cancer
1088.7262070628428	-10.1268723088528	1072.9723428661507	1.50279191795198	0.983	264	29	SKCM	THALIDOMIDE	Approved in cancer
717.7190529213163	25.1781647263751	737.052144820593	7.35011843354147	0.582	512	74	UCEC	RO4987655	Clinical trials in cancer
161.19309881225752	-29.2532606944528	200.30734059529024	-1.09329017238315	0.0006	502	53	KIRC	N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE	Experimental
1036.5009393181124	-8.65277656163551	1035.0750403501447	1.98846319000978	0.93	543	63	LUAD	GEFITINIB	Approved in same tumor type
223.10127271040486	37.6829497062179	209.70883840075695	-0.82295205101218	0.0004	153	23	BLCA	PARBENDAZOLE	Experimental
377.8566399393294	-4.62332902817232	358.6148870233231	-5.35206905514207	0.181	512	77	UCEC	172889-27-9	Clinical trials
187.85888616423503	15.8929272858357	195.2232223926848	-4.42079105913763	0.0004	264	57	SKCM	NG25	Experimental
205.4876058947159	60.11759221504	192.52815574592785	-3.39594042269897	0.0008	543	72	LUAD	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
624.4271074460361	-76.8389823243973	676.8141214612638	23.0415961173994	0.526	435	211	THCA	391210-10-9	Clinical trials in cancer
1008.0945624666299	32.3718467377064	1041.851979934066	20.9349202979497	0.923	435	211	THCA	ARSENIC TRIOXIDE	Approved in cancer
619.5952688569122	-58.0131523041105	688.7850356260756	38.2811146803433	0.523	435	211	THCA	BMS-908662	Clinical trials in cancer
766.36067841646	95.1605463427118	730.4887445894726	-3.6169425088811	0.552	57	24	PAAD	PWT33597	Clinical trials in cancer
786.4801884003228	16.1296348017503	746.9750640994396	-2.82119070932703	0.594	512	142	UCEC	SF1126	Clinical trials in cancer
659.665792095205	0.586534243648771	688.3690842932099	-5.68676329590517	0.535	502	58	KIRC	TIVOZANIB	Clinical trials in cancer
547.1242190955588	0.458962898158831	554.4434117802297	5.40802414864902	0.394	264	29	SKCM	MESALAZINE	Approved in other pathologies
648.1555651714349	48.0154254015285	676.7964560848675	41.6582385781867	0.543	264	112	SKCM	RO5212054	Clinical trials in cancer
1089.2759673965274	-40.4919967521489	1114.6032671540424	-4.01108261021045	0.998	264	130	SKCM	DASATINIB	Approved in cancer
570.3946214014758	1.83150613527906	575.2964607341812	-0.168782278132653	0.412	512	66	UCEC	ZSTK474	Clinical trials in cancer
756.65049128351	7.41009942626323	741.1668111767469	2.03879623400621	0.583	543	77	LUAD	ENCORAFENIB	Clinical trials in cancer
186.88435790377758	-31.8100948708135	190.82915420997338	-7.242339902504	0.0006	502	53	KIRC	CHEMBL114500	Experimental
819.668521703924	67.429020196129	806.8643328261368	16.7801545510224	0.584	264	188	SKCM	AZD8330	Clinical trials in cancer
230.63945607422676	-48.4533302464803	210.53716067004834	1.5217353078217	0.0006	169	44	READ	5-BROMO-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]BENZAMIDE	Experimental
725.4526560817528	-45.1182700249695	719.8495641651156	6.99182038713707	0.583	264	40	SKCM	TALMAPIMOD	Clinical trials in cancer
933.5832311816043	3.53283413147656	934.7770981209671	-2.98997836125636e-05	0.815	202	23	LAML	CETUXIMAB	Approved in cancer
790.7841970978918	62.3243586225404	711.4249103706256	21.4216674784855	0.594	512	142	UCEC	PWT33597	Clinical trials in cancer
652.2354094589805	28.9636018263126	687.8095748077513	14.0870007062983	0.523	202	53	LAML	PKI-587	Clinical trials in cancer
220.58222647161614	-39.9827734822542	197.92069988822428	-10.5984730002219	0.0006	264	35	SKCM	CHEMBL410668	Experimental
713.1170670191735	-24.1285867705588	714.6449258407661	4.24435318815722	0.596	264	38	SKCM	MASITINIB	Clinical trials in cancer
299.0323810490911	2.70942831719779	306.4138686322819	-5.03068135747549	0.111	502	54	KIRC	TRIFLUSAL	Clinical trials
197.91418015799476	-15.5218015681668	193.45026615449012	-3.93108489575093	0.0006	502	53	KIRC	1,6-DI-O-PHOSPHONO-D-TAGATOSE	Experimental
222.26300129983886	-68.9869951684442	178.86515329906982	-20.1488416033985	0.0004	264	110	SKCM	NEOPELTOLIDE	Experimental
659.7034988653047	-34.3432697599284	669.5208267222386	5.4208483417533	0.523	599	107	OV	OBATOCLAX	Clinical trials in cancer
1120.7265468801845	-11.9116397098879	1046.5333343170248	5.78197340293647	0.937	57	24	PAAD	COBIMETINIB	Approved in cancer
223.45213692487792	-23.1850145815606	206.91156168072942	-3.48159490116245	0.0004	292	38	STAD	KINETIN RIBOSIDE	Experimental
573.3680293908027	-5.28829356142313	579.5948640165661	6.62182927528102	0.423	934	215	BRCA	CH5132799	Clinical trials in cancer
1100.4115490925074	18.4135763272586	1100.8281765368856	10.4146039311374	1	512	106	UCEC	EVEROLIMUS	Approved in cancer
675.9555747602097	23.224543320148	674.3774726804503	-1.93060382677413	0.531	153	22	BLCA	S-8184	Clinical trials in cancer
965.8607770577411	-10.712783793234	957.1210321417991	-8.46433274293011	0.841	57	24	PAAD	PEMETREXED	Approved in cancer
708.1311052204749	-0.385822444812447	707.2220850000089	2.51120228620448	0.562	599	68	GBM	GDC-0941	Clinical trials in cancer
769.1887223190475	25.5193351300956	707.9461858598759	13.7359721413247	0.582	512	74	UCEC	BI847325	Clinical trials in cancer
716.6098556768738	-53.6938022983136	687.9997853212983	-6.51508361215747e-06	0.542	543	72	LUAD	212631-79-3	Clinical trials in cancer
666.3580781898538	-20.3455151721599	696.6999043005648	-4.55748971683488	0.545	934	224	BRCA	PF-04691502	Clinical trials in cancer
782.4809961270475	42.4549856501397	754.9903305431669	11.0782092672172	0.594	512	141	UCEC	XL147	Clinical trials in cancer
750.8727136506508	-43.1680864504901	724.8149408664286	-3.04975576275024	0.596	343	62	HNSC	XL765	Clinical trials in cancer
202.01771178581478	8.32788575369216	189.0336143770398	-0.0744801971725337	0.0006	512	77	UCEC	1-(1-METHYLETHYL)-3-QUINOLIN-6-YL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	Experimental
748.5520443335088	27.2424083257858	738.8262041449206	-17.3719532319147	0.581	512	70	UCEC	CC-401	Clinical trials in cancer
674.9343012598163	-9.1554058829758	682.6474891085795	21.1320065488612	0.546	934	224	BRCA	PKI-587	Clinical trials in cancer
100.17638229161463	-31.6327023159716	213.34738910536348	-43.8621788273988	0.0008	222	127	LGG	2&#39;-MONOPHOSPHOADENOSINE 5&#39;-DIPHOSPHORIBOSE	Experimental
528.5777245253742	4.47163721468374	549.4976572265657	0.156651807604703	0.384	222	56	LGG	IBUPROFEN	Approved in other pathologies
997.507628497778	3.35478405424195	1008.5797909594788	-2.34500974598052	0.892	169	41	READ	EVEROLIMUS	Approved in cancer
754.4787075596955	46.1037337292463	731.8016876825172	4.69534831875762	0.584	543	74	LUAD	SF1126	Clinical trials in cancer
718.042157504774	83.5027916697236	679.8126769847302	29.8256862585432	0.552	57	24	PAAD	GDC-0941	Clinical trials in cancer
138.77634904784622	-44.2790982870732	208.36499785020183	-1.11996491364062	0.0004	934	219	BRCA	EVODIAMINE	Experimental
164.69022999260724	-123.50950075513	248.25382780666786	-6.80278341996291	0.0008	264	177	SKCM	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
1085.7045883156477	-25.6172538076263	1080.1310970877473	3.98587665459854	0.981	222	55	LGG	ERIBULIN	Approved in cancer
184.11965648323644	-45.3287090633953	217.59578664197696	13.7315741890111	0.0006	264	35	SKCM	4-{4-[(5-HYDROXY-2-METHYLPHENYL)AMINO]QUINOLIN-7-YL}-1,3-THIAZOLE-2-CARBALDEHYDE	Experimental
705.027514779681	-38.923152261893	716.3641699597675	-28.5631506315713	0.584	264	34	SKCM	XL-228	Clinical trials in cancer
736.1303154326898	2.26547507858814	746.5390132944101	0.83162438575846	0.592	153	26	BLCA	GSK2636771	Clinical trials in cancer
800.0969003946993	16.4112589717298	704.6551661630878	9.22451625994404	0.6	169	44	READ	SELUMETINIB	Clinical trials in cancer
185.85460513210867	-3.96025034271983	200.81453318342875	18.2039840772798	0.0006	502	56	KIRC	CHEMBL1230023	Experimental
657.0327943310141	62.187020026129	725.5044937740023	-19.6921944870908	0.552	57	24	PAAD	SF1126	Clinical trials in cancer
541.1478946425167	-1.12283129769699	540.8648704950581	-5.17388932681411	0.381	512	77	UCEC	CITRIC ACID	Approved in other pathologies
227.1875621095028	-86.2634745705329	154.52751590675192	18.0441661407845	0.0006	264	131	SKCM	1,6-HEXANEDIOL	Experimental
1051.4912515880987	-11.9452488170285	1056.9998651169574	0.000596810955812543	0.952	389	59	LUSC	DOCETAXEL	Approved in cancer
347.4016527513126	-6.75307096049633	366.26791628631946	0.590599077002082	0.181	512	77	UCEC	OXALIC ACID	Clinical trials
163.77477176946857	13.488069990397	194.38208320586816	-22.4383946023639	0.0004	512	54	UCEC	N-ISOPROPYLPHTHALIMIDE	Experimental
708.7044848507055	-14.7882084403144	722.7606040689228	-6.15826142193123	0.583	292	48	STAD	NAVITOCLAX	Clinical trials in cancer
637.3453703644149	-0.968531556802191	643.9607225225142	-2.05623866081305	0.523	202	53	LAML	NVP-BGJ398	Clinical trials in cancer
681.3731848524391	-64.9890366506498	734.7938148663856	19.338599112386	0.593	423	80	COAD	GDC-0941	Clinical trials in cancer
650.4271067098856	36.7656501603649	654.5475443892803	-17.5825050572967	0.512	202	32	LAML	212631-79-3	Clinical trials in cancer
690.4009578130995	-3.63203540514459	718.6293445275734	-2.06047272606679	0.583	292	37	STAD	OBATOCLAX	Clinical trials in cancer
131.121669183349	-8.73712698097444	185.90080438624005	8.7964598126423	0.0004	934	214	BRCA	AS-605240	Experimental
131.43555023811592	0.797876086890454	203.87510744088016	14.7503452638316	0.0004	934	231	BRCA	937174-76-0	Experimental
655.4671084385633	-17.2419827907636	685.2797558596477	-9.1225170138996	0.535	502	58	KIRC	FORETINIB	Clinical trials in cancer
818.9303153753143	16.5244042753824	785.2075935426619	23.8724523270512	0.593	264	113	SKCM	GDC-0980	Clinical trials in cancer
780.3514860867012	28.5486709771407	754.6481576555192	-33.3276992937926	0.594	264	113	SKCM	PWT33597	Clinical trials in cancer
180.6273000409629	-54.9553326884355	192.5132072543798	-9.6574806352105	0.0006	423	63	COAD	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	Experimental
229.49220159281435	61.2950260558706	224.28534438747093	20.3768049575942	0.0008	512	75	UCEC	FR 180204	Experimental
679.1995034833909	30.1666405734987	695.1164607556736	-1.35860033053518	0.553	343	84	HNSC	OBATOCLAX	Clinical trials in cancer
202.29254888428295	25.0804887599014	196.14774322211673	-1.04876089081768	0.0004	153	22	BLCA	EVODIAMINE	Experimental
511.6653242344001	-0.376569042540524	516.0001177370783	0.000197749949848003	0.351	153	22	BLCA	IBUPROFEN	Approved in other pathologies
346.3269521394351	-26.3637143696902	323.28450336998145	0.961207939985911	0.132	57	24	PAAD	AM-111	Clinical trials
290.9138863996688	42.7121720508876	191.55771202714854	44.4970281548549	0.0006	435	211	THCA	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	Experimental
1100.4827001207216	-4.62983820017632	1086.7493881880966	-1.9875900408374	0.984	423	65	COAD	PACLITAXEL	Approved in cancer
198.4717685556682	-74.9083906739702	183.70424274368378	7.57108572037532	0.0006	423	63	COAD	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
658.2470444939739	36.9073513497102	692.8640407609407	-18.5995157536695	0.545	934	222	BRCA	COPANLISIB	Clinical trials in cancer
995.3055292126224	22.4766907811286	1041.9756774181394	2.61554283563419	0.932	934	302	BRCA	DOCETAXEL	Approved in same tumor type
218.59611536319917	41.9017711876456	215.27387750877784	-18.3157946839153	0.0006	512	77	UCEC	RU79073	Experimental
235.4221370442613	21.7353536369258	194.0393354709994	11.0018111762548	0.0006	169	41	READ	GUANOSINE 5&#39;-DIPHOSPHATE	Experimental
255.12049285434702	15.6882722261281	194.3826918954603	1.50895790648275	0.0006	543	71	LUAD	SB220025	Experimental
1109.2808067060673	-12.0731977377596	1098.5476714679828	-4.07621878536958	1	512	78	UCEC	SORAFENIB	Approved in cancer
560.4822881186656	-0.307072337820301	571.1113981042081	2.84494626718146	0.412	512	66	UCEC	1312445-63-8	Clinical trials in cancer
208.3145517426522	-0.508995767763508	218.36315258131495	4.01015020418458	0.0006	502	53	KIRC	NAPHTHOL AS-E PHOSPHATE	Experimental
682.6399865678186	0.398846933424352	732.0395788697285	-0.332268852956986	0.583	423	65	COAD	OBLIMERSEN	Clinical trials in cancer
631.2866411799347	48.7376059686288	650.3854173815505	-27.0211638409347	0.522	57	24	PAAD	RO4987655	Clinical trials in cancer
343.79645857409645	-1.19136107828427	346.9998758302442	0.000205612522790943	0.163	599	68	GBM	QUERCETIN	Clinical trials
1057.6936798700071	-2.14450403399078	1083.053186208764	-5.85992684705798	0.982	222	59	LGG	DOCETAXEL	Approved in cancer
294.4771006804736	-54.6874441254363	183.8190886914826	-10.4912653076308	0.0006	435	211	THCA	2-[(2-CHLORO-4-IODOPHENYL)AMINO]-N-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}-3,4-DIFLUOROBENZAMIDE	Experimental
231.24062429114863	54.0357240035541	177.2842639478017	11.3749913138546	0.0004	169	38	READ	N-ISOPROPYLPHTHALIMIDE	Experimental
639.9630180836145	-19.8327428568706	666.3220136268737	8.22942449278071	0.511	502	53	KIRC	DIHYDROXYACETONE PHOSPHATE	Clinical trials in cancer
224.1549230616549	-32.5559744533373	198.73858355637998	4.56051326835882	0.0004	202	23	LAML	GTP-14564	Experimental
764.2747973837816	-48.7014479592072	732.2490076257868	34.7304735872681	0.594	264	35	SKCM	TRICIRIBINE	Clinical trials in cancer
77.2314805746405	-35.8949994383318	241.1107614101506	20.1666599267646	0.0004	222	134	LGG	LY2183240	Experimental
211.88533575951493	41.2545383639804	200.9559258652897	-8.60056208346185	0.0006	512	78	UCEC	BISINDOLYLMALEIMIDE I	Experimental
203.4734451967132	-6.30737125425125	213.61770332897387	5.13435496091051	0.0008	202	23	LAML	ISOCITRIC ACID	Experimental
151.16728685653	34.1321412078909	197.95535338977842	19.3480340875062	0.0006	512	61	UCEC	1,4-DITHIOTHREITOL	Experimental
729.944984736071	42.6648501571577	744.5309364788914	-3.09235001264005	0.596	389	48	LUSC	NVP-BGJ398	Clinical trials in cancer
506.3600687806861	6.42757535930321	506.7748468013406	0.147335806710771	0.341	343	54	HNSC	CAFFEINE	Approved in other pathologies
226.638791053244	7.45255060490314	207.64121528853167	-32.1283987763194	0.0006	512	77	UCEC	PASBN	Experimental
204.0917286823912	-14.3111641557406	196.03044545429586	-25.5169550262585	0.0004	264	57	SKCM	TL-1-85	Experimental
743.4303913699949	-89.0972364505915	768.3837766151481	21.2909643229109	0.593	264	112	SKCM	GDC-0941	Clinical trials in cancer
310.24344275761024	51.5409432239545	180.44427969574545	34.8814787182321	0.0004	222	129	LGG	GW843682X	Experimental
377.5175189985244	-11.8166981621221	360.3948297682244	-3.10527020310519	0.181	423	89	COAD	ANTIBIOTIC K 252A	Clinical trials
89.59451734681853	52.3377621831038	170.33686101928572	10.6494822667987	0.0004	222	130	LGG	FQI-1	Experimental
224.8577169193171	21.3289460350197	202.6698510246202	-2.02677050745888	0.0008	202	24	LAML	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
161.55565271003258	-40.4306007430867	212.22083194525004	11.1666174339348	0.0008	423	89	COAD	N-(5-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]PHENYL}-1,3,4-OXADIAZOL-2-YL)ETHANE-1,2-DIAMINE	Experimental
559.8692054467335	6.81419781447011	571.0001332044254	0.000166516001513628	0.412	169	38	READ	GI-4000	Clinical trials in cancer
176.92945939917286	-24.0396280233252	202.46279114387724	-16.7857697001923	0.0006	264	33	SKCM	2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO}BENZAMIDE	Experimental
1081.8754671985623	44.4128010307257	1038.7538774199409	-9.15891176521416	0.939	57	24	PAAD	TRAMETINIB	Approved in cancer
144.52154507148708	32.6281340670242	190.74625224076107	32.0162021110312	0.0004	512	112	UCEC	PIPERLONGUMINE	Experimental
163.27583336120608	8.24596278343279	209.9314466506116	-6.1576038829669	0.0008	343	52	HNSC	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	Experimental
502.128596364053	1.64657986819068	506.9999139319031	-0.000161428966748645	0.341	934	107	BRCA	IBUPROFEN	Approved in other pathologies
195.16443421012627	-37.1238282360185	185.4485776434739	19.921297422331	0.0006	264	35	SKCM	CHEMBL257341	Experimental
812.3369541011684	-36.4126832014944	731.0877252076888	18.201403846605	0.596	264	115	SKCM	NVP-BGJ398	Clinical trials in cancer
681.875713017019	-40.0569590106929	691.0564835590687	15.4125856208279	0.547	934	225	BRCA	BYL-719	Clinical trials in cancer
723.3380847064277	42.9178672743304	734.4458605806527	10.5970568967375	0.584	543	74	LUAD	GDC-0941	Clinical trials in cancer
199.81680641078546	-30.4981183173071	180.0750907949966	9.40668846641302	0.0006	502	56	KIRC	N-{(3R,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N&#39;-(3-CHLOROBENZYL)ETHANE-1,2-DIAMINE	Experimental
242.8478591200823	-8.86480204284746	176.81671258665097	24.2211794748449	0.0004	512	76	UCEC	TIPIFARNIB-P2	Experimental
315.4927413449169	3.41920859586298	309.0022200403963	0.00225661743388628	0.121	599	107	OV	EDARAVONE	Clinical trials
1110.9932628506965	-6.64538350428302	1090.1918833910595	-3.2818785400944	0.988	543	72	LUAD	TRAMETINIB	Approved in cancer
282.2649400566219	-98.1469725752045	210.2910502750528	39.0264087499036	0.0008	264	179	SKCM	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	Experimental
310.1795454445691	-5.08475763536504	302.36318270135234	-6.36627035237279	0.111	502	53	KIRC	SIRNA-027	Clinical trials
480.5475513883482	3.3870505544038	482.22743397649225	-2.45953988937046	0.311	57	7	PAAD	IBUPROFEN	Approved in other pathologies
645.1637684916403	-2.74663827701571	678.5242790927772	-5.9134320870935	0.533	153	22	BLCA	OBLIMERSEN	Clinical trials in cancer
189.45927564651043	-113.342222430142	155.82949124401836	56.7136096654826	0.0008	264	177	SKCM	CHEBI:83275	Experimental
210.70974594518282	-8.30521893181148	204.73983330338947	-1.95959034407656	0.0008	153	16	BLCA	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	Experimental
332.50381139945597	-10.9689663917253	326.99998159309547	0.000362372588483595	0.141	389	45	LUSC	EDARAVONE	Clinical trials
724.5628926295014	25.0249870097984	722.0775218439674	-11.9786157248421	0.582	543	72	LUAD	RO4987655	Clinical trials in cancer
556.6163155809307	-3.15697158297849	551.94261339199	-3.89799093196547	0.391	512	57	UCEC	CARVEDILOL	Approved in other pathologies
760.7505459298098	40.4474397313201	755.0781245354723	-10.6652605271586	0.596	512	147	UCEC	NVP-BGJ398	Clinical trials in cancer
183.026518987507	-30.7480848957284	187.9146864214695	-10.7271441749663	0.0006	502	56	KIRC	L-HOMOARGININE	Experimental
730.4543546607661	77.0836560457054	706.429880804128	5.44410698997501	0.595	512	142	UCEC	PKI-587	Clinical trials in cancer
99.72900993257102	-56.664367519134	246.20624071382872	69.6610338235887	0.0008	264	185	SKCM	DB06892	Experimental
765.4625486600471	11.2979649635474	733.4563230739199	3.53269305281782	0.581	512	61	UCEC	AVI4126	Clinical trials in cancer
313.084659170399	-8.14907404409374	307.41584056528467	4.18546535212931	0.111	502	53	KIRC	TELBERMIN	Clinical trials
1107.3949693920902	-33.7816271398813	1077.0008542696696	-29.5205752825286	0.984	264	125	SKCM	PACLITAXEL	Approved in cancer
221.32482066096262	0.131407369427762	200.88152301821833	2.48923782507239	0.0006	512	77	UCEC	RU78262	Experimental
250.8527239231846	6.98105623987362	209.07772412242016	4.11292041310071	0.0008	202	24	LAML	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	Experimental
795.7880599081542	-28.3412739174848	708.9449911268041	-17.5956111901269	0.55	435	211	THCA	SELUMETINIB	Clinical trials in cancer
1073.8386665449718	29.2048725156727	1055.9406646258012	-8.60119259177813	0.941	57	25	PAAD	BOSUTINIB	Approved in cancer
313.27507600204507	-2.02448479368243	317.9999624714982	-0.000272204287739441	0.131	934	105	BRCA	EDARAVONE	Clinical trials
213.90893532767691	4.65000017715704	209.61998494609665	-9.3106627339846	0.0004	543	66	LUAD	NSC632839	Experimental
661.1980887718609	88.9338528423873	681.2239366168907	-14.6907760879932	0.536	57	24	PAAD	REFAMETINIB	Clinical trials in cancer
237.60833866721393	39.9765386619433	203.88282670480322	25.0288562311024	0.0008	512	142	UCEC	PI-103	Experimental
222.62411846957767	32.2390042598468	223.90471129630035	8.49579453074801	0.0006	512	77	UCEC	RU79072	Experimental
253.03070321918963	-33.7684065430544	185.6352527102336	-10.7684568161549	0.0006	512	74	UCEC	DB06892	Experimental
472.7770718700787	-2.01609212117307	482.2722120279551	2.4534292281476	0.311	57	7	PAAD	RASAGILINE	Approved in other pathologies
716.93664189667	-83.0822544397536	735.6199545295269	-12.2273832717819	0.596	423	89	COAD	391210-10-9	Clinical trials in cancer
147.59859145904005	16.4367696699758	197.0459972777208	-13.2967028414595	0.0004	512	79	UCEC	ML214	Experimental
229.15947440680506	-33.0030510284112	188.5426692459735	6.50161424787029	0.0008	343	54	HNSC	NVP-BGT226	Experimental
717.8578064983461	-26.7279137674499	740.9444572466447	47.3711745300284	0.585	264	37	SKCM	LINIFANIB	Clinical trials in cancer
180.48402304577996	-15.6856357910058	170.76926344437425	-45.4113351604351	0.0004	264	36	SKCM	ZEBULARINE	Experimental
701.9617805462829	11.3150624289332	711.2518487228789	-25.0305324945139	0.575	264	31	SKCM	VATALANIB	Clinical trials in cancer
216.8525345907527	-36.2205840920362	205.36603871841604	17.3834803209249	0.0006	502	56	KIRC	CACODYLIC ACID	Experimental
176.66217647819664	24.8082748047585	201.9970965076468	1.01151588718881	0.0004	343	44	HNSC	BISTRAMIDE A	Experimental
269.58205890766413	-19.5471562728056	208.18273768931718	51.4720009439291	0.0004	435	183	THCA	P-0850	Experimental
1046.509729398697	10.8378709812385	1037.7582304739212	-2.47744312051395	0.936	502	58	KIRC	CABOZANTINIB	Approved in cancer
723.1632391345668	-66.1659092104124	753.2225865993025	-2.64813635777818	0.585	264	40	SKCM	CEDIRANIB	Clinical trials in cancer
193.56601276925463	-26.8582915382344	198.66678497291716	2.98698465824532	0.0006	502	53	KIRC	AEBSF	Experimental
674.7740113187951	16.2161031466964	682.040302506014	4.38977960578882	0.531	502	57	KIRC	BEVACIZUMAB + TRASTUZUMAB	Clinical trials in cancer
666.13263351918	10.6596543111788	679.89001321793	16.891746641227	0.524	202	32	LAML	391210-10-9	Clinical trials in cancer
241.76669316689512	-57.6516330707151	188.35369182470563	-15.3177596119776	0.0004	934	215	BRCA	BISTRAMIDE A	Experimental
190.4853472709004	39.4621113724659	197.6230149763286	13.9740923229365	0.0006	512	77	UCEC	1-CYCLOBUTYL-3-(3,4-DIMETHOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	Experimental
